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technical developmentS for clinical mr applicationS 
at 7 t
1. Resonance frequency fluctuations are a major cause of image artifacts in 
Alzheimer’s Disease patients at high field (this thesis)
2. Modern RF coils with a high channel count can be used for accurate, real-time 
measurement of resonance frequency fluctuations using a navigator echo 
approach. (this thesis)
3. The increased phase shift between gray and white matter is a promising marker 
to reveal underlying AD pathology. (this thesis)
4. The frequent use of local Tx/Rx coils at 7 Tesla requires a specific RF power 
calibration method. (this thesis)
5. The effect of field strength on clinical diagnosis is difficult to quantify (J. Duyn, 
Neuroimage. 2012 Aug 15;62(2):1241-8)
6. Successful new techniques need to have the ability to provide unique contrast 
without sacrificing routine imaging contrast. (D. Sodickson)
7. A clinical role for tailored 7T cardiac MR applications is at the moment merely a 
vision. (T. Niendorf, Eur Radiol. 2010 Dec;20(12):2806-16)
8. High-field susceptibility-based MRI contrast can be used to reveal the local 
cortical architecture based on iron distribution. (M. Fukunaga, Proc Natl Acad Sci 
U S A. 2010 Feb 23;107(8):3834-9)
9. De ontwikkeling van 7 Tesla MRI is eerder technologie gedreven dan toepassings 
gedreven.
10. Alles is mogelijk. Wat mogelijk is, gebeurt. Alles gebeurt. (H. Mulisch)
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introduction
Since the introduction of magnetic resonance imaging (MRI) in hospitals 
great efforts have been made in enhancing this technique and enabling its 
use in clinical practice. Constant improvements in field strength, gradients, 
coils and pulse-sequences have led to a steady increase in the number of MRI 
exams. To date more than 150 million examinations have been performed 
worldwide. Only recently, the conventional field strength for most exams 
was 1.5 Tesla, and 3 Tesla MRI scanners were used almost exclusively in large 
academic hospitals. Currently, the standard for many applications is shifting 
towards 3 Tesla due to improved image quality and information content. The 
recent introduction of whole body 7 Tesla MRI scanners has created a new 
research field, which requires new technical developments to benefit from 
its potential. At the end of 2012 approximately 35 of these systems were 
in operation, exclusively in research locations and academic hospitals. The 
work presented in this thesis describes a number of technical developments 
to enable the application of 7 Tesla MRI in a clinical (research) setting.
A higher magnetic field strength leads to an increased magnetization of spins, 
which in turn results in higher signal-to-noise ratio (SNR) that can be used for 
more detailed imaging, i.e. higher spatial resolution, shorter scanning times 
or increased (quantitative) information content. In addition, most contrast 
mechanisms are also dependent on field strength, leading to visualization of 
structures not visible at lower field strengths (1–5).
However on the downside, the technical complexity scales with field streng-
th and not all previously developed techniques at lower field strengths can 
be translated easily to 7 Tesla. The increased magnetic field inhomogeneity, 
increased radiofrequency (RF) field (B1) inhomogeneity due to shorter RF 
wavelengths and more easily reached temperature specific absorption rate 
(SAR) limits lead to important hardware and sequence challenges. It is cru-
cial for the clinical acceptance and added value of 7 Tesla MRI to find soluti-
ons for these problems and to define the areas in which 7 Tesla MRI can help 
to improve diagnosis.
Literature shows promising results of early studies performed in patients 
with neurodegenerative diseases. Increased visualization of lesions in pa-
tients with Multiple Sclerosis (MS)  (5, 6), increased sensitivity to the detec-
tion of cerebral microbleeds, common to many neurodegenerative diseases 
(7, 8) and visualization of small lenticulostriate arteries (2, 9, 10) could be ob-
tained with 7 Tesla MRI. Initially imaging outside of the brain was expected to 
benefit less from the higher magnetic field strength, because the dimensions 
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of the human body lead to pronounced B1 inhomogeneities and the large air 
cavities create strong B0 inhomogeneities. However, with appropriate modi-
fication there are areas that could benefit. In imaging of the coronary arter-
ies the increased SNR and improved background suppression due to longer 
longitudinal relaxation values (T1) could allow for a higher spatial resolution 
to be able to assess branching vessels. Initial results have shown the feasi-
bility of cardiac imaging (11, 12). Another technique, which is expected to 
benefit is magnetic resonance spectroscopy (MRS), both in the brain as well 
as in other anatomies. The higher precession frequency results in a greater 
frequency difference (chemical shift) between different metabolites and al-
lows for the quantification of more metabolites with higher accuracy (13, 
14). The quality of an MR spectrum relies strongly on a homogeneous B0 and 
B1 field, which are more difficult to achieve at a 7 Tesla than at lower field 
strengths. Therefore the full potential of MRS can only be obtained with suit-
able modifications.
In this thesis techniques for different anatomies of the human body were de-
veloped: brain, cardiac and leg muscle. This thesis is divided into three parts: 
part one deals with technical solutions for body applications, in particular to 
minimize the influence of increased B1-inhomogeneity. Part two describes 
developments to improve high resolution brain imaging and the last part 
provides clinical applications of 7 Tesla MRI and describes how examinations 
are perceived by healthy subjects. 
The first part, consisting of chapter 2, 3 and 4 is concerned with designing 
appropriate sequences and coils to cope with B1-homogeneity problems. 
The precession frequency of spins (Larmor frequency) is linearly dependent 
on the applied field strength and for proton nuclei at 7 Tesla, the most abun-
dant of MR detectable spins in the human body the resonance frequency is 
approximately 300 MHz. A linear reduction in wavelength is observed with 
increasing Larmor frequency and at 7 Tesla the corresponding wavelength 
in tissue is in the same range as the dimensions of the human body (ap-
proximately 11 cm) leading to B1 inhomogeneities that are non-existent or 
not as severe at 3 Tesla and 1.5 Tesla systems. As a result it is much more 
complicated to design suitable RF coils that have sufficient homogeneity 
over a large region of interest, a typical requirement for most imaging and 
spectroscopy studies. At the time of the introduction of 7 Tesla MRI scanners 
the only commercially available coil was a head coil.  Therefore, in order to 
image other anatomies custom coil design was required. The second chapter 
describes the design of a coil and corresponding sequence modifications to 
enable imaging of the heart. Different coil configurations have been tested 
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to ensure sufficient coverage to image the entire heart, while avoiding tissue 
induced signal voids due to destructive RF field interference. The third chap-
ter uses this coil to visualize the lumen of the right coronary artery in human 
volunteers. The small size of the coronary arteries requires high resolution 
imaging and therefore results in long scanning times. A higher magnetic field 
strength could prove beneficial for faster or more detailed visualization of 
the coronary arteries and the branching vessels in particular. In this chapter 
a comparison is made with 3 Tesla, and improved contrast and vessel sharp-
ness were found at 7 Tesla compared to a similar protocol at 3 Tesla. In the 
fourth chapter a calibration sequence is introduced that measures locally 
the B1-field. Before each MR experiment the system needs to be calibrated 
to establish a relation between the amount of power needed from the RF 
amplifier and the resulting B1-field. This relation varies depending on sub-
ject, imaging location and RF coil. Conventionally a rapid MRI sequence is 
used that measures the average B1-field over a large region. This method 
is valid when the B1 can be considered constant within this region, which 
is the case at lower field strengths and when using a RF body coil for exci-
tation. At 7 Tesla and especially when using local RF coils this no longer the 
case. Therefore, an extension of the conventional calibration was designed 
to specifically measure the B1-field in a small region-of-interest, which better 
represents the true underlying inhomogeneous B1-field.  When this area of 
interest is small enough, such as in preparation of a single voxel MRS expe-
riment the B1-field can be approximated as homogeneous. Using a volume 
selective RF calibration it was possible to correctly estimate the local flip 
angle. Subsequently, MR spectra obtained with these RF settings resulted in 
higher signal-to-noise ratios.
The second part, consisting of chapter 5, 6 and 7 deals with technical deve-
lopments aimed at high resolution brain imaging. One of the most striking 
examples of changed and increased contrast at 7 Tesla is provided by T2
*-
weighted images of the brain. This contrast is generated by a gradient echo 
sequence with a sufficiently long echo time and is sensitive to magnetic field 
inhomogeneities. Because the MR signal is a complex signal, both phase and 
magnitude images are obtained, which contain different information. The 
magnitude images reflect the T2
*-value of the tissue, while the phase images 
are directly related to the underlying magnetic field.  The fifth chapter des-
cribes the application of a T2
*-weighted sequence in AD patients, because it 
was hypothesized that the high sensitivity of this sequence to magnetic field 
inhomogeneities and thus to disease specific changes in tissue iron concen-
tration, would enable the detection of AD-plaques. However, the sequence 
is also sensitive to unwanted static and dynamic magnetic field inhomogen-
14  |
eities caused by e.g. air cavities, respiration and body movements. This pro-
blem is greater at high magnetic field strengths, because the amplitude of 
the inhomogeneities scales linearly with the magnetic field strength. Where-
as static field inhomogeneities result in artifacts close to the field disturban-
ce, dynamic magnetic field fluctuations result in an overall degradation of 
the image quality. To obtain reliable image quality in AD patients a sequence 
modification had to be made to dynamically measure the magnetic field du-
ring image acquisition, termed a navigator echo. Retrospectively this infor-
mation can be used to remove the effect of the unwanted magnetic field 
inhomogeneities from the data to obtain high quality data. The sixth chapter 
introduces an extension of this technique by including a measurement of 
the spatial variation within a slice by using multiple coil elements and the 
corresponding sensitivity profiles, termed sensitivity encoded (SENSE) navi-
gators. The corresponding image quality of corrupted scans was proven to be 
substantially improved using the extended technique. Chapter 7 describes 
the implementation of a very efficient sequence to obtain whole brain high 
resolution T2
*-weighted images using echo planar imaging (EPI). EPI is not 
frequently used for high resolution imaging, mainly due to image distortions 
and signal voids. The sequence described in this chapter limits the amount 
of distortions, while obtaining a significant gain in speed to allow for whole 
brain acquisitions within reasonable scanning times. This is important for 
clinical use and it also reduces the chance that images are corrupted by mo-
tion. 
Finally the third part, consisting of chapter 8, 9 and 10 demonstrates the ap-
plication of 7 Tesla in clinical studies. Chapter 8 describes a study performed 
in patients with AD using a high resolution T2
*-weighted sequence, which 
was corrected for dynamic magnetic field fluctuations (see chapter 5). One 
of the hallmarks of the disease is the deposition of the protein Amyloid-b lo-
cally in the cortex, co-localized with iron. By using the phase of the complex 
MR signal a measure for the susceptibility difference between neighboring 
tissues can be obtained.  This measure is expected to change depending on 
the amount of iron present. The chapter shows that phase measurements 
provide an accurate tool to differentiate AD patients from healthy controls, 
potentially enabling to follow disease progress in an earlier stage. Chapter 9 
provides a review of the current state of clinical studies that have been per-
formed at 7 Tesla in patients with neurodegenerative diseases. At the time of 
writing only a limited number of patient studies have been performed using 
7 Tesla.  Even though the full potential of improved detail and image quality 
compared to lower field strengths still remains to be proven, specific cases 
of 7 Tesla MRI have demonstrated an advantage over lower field strengths. 
 |  15introduCtion
In chapter 10 the results of a short survey that was conducted with the first 
101 healthy volunteers participating in 7 Tesla MRI studies are presented. 
How well a 7 Tesla MRI examination is perceived is of great importance for 
the patient acceptance of 7 Tesla MRI. Although some side effects were men-
tioned, mostly nausea and scanner noise, the large majority of the subjects 
felt comfortable during the examination.
Chapter 11 provides a general discussion of these scientific chapters.
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AbstrAct
Morphological and functional cardiac MRI can potentially benefit greatly 
from the recent advent of commercial high-field (7 Tesla and above) MRI 
systems. However, conventional hardware configurations at lower field 
using a body coil for homogeneous transmission are not available at these 
field strengths. Sophisticated multiple-transmit-channel systems have been 
shown to be able to image the human heart at 7 Tesla (T) but such systems 
are currently not widely available. In this paper, we empirically optimize the 
design of a simple quadrature coil for cardiac imaging at 7 T. The size, geo-
metry, and position have been chosen to produce a B1 field with no tissue-
induced signal voids within the heart. Standard navigator echoes for gating 
were adapted for operation at the heart/lung interface, directly along the 
head-foot direction.  Using this setup, conventional and high resolution cine 
functional imaging have been successfully performed, as has morphological 
imaging of the right coronary artery. 
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The majority of high field MRI studies have focused on the brain, with deve-
lopments such as transmit arrays(1), contrast optimization (2) and RF pulse 
design for increased B1 homogeneity (3) forming a few of the areas of active 
technical research. Musculoskeletal imaging at 7 T has also seen a recent 
surge in activity (4–6). Abdominal imaging is acknowledged to be the most 
challenging area for high field MRI due to the large dimensions of the torso. 
The fact that these dimensions are now significantly greater than the wave-
length of the electromagnetic (EM) radiation in tissue result in sample indu-
ced inhomogeneities in the transmitted and received B1 fields. The complex 
wave behavior can also cause electric field “hot-spots”, resulting in raised 
local heating. Similar effects in the field of electromagnetic hyperthermia 
have been known for many decades, as has the solution of using transmit 
arrays with different magnitudes and phases applied to each element of the 
array (7, 8). In MRI terms, this process has been termed “B1-shimming” (9), 
in which the spatial distributions of the magnetic component of the EM field 
is the major focus of the optimization strategy. 
Only recently has it been shown that whole-body imaging is feasible at 7 
Tesla and above (10). The authors showed results from both an actively de-
tunable TEM resonator combined with multi-channel stripline detector, and 
a full transmit array (10). Specific results have also been shown for the heart 
using this type of RF hardware (11). This approach can be considered as the 
optimum engineering solution, but does require extensive hardware design 
and construction, and a very high level of technical skill to implement succes-
sfully. The purpose of our current study was to determine whether a much 
more simple approach could be used to acquire both morphological and 
functional cardiac images of clinical utility at 7 T. 
In terms of cardiac imaging, the pros and cons of moving from lower to hi-
gher magnetic fields have been discussed previously in (12) and references 
therein, comparing 1.5 T and 3 T: such considerations are also pertinent 
when considering cardiac imaging at 7 T. Briefly, the advantages of higher 
fields include improved tagging due to the prolonged T1 time of the myocar-
dium, improved perfusion imaging both due to the increased signal-to-noise 
(S/N) and the longer myocardial T1 values, and a higher velocity-to-noise ra-
tio in blood velocity measurements. Specific challenges outlined in (12) in-
cluded implementation of high efficiency balanced SSFP sequences without 
off-resonance banding artifacts, the detrimental effects of B1 and B0 inhomo-
geneity on inversion-recovery prepared sequences in particular, and the high 
potential specific absorption ratio (SAR). Although not mentioned, localized 
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MR spectroscopy is also an area that should profit considerably from the hi-
gher field. Based upon these observations, the potential of cardiac imaging 
at 7 T appears very high.
In this paper we show that a simple RF coil configuration can be used to ac-
quire high quality cardiac images at 7 T. The geometry of a quadrature trans-
mit/receive surface coil was optimized to achieve coverage across the entire 
heart, enabling acquisition of functional cine images in both four-chamber 
and two-chamber cross-sections, as well as morphological images of the 
right coronary artery (RCA). 
MaTeRialS and MeThodS
All experiments were performed using a Philips Achieva 7 T whole body sy-
stem. The system has a single proton RF transmit channel, with two quadra-
ture ports available on the RF interface box, through which custom-built coils 
can be connected via simple type-N connectors. The maximum power from 
the RF amplifier is 4 kW, with approximately a 50% loss through ~20 meters 
of cabling between the amplifier and coil interface: the maximum available 
power for each quadrature channel is therefore ~1 kW. All experiments were 
approved by the Commissie Medische Ethiek at the Leiden University Medi-
cal Center.
RF coil geometry. 
In addition to improving the S/N, quadrature coils help to alleviate the B1 
inhomogeneities encountered at high field (13). In this study, the different 
quadrature coil configurations tested included overlapped circular and rect-
angular loops, rectangular loops with central common capacitors (14), and 
loop/butterfly pairs (15): this list is certainly not exhaustive, but represents 
the most commonly used configurations. For a given size, the performance 
of each coil was assessed in terms of B1 homogeneity and S/N. Any coil ar-
rangement that produced a significant dark “banding” within the image was 
discarded, irrespective of the S/N. Empirically, we observed that the opti-
mum arrangement was the loop/butterfly pair. As described by Kumar and 
Bottomley (16), for circular loops the geometry that produces the maximum 
intrinsic S/N (excluding system and conductive losses in the detector) at a 
depth d is given at low frequencies by r0 = d/√5 and  r8=0.6d, where r0 is the 
radius of the single loop, and r8 that of each half of the butterfly coil. The 
distance to the center of the heart from the surface of the chest in a typical 
volunteer was approximately 10 cm: the single loop was placed 2 cm above 
the chest, and the butterfly coil 1 cm above the chest, in accordance with the 
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“liftoff” phenomenon described by Suits et al. (17). These numbers give val-
ues of 10.8 cm for the diameter of the single loop and 13.2 cm for the diam-
eter of each loop of the butterfly coil. Upon testing, it was found that these 
dimensions did not give sufficient penetration for the posterior part of the 
heart to be seen with sufficient S/N, and so the dimensions were increased 
successively until the heart could be fully visualized. The values determined 
empirically were 15 cm diameter for the single loop and 18 cm diameter for 
each loop of the butterfly coil. The RF coils were segmented into conduc-
tor lengths of 6 cm, corresponding to ~λ/16 at 298 MHz, using 3.9 pF non-
magnetic capacitors (ATC, Series B, Huntington Station, NY). Three variable 
capacitors (1-40 pF, Johansson, Camarillo, CA) were used for fine tuning and 
impedance matching in a balanced configuration. A lattice balun was used 
to improve the balance of the coil. Finally, a 1 cm diameter gap, filled with 
foam, was used between the coil and patient to avoid very heavy sample 
losses (17). Figures 1(a), (b) and (c) show schematics and a photograph of the 
coil geometry and placement on the subject. 
Network analyzer measurements were performed on the patient outside the 
magnet and, after fine tuning, the S11 and S22 parameters were both less than 
-20 dB, with the S21 between -18 and -24 dB for all patients studied. The un-
loaded and loaded Q values were measured to be 186 and 18, respectively. 
There is a negligible frequency shift when the coil is placed on the patient 
since the 1 cm spacer reduces the interaction of the strong electric fields 
around each capacitor with the body. 
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Figure 1. Schematic of RF coils
(a) The single loop (gray lines)/butterfly coil (black lines) configuration. Capacitors are de-
noted by the small boxes. The impedance matching networks are shown for each coil. (b) 
Physical placement of the coils on the subject’s chest. The shaded regions represent open-
core foam of thickness 1 cm. (c) Photograph of the coil assembly placed on top of the volun-
teer, and interfaced to the quadrature transmit/receive box of the Philips 7 tesla.
Vector electrocardiogram (vEKG). 
A four-channel commercial vector ECG (VECG) module was used to trigger 
from the R-wave. Despite the well-known magneto-hydraulic effect, EKG’s 
were obtained in the vast majority of cases without the need for electrode 
repositioning, as has also been reported by Snyder et al (11).
Navigator gating. 
Navigator echo gating was used for imaging the RCA using a “pencil-beam” 
navigator. Conventional navigator gating has the pencil beam centered on 
the right hemi diaphragm, at the lung/liver interface in a head/foot direction. 
Since coverage was limited in the head/foot direction using the surface coil 
setup, we adapted the pencil beam to be situated at the heart/lung inter-
face, but maintaining the head/foot direction of the navigator. This approach 
was based on previous experience of coronary artery imaging at 7 T (18), and 
proved to be highly reproducible despite the relatively small surface area 
perpendicular to the navigator beam, as compared to the conventional con-
figuration. 
Cine imaging.
Cine images were acquired using a segmented gradient echo sequence with 
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RF spoiling and crusher gradients to eliminate transverse magnetization. A 
TURBOFLASH gradient echo sequence was used for prescribing the short axis 
views planes for cine imaging. Multislice cine scans were acquired in multiple 
breath-holds (acquiring one or two slices per breath-hold).with the following 
parameters: TR / TE =4 ms / 2.4 ms, tip angle=20°, voxel size = 1.3 x 1.4 x 8 
mm3, 12-14 slices. VECG triggering was used retrospectively to reconstruct 
33 heart phases. High resolution cine images were acquired for a single slice 
in a breath hold of ~20 s with the following parameters: TR / TE = 5.4 / 3.4 
ms, tip angle = 20°, voxel size = 0.65 x 0.7 x  8 mm3.
Coronary artery imaging. 
The procedure for acquisition of the coronary artery geometry is described 
in detail elsewhere (18). To summarize, the basic steps are to acquire scout 
scans for the visual identification of the time period (Td) of minimal coronary 
motion. The scan plane is then localized parallel to the right coronary artery 
(RCA). Free-breathing 3D coronary MRA (segmented k-space gradient-echo 
imaging, TR=4 ms, TE=1.5 ms, RF excitation angle=15°, field-of-view=320x291 
mm2, scan matrix=392x373, 15 slices, slice thickness=2 mm, acquisition win-
dow ~ 100 ms , scan time ~ 5 min) was performed using prospective navigator 
gating with the 2D selective navigator localized at the heart-lung interface. 
Image data were collected in mid-diastole at the predetermined time Td. An 
adiabatic spectrally selective inversion recovery module with inversion time 
(TI) = 305ms was used for fat suppression to enhance the endogenous con-
trast between the coronary blood-pool and epicardial fat.  
Estimation of B1
+ for SAR calculations. 
The B1
+ field was estimated using an interleaved dual repetition FLASH se-
quence which allows a direct calculation of the tip angle distribution (19). 
The following parameters were used: TR1 / TR2 / TE = 15 / 75 / 1.0 ms, tip an-
gle = 40°, voxel size = 2.3 x 4.6 x 15 mm3, 15 signal averages, total scan dura-
tion was 3 minutes. Images were acquired in the transverse plane for measu-
rements at the chest surface and also at the center of the heart. Fifteen 
signal averages were acquired to reduce the effects of heart motion on the 
estimated B1
+ map. It should be noted that the results obtained are only esti-
mations, and are not absolutely quantitative due to the fact that, for practi-
cal purposes of scanning time, the maps were acquired in 2D rather than 3D 
scans (20). Because of the thick slice and the number of averages the effect 
that respiratory and cardiac motion have on the steady state magnetization 
is expected to be minimal.
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results
Coil performance.
Figure 2 shows images acquired with three different RF coil configurations 
using a low flip angle, low resolution TURBOFLASH sequence to assess the B1 
profile of each configuration. Figure 2a uses a single loop coil, and displays 
minor non-uniformity in the image, as predicted by a number of previous 
studies. Figure 2b shows the results of using the loop/butterfly combina-
tion driven in quadrature, with not only the expected increase in penetration 
depth, but also an improvement in the B1 uniformity. The improvement in B1 
may also be indirectly appreciated considering the increased CNR between 
the septal wall and the two ventricles, the improved B1 results to a higher 
effective flip angle. It should be noted that the symmetric sensitivity profile 
of the quadrature coil arises from the combination of two asymmetric fields, 
the B1
+ transmit field and the B1
- receive field, as described previously by 
Wang et al.(21).  Figure 2c is illustrative, in the sense that the two coils are 
driven in an anti-quadrature configuration, and gives a good indication of 
areas in which the B1 fields of the two coils are orthogonal. 
Cine-scans. 
Individual frames of a cine-sequence at a “conventional” spatial resolution 
of 1.3 x 1.4 x 8 mm3 are shown in Figures 3 and 4 for the short-axis and four-
chamber configurations, respectively. There is excellent blood/myocardium 
contrast and no areas of B1 inhomogeneity beyond those which are associ-
ated with the intrinsic drop-off of B1 amplitude from a surface coil. The SNR 
of the myocardium was measured to be between 10 and 25:1depending on 
the particular area of the myocardium, the SNR of the left ventricle was bet-
ween 20 and 40:1. In order to take advantage of the high sensitivity of the 7 
T, a high resolution cine scan was run on one volunteer. Images with a spatial 
resolution of 0.65 x 0.7 x 8 mm3 are shown in Figure 5. Although the SNR is 
obviously reduced compared to the images in Figures 3 and 4, there is much 
finer definition of the cardiac muscles. 
Coronary artery imaging. 
Figure 6 shows successive slices in which the right coronary artery can be 
easily visualized, together with an expanded view for clarity. There is good 
contrast between the artery and the surrounding tissue, allowing clear de-
lineation of the artery walls. In all high field human studies, an important 
issue is the specific absorption rate (SAR), both in terms of local and average 
values. 
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Figure 2.  Scout images of different coil configurations
Coronal (left) and axial (right) low-resolution scout images acquired using different coil con-
figurations. (a) Single loop coil, (b) loop/butterfly pair in quadrature configuration, (c) loop/
butterfly pair in an anti-quadrature configuration. SAR estimation. 
Despite some initial promising studies using direct MRI temperature measu-
rements in vivo, it remains extremely challenging to measure SAR directly, 
and so most estimations are based on computer simulations. Since blood 
perfusion is not included in the majority of simulations, one must also re-
cognize that such simulations represent “worst-case” scenarios in terms of 
causing actual tissue heating.  We have based our SAR estimations on pre-
vious work by Collins and Smith (22), who specifically modeled the SAR for 
a surface coil adjacent to an anatomically-correct human body model. The 
regions of highest SAR were found to be at the right medial portion of the 
pectoral muscle near the superior end of the sternum: the SAR in the heart 
itself is extremely low. The authors provide appropriate scaling factors for 
setups different than the particular one which they studied. 
Figure 3. Images from a short-axis cine sequence. 
Images are acquired over eight breath-holds with times corresponding to 25 ms intervals. 
Shown is every fourth image acquired at times 0, 99, 198 and 297 ms after the R-wave.
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Figure 4. Images from a four-chamber cine sequence. 
Images are acquired over eight breath-holds with times corresponding to 27 ms intervals. 
Every fourth images is shown above at times 108, 216, 324 and 432 ms after the R-wave. 
Data acquisition parameters are described in the main text. The right coronary artery can 
also be seen (small arrow) perpendicular to the slice dimension.
The initial step was to estimate the B1
+ using the same power level as for all 
the cine sequences. Using the technique outlined previously our estimated 
B1
+ at the center of the heart was 1.4 µT (using a 0.6 ms duration half sinc-
gauss excitation pulse) and at the surface of the chest was 4.9 µT, compared 
to values of 1.875 µT and 20 µT from a 3 ms rectangular pulse used in the 
Collins paper (22).  The difference in the ratios of the two values can be at 
least in part explained by the larger surface coil chosen for the simulations (a 
22.9 cm diameter linear surface coil with four-port drive). The results from 
the Collins and Smith paper were interpolated to values at 298.1 MHz since 
frequencies of 64, 125, 175, 260 and 345 MHz were used in the original sim-
ulations. Using the fact that the SAR is proportional to the time integral of 
the magnitude of the square of the B1
+ field, we can arrive at approximate 
SAR values. The SAR in the heart is, as derived from the relative B1
+ values, 
negligible compared to that at the chest surface. As noted by Collins and 
Smith, the local SAR is the limiting factor, since the average SAR is up to two 
orders of magnitude less. The estimated value of local SAR at the chest sur-
face is ~0.2 W/kg per 1 g of tissue, which is more than a factor-of-four below 
those of the Food and Drug Administration (FDA) and International Electro-
technical Commission (IEC). 
Figure 5. Images from a high resolution short-axis cine sequence.
Every fourth frame from a high-resolution cine sequence showing excellent delineation of 
the papillary muscles in the myocardium. Images were acquired every 35 ms.
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Figure 6. Right coronary artery.
Two successive slices through a volunteer showing the right coronary artery.(top). Expan-
sion of the images showing more clearly the delineation of the artery (bottom).
conclusions
Although the optimum RF engineering configuration for high field body ima-
ging will ultimately consist of separate multi-channel transmit and receive 
arrays, this setup is not widely available at the current time, and there is a 
sentiment that it is not possible to perform useful body imaging at 7 tesla 
and above without such technology. The results shown here illustrate that a 
well-designed simple coil setup is capable of obtaining both cine-cardiac se-
quences for functional applications, as well as structural information related 
to, for example, dimensions of the coronary artery. 
A number of challenges remain to be addressed. For example, the use of 
high efficiency balanced imaging sequences is routine at 1.5 tesla, but has 
proved challenging to implement at 3 tesla (12) and is likely to require so-
phisticated higher order shimming to be even feasible at 7 tesla. The lack 
of a body-coil for uniform excitation also makes many standard preparation 
modules for imaging sequences difficult: for example, black-blood imaging 
or quantitative velocity measurements. One of the most promising applica-
tions for very high field cardiac MR is localized cardiac spectroscopy (both 
homonuclear and heteronuclear), which has the advantage of significantly 
enhanced spectral resolution, but again has a number of significant challen-
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ges in order to obtain high quality spectra. The aim of this current paper is 
to show that, even with relatively simple RF coil design, both functional and 
structural information can be obtained, and that many groups can now apply 
their expertise acquired at lower fields to the challenges of cardiac MR at7 
tesla and above. 
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AbstrAct
Purpose:
To objectively compare quantitative parameters related to image quality at-
tained at coronary magnetic resonance (MR) angiography of the right coro-
nary artery (RCA) performed at 7 Tesla (T) and 3 T.
Materials and Methods:
Institutional review board approval was obtained, and volunteers provided 
signed informed consent. Ten healthy adult volunteers (mean age ± standard 
deviation, 25 years ± 4; seven men, three women) underwent navigator-ga-
ted three-dimensional MR angiography of the RCA at 7 T and 3 T. For 7 T, 
a custom-built quadrature radiofrequency transmit-receive surface coil was 
used. At 3 T, a commercial body radiofrequency transmit coil and a cardiac 
coil array for signal reception were used. Segmented k-space gradient-echo 
imaging with spectrally selective adiabatic fat suppression was performed, 
and imaging parameters were similar at both field strengths. Contrast-to-
noise ratio between blood and epicardial fat; signal-to-noise ratio of the 
blood pool; RCA vessel sharpness, diameter, and length; and navigator ef-
ficiency were quantified at both field strengths and compared by using a 
Mann-Whitney U test.
Results:
The contrast-to-noise ratio between blood and epicardial fat was significant-
ly improved at 7 T when compared with that at 3 T (87 ± 34 versus 52 ± 13; 
P = .01). Signal-to-noise ratio of the blood pool was increased at 7 T (109 ± 
47 versus 67 ± 19; P = .02). Vessel sharpness obtained at 7 T was also higher 
(58% ± 9 versus 50% ± 5; P = .04). At the same time, RCA vessel diameter and 
length and navigator efficiency showed no significant field strength depen-
dent difference.
Conclusion:
In our quantitative and qualitative study comparing in vivo human imaging 
of the RCA at 7 T and 3 T in young healthy volunteers, parameters related to 
image quality attained at 7 T equal or surpass those from 3 T.
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introduction
Currently, relatively few (approximately 40) 7 T magnetic resonance (MR) 
imaging systems are available for human use, and most of them are situa-
ted in research centers. High-field-strength cardiac MR imaging initially was 
thought to be problematic due to magnetic field inhomogeneity and spe-
cific absorption rate constraints. Furthermore, contemporary commercial 7 
T units are not routinely equipped with body radiofrequency (RF) transmit 
coils or surface RF receive coils. Despite these major challenges, a number of 
research groups already have demonstrated the feasibility of cardiac imaging 
at 7 T and beyond (1–5). Initial attempts focusing on coronary artery imaging 
at 7 T showed that these barriers can be removed successfully, and initial in 
vivo human images were promising (6). Although these early 7 T studies were 
conducted by using single-channel RF transmit-receive coil architecture, re-
cent advances in surface coil technology seem particularly promising. Howe-
ver, although an improvement in image quality may be expected at higher 
magnetic field strength (7), there have been no reports, to our knowledge, 
on cardiac MR imaging studies in which investigators directly and objectively 
compare parameters related to image quality at 7 T with those obtained at 
lower field strength. Therefore, the purpose of our study was to objectively 
compare quantitative parameters related to image quality attained at coro-
nary MR angiography of the right coronary artery (RCA) performed at 7 T 
and 3 T.
MaTeRialS and MeThodS
Our study was approved by our institutional review board, and all volunteers 
provided signed informed consent. Three-dimensional (3D) MR angiography 
of the right coronary system was performed in 10 healthy young adult vo-
lunteers (mean age ± standard deviation, 25 years ± 4; seven men, three 
women) who underwent imaging at 7 T and 3 T (Achieva; Philips Healthcare, 
Best, the Netherlands) in a prospective study design. For practical reasons, 
7 T imaging always occurred before 3 T imaging. Coronary MR Angiography 
was performed with prospective navigator technology and vector electrocar-
diographic (ECG) triggering (8). All volunteers underwent imaging in a head-
first, supine position. None of the volunteers received nitroglycerin before 
MR imaging. The mean interval between the two examinations was 8 weeks 
± 5.
Imaging at 7 T
A quadrature transmit-receive surface coil consisting of two overlapping 
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loops (13-cm diameter each) was constructed in-house (Fig 1). The coil size 
is larger than described previously (4, 6) to improve volumetric coverage. 
First, non–ECG-triggered scout images in coronal, transverse, and sagittal 
orientations were acquired to plan subsequent images and to localize the 
two-dimensional selective navigator. At 7 T, the navigator was placed at the 
lung-heart interface because of the limited sensitive volume of the surface 
coil. Second, ECG-triggered, breath-hold multisection transverse cine scout 
imaging was performed for both the determination of the period of minimal 
coronary motion (trigger delay) and the volume targeting of the 3D stack 
in parallel with the middiastolic RCA. Finally, volume-targeted coronary MR 
angiography was performed by using a 3D segmented k-space gradient-echo 
imaging technique (parameters are in Table 1) combined with a spectrally 
selective adiabatic inversion-recovery pulse (inversion time, 200 msec) for 
fat saturation. First-order local volume shimming at the anatomic level of the 
RCA was performed in all cases.
Figure 1:RF coil
Custom-built quadrature RF transmit-receive surface coil consisting of two 13-cm elements 
used for our study at 7 T.
Imaging at 3 T
On the 3 T system, the body coil was used for RF transmission, with a commer-
cial six-element cardiac coil array for signal reception. Scout imaging inclu-
ded free-breathing, retrospectively ECG-gated, two-dimensional cine balan-
ced fast gradient-echo imaging in a horizontal long-axis view (four-chamber) 
to determine the trigger delay. Furthermore, ECG-triggered free-breathing 
navigator-gated and corrected 3D gradient-echo whole-heart imaging was 
performed for the anatomic localization of the RCA. After scout imaging, two 
coronary imaging sequences were performed at 3 T with different naviga-
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tor localization in random order: (a) with navigator localization at the lung-
heart interface (navigator at heart) and (b) with navigator localization at the 
lung-liver interface (navigator at liver). Both 3 T coronary imaging sequences 
consisted of a 3D segmented k-space gradient-echo technique with spec-
trally selective adiabatic inversion recovery (inversion time, 150 msec) for fat 
saturation. The coronary MR angiography imaging parameters were similar 
(Table 1) at both field strengths to support a fair quantitative comparison.
Table 1: Imaging Parameters at 7 T and 3 T Coronary MR Angiography
Field strength 7 Tesla 3 Tesla 3 Tesla






















Fat suppression Adiabatic SPIR Adiabatic SPIR Adiabatic SPIR
TR (ms) 4.3 4.3 4.3
TE (ms) 1.38 1.38 1.38







Number of slices 30 30 30
Field of view 
(mm²)
420x268 420x269 420x269
Matrix 512x312 512x312 512x312





Images were processed and analyzed by using the Soap-Bubble tool (9). 
Both a visual qualitative description and a direct quantitative comparison 
between 7 T and 3 T images were performed. All data analyses were perfor-
med by one physician (S.G.C.v.E., with 4 years of experience in cardiac MR 
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imaging) with the supervision of a senior researcher (M.S., with 18 years of 
experience in cardiac MR imaging).
The following parameters were measured: contrast-to-noise ratio (CNR) bet-
ween the blood pool and the epicardial fat, signal-to-noise ratio (SNR) of the 
blood pool, RCA vessel sharpness and diameter of the first 4 cm, and visible 
vessel length. The CNR was defined as the difference in signal intensity bet-
ween a manually placed region of interest (ROI) in the aortic root (mean ROI 
area, 1.80 cm2 ± 0.60) near the offshoot of the RCA, and that of an ROI placed 
in the epicardial fat adjacent to the proximal RCA (mean ROI area, 0.90 cm2 
± 0.61), divided by the standard deviation of the background signal from an 
ROI positioned anterior to the chest wall (noise; mean ROI area, 9.95 cm2 ± 
3.98). The SNR was calculated for the blood signal intensity in the described 
ROI localized in the aortic root. The average signal intensity from this ROI was 
divided by the noise. Vessel sharpness was measured by using signal inten-
sity gradients perpendicular to the 3D course of the RCA and was calculated 
for the proximal 4 cm of the RCA (9). The RCA vessel length was measured 
manually, and both vessel sharpness and diameter for the proximal 4 cm of 
the RCA were calculated automatically by the software.
Statistical Analysis
Data are presented as mean ± standard deviation. Comparisons were made 
between the results obtained at 7 T and 3 T and between the results ob-
tained with the different navigator positions at 3 T. For comparisons, a non-
parametric Mann-Whitney U test was used. P < .05 was considered to indi-
cate a statistically significant difference.
results
Coronary MR angiography was performed successfully in all volunteers at 
both field strengths. At 7 T, one study volunteer complained about vertigo 
while the table was moving. All quantitative findings are listed in Table 2. 
Total time in the magnet was on average 30 minutes at 7 T and 20 minutes 
at 3 T.
Figures 2–4 illustrate example coronary MR angiography reformations ob-
tained at 7 T and at 3 T. All images show high signal intensity of the coronary 
artery lumen, while that of the surrounding epicardial fat is suppressed. At 7 
T, suppression of the epicardial fat appears visually improved when compa-
red with that at 3 T (Fig 2). Consistent with these findings, quantitative CNR 
between the blood pool and epicardial fat was significantly improved at 7 T 
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(7 T versus 3 T navigator at heart, P = .013; 7 T versus 3 T navigator at liver, 
P = .009). 










CNR 87.5 ± 33.9* 51.7 ± 12.7 47.8 ± 15.2
SNR blood pool 109.2 ± 46.9* 66.9 ± 19.4 67.2 ± 24.9
RCA vessel sharpness 
(%)
58.3 ± 8.9* 49.7 ± 5.1 48.9 ± 7.5
RCA vessel length (cm) 7.24 ± 2.34 8.21 ± 2.19 7.99 ± 2.73
RCA diameter, first 4 cm 
(mm)
2.97 ± 0.27 3.07 ± 0.38 3.07 ± 0.37
Navigator efficiency (%) 54 ± 20 53 ± 20 46 ± 14
Acquisition time (sec) 469 ± 225 410 ± 180 470 ± 191
Heart rate (beats / min) 70 ± 15 67 ± 10 69 ± 10
* significantly different from 3 T (p<0.05). CNR: contrast-to-noise ratio between proximal 
coronary blood pool and surrounding perivascular tissue; RCA: right coronary artery; SNR: 
signal-to-noise ratio 
Visually, the contrast between the myocardium and the blood pool in the 
left ventricle is rather shallow at 7 T as shown in Figures 3 and  and4.4. When 
compared with that at 3 T, the SNR of the blood pool measured on the 7 T 
images was 60% higher (7 T versus 3 T navigator at heart, P = .023; 7 T ver-
sus 3 T navigator at liver, P = .027). Improved delineation of the RCA at 7 T is 
visible in Figure 3, with good depiction of RCA branches and distal segments. 
Consistent with these findings, objective vessel sharpness analysis demon-
strated improved quantitative vessel conspicuity at 7 T (versus 3 T navigator 
at heart, P = .038; versus 3 T navigator at liver; P = .031). Even though cons-
traints related to the B1 field and coil sensitivity adversely affected the signal 
more distant to the surface transmit-receive coil at 7 T (Figs 2–4), there was 
no significant difference in vessel length (7 T versus 3 T navigator at heart, 
P = .233; 7 T versus 3 T navigator at liver, P = .414) or vessel diameter (7 T 
versus 3 T navigator at heart, P = .653; 7 T versus 3 T navigator at liver, P = 
.567) measurements among the images from the different field strengths. 
Navigator efficiency (7 T versus 3 T navigator at heart, P = .970; 7 T versus 3 
T navigator at liver, P = .272) and total data acquisition time (7 T versus 3 T 
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navigator at heart, P = .520; 7 T versus 3 T navigator at liver, P = .821) also 
were not field strength dependent. No significant difference in CNR between 
the blood pool and epicardial fat, SNR of the blood pool, RCA vessel sharp-
ness, vessel length, vessel diameter, navigator efficiency, or acquisition time 
was found between the 3 T images acquired with the different navigator 
localizations.
Figure 2: Coronary MR angiograms of the RCA.
Obtained at (a) 7 T and (b) 3 T in the same healthy 18-year-old man (double oblique volume 
targeted plane parallel to the RCA). Improved suppression of the epicardial fat (long dotted 
arrow) with high contrast between the blood and epicardial fat is visible at 7 T. At both fi eld 
strengths, a number of small branching vessels are depicted (short dashed arrows). Also at 
7 T, a long portion of the RCA is visible (solid arrow = distal part of RCA). Ao = aortic root, LV 
= left ventricle, RV = right ventricle, TW = thoracic wall.
discussion
In our study comparing 7 T and 3 T RCA coronary MR angiography in young 
healthy volunteers, we found improved CNR between the blood pool and the 
epicardial fat, enhanced SNR of the blood pool, and increased vessel sharp-
ness at 7 T. These findings may have implications, since vessel conspicuity 
and well-defined borders of the coronary arteries support improved identifi-
cation of significant coronary artery stenoses.
The results of a multicenter study indicate that multidetector computed to-
mography (CT) is highly promising and superior to MR angiography for the 
noninvasive evaluation of significant proximal coronary stenoses (10). Howe-
ver, the most recent data from a coronary MR angiography multicenter trial 
(11) demonstrate substantial progress, and further improvement in SNR di-
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agnostic quality approaching that of CT angiography may be expected soon; 
therefore, the development of new MR imaging methodology at higher mag-
netic field strength is of particular interest.
Figure 3: Coronary MR angiograms of the RCA.
Double oblique volume targeted plane parallel to the RCA) in a healthy 26-year-old man 
display a high visual vessel defi nition (dotted arrows) in (a) the 7 T image compared with 
that at (b) 3 T. At 7 T, contrast is limited between the myocardium ( . ) and the blood pool ( .. 
). Multiple RCA side branches (dashed arrows) and distal parts of the RCA (solid arrow) are 
depicted clearly at both fi eld strengths.
Approximately a twofold increase in SNR is predicted at 7 T when compared 
with 3 T (7, 12), whereas a 60% SNR improvement was found in our study, 
which may be explained with the prolonged T1 at 7 T and the depth pene-
tration of the RF transmit-receive coil, which was clearly inferior to that at 3 
T. However, a significant 60% increase in SNR with a simple coil design is en-
couraging and emphasizes the need for further developments in coil techno-
logy. Recent advances in RF transmit arrays (2, 3) are a step in this direction. 
Findings from previous studies in which investigators compared 1.5 T and 3 
T coronary MR angiography (13–15) clearly demonstrated that the expected 
100% improvement in SNR could not be obtained. At 7 T, the lack of com-
mercially available RF coils and the only recent availability of 7 T for whole-
body human use constitute additional 7 T–specific limitations. Despite these 
limitations, the reported 60% improvement in SNR, when going from 3 T to 7 
T, is consistent with that reported for direct 1.5 T versus 3 T.
Our findings of increased vessel sharpness at 7 T suggest that motion sup-
pression works effectively at 7 T, since vessel sharpness depends on the per-
formance of ECG triggering and the respiratory navigator. Two similar ima-
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ging sequences with different navigator localizations were performed at 3 
T to exclude the influence of navigator localization on the quantitative pa-
rameters related to image quality. Consistent with earlier findings (16), no 
navigator-dependent quantitative differences were observed.
Figure 4: Sinoatrial nodal artery (SN) and a proximal branch of the RCA.
Image obtained in a double oblique volume targeted plane parallel to the RCA in a healthy 
28-year-old man. (a) At 7 T, there is not much difference in signal intensity between the 
blood pool ( . ) and the myocardium ( .. ). (b) At 3 T, this contrast is slightly improved. On b 
, the great cardiac vein (GCV ) can be identifi ed easily, but this structure is less visible on a 
, likely because of shortened T2* at 7 T, as well as limited surface coil RF penetration. Ao = 
aortic root, dashed arrow = RCA side branch.
The results from the RCA vessel length and diameter measurements were 
similar for both field strengths. This finding suggests that coverage and RF 
penetration of the surface coil at 7 T may not be limiting factors for visuali-
zation of the RCA.
The situation for the left coronary system is different. On the one hand, the 
penetration depth of the current transmit-receive coil is limited, so parts of 
the left coronary system may not be visualized easily. On the other hand, 
an enhancement of the contrast between myocardium and the blood pool 
is mandatory for visualizing the left coronary system. At 3 T, such contrast 
enhancement has been obtained with adiabatic T2 preparation (17) or with 
the combination of extracellular contrast agents and inversion recovery (18). 
However, at 7 T, specific absorption rate constraints preclude the use of the 
T2 preparation, and alternative 7 T–specific solutions with or without con-
trast agents remain to be explored. Finally, although a 60% increase in SNR 
was obtained at 7 T, we have not used this gain for increased spatial resolu-
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tion. However, the objective of our work was a direct, quantitative, objective 
comparison with 3 T.
In conclusion, although substantial challenges are associated with 7 T car-
diac MR imaging, a number of them have been addressed successfully. In 
our study directly comparing in vivo human imaging of the RCA at 7 T and 
3 T in young healthy volunteers, quantitative parameters related to image 
quality attained at 7 T equal or surpass those from 3 T. Our results clearly 
warrant further evaluation in patients with coronary artery disease to assess 
the potential of our 7 T approach for the visualization of luminal RCA disease. 
Future work will concentrate on refinements in coil technology and contrast 
generation to support concomitant imaging of the left coronary system.
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AbstrAct
Large variations of tip angle within a slice can lead to suboptimal pulse po-
wer optimization using standard techniques, which measure the average tip 
angle over a slice: this effect is especially pronounced at fields of 7 T and 
above. A technique is introduced that performs a volume-selective power 
optimization in less than 10 seconds, and automatically calibrates the radio-
frequency (RF) pulses for subsequent spectroscopy scans. Using this tech-
nique, MR spectra were acquired in the human calf of seven healthy vo-
lunteers with a partial volume Tx / Rx coil. Increases in signal-to-noise-ratio 
(SNR) based upon the unsuppressed water signal between 22 ± 5% and 166 
± 42%, compared to spectra obtained with the conventional power calibra-
tion technique, were measured in different regions of the calf muscle. This 
new technique was able to measure the inhomogeneous RF field at 7 T and 
resulted in a considerable SNR increase.
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introduction
Human MRI at high magnetic fields, i.e., 7T and above, has to overcome a 
large variation in the strength of the radiofrequency field (B1) over the ima-
ging volume. The primary, intrinsic reason is that the wavelength of the cor-
responding radiofrequency (RF) excitation and reception is less than, or com-
parable to, the dimensions of the body. The second, more practical reason 
is that the lack of a body coil, particularly on commercial systems, leads to 
a more frequent use of local Tx / Rx surface coils than at lower field. Both of 
these factors result in accurate tip angle calibration techniques being very 
important for obtaining the optimal SNR. Conventional methods used com-
monly at lower field strengths, which measure the tip angle averaged over a 
slice or over the complete sensitive volume of the coil (1, 2) lead to subopti-
mal results at high field, as outlined by a recent article on 7 T cardiac imaging 
(3).
Many different approaches have been proposed for B1 mapping, including 
those based on repeated measurements with different tip angles (4–6), dif-
ferent repetition times (7), measuring the ratio between the signal intensity 
from spin echoes and stimulated echoes (1, 2, 8, 9), and detecting tip angle 
related phase changes (10). These methods can be divided in two categories: 
first, those that use gradients to encode the entire volume and calculate the 
tip angle on a pixel-by-pixel basis (4–10), and second, those that measure the 
tip angle over a large volume using non-selective, or slice-selective RF pulses 
(1, 2). Methods in the first category tend to be lengthy procedures and are 
therefore not suitable for use as a calibration sequence in a clinical setting. 
Methods in the second category are fast but lead to inaccurate results when 
the B1 distribution is very inhomogeneous.
In this work, a simple technique is introduced that measures the tip angle 
in a small volume of interest (VOI) using four slice-selective RF pulses. 
The method, which we have called volume-selective power optimization 
(POvolume), measures the ratio of the signal from two stimulated echoes (STE) 
to calculate the average tip angle in the VOI. The optimal value is found by 
an iterative approach, and this value is used to automatically calibrate the 
RF amplifier. Since only a small volume is measured, the technique is very 
fast (2s per iteration). Experiments such as single voxel spectroscopy are 
expected to benefit most because of the high sensitivity of the signal intensity 
to suboptimal power settings of the three RF pulses used for localization. 
In this study, we compared the SNR of localized MR spectra in the calf ac-
quired with this new technique with a conventional three pulse calibration 
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technique (POslice), the standard on most commercial MR systems that aver-
ages the measured tip angle over a slice through the center of the VOI (2).
MeThodS
All experiments were performed on a commercial 7 T Philips Achieva MRI 
scanner (Philips Healthcare, Best, The Netherlands). A quadrature half-vol-
ume Tx/Rx coil was constructed for the human calf. Two square loops of 
dimensions 10 cm were constructed from copper tape (1 cm wide, 25 µm 
thick), which was fixed to a flexible Teflon former (2 mm thickness). The 
loops were capacitively split into sections ~5 cm in length, corresponding to 
1/20th of the RF wavelength at 7 T. The two loops were overlapped by ~10% 
to minimize mutual inductance. Balanced impedance matching using vari-
able capacitors and a lattice balun were used for each excitation port, which 
were fed from the quadrature outputs of the Philips transmit/receive inter-
face box. The entire coil assembly was mounted on a rigid semi-cylindrical 
plexiglass former (thickness 5 mm, inner diameter 15 cm). A layer of foam, 
~1 cm thick, was placed inside the cylinder, and the subject’s lower leg lay on 
top of this foam layer. 
Subjects
Seven volunteers (6 males, 1 female, age 37 ± 9 years) were scanned and 
localized spectra were obtained at multiple locations with respect to the coil. 
In addition, a B1 map was obtained from one volunteer to show the RF ho-
mogeneity of the coil. Informed consent was obtained from all subjects in 
accordance with guidelines of the local medical ethics committee.
Calibration sequence 
The power of the RF amplifier was calibrated by measuring the tip angle in 
a VOI using the ratio of the signal intensities from two stimulated echoes 
for the four-pulse sequence shown in Figure 1. A three-dimensional volume 
was selected using four slice-selective RF pulses. The first three pulses were 
applied with the gradients in orthogonal directions, with the fourth RF pulse 
applied simultaneously with the gradient in the same direction as during the 
third RF pulse. The resulting stimulated echo signals were acquired. All other 
free induction decay and echo pathways were carefully spoiled using crusher 
gradients. 
The ratio of the two STE signals, ISTE2 and ISTE1, is given by (11):
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  [1]
where αi denotes the RF pulse angle for the different pulses, and τi denotes 
the time at which each RF pulse is applied. When α2 equals α3 Eq. [1] reduces 
to:
  [2]
The value of τ3 is chosen such that τ3 << T1 (12). Therefore the tip angle can be 
accurately estimated for the selected volume using the following equation:
 [3]
For the pulse sequence in Figure 1, the maximum signal intensity for the STE2 
signal occurs when the tip angle for α0 and α1 is 90°, and 45° for α2 and α3. 
The volume for the POvolume was identical to the VOI of the spectroscopy ex-
periment that followed the calibration sequence. The following parameters 
were used: repetition time (TR) / TESTE1 / TESTE2 = 2000 ms / 31 ms/ 51 ms. The 
tip angle in the VOI was calculated online and was used for the next iteration 
to set the RF amplifier. When the measured tip angle deviated more than 3 
degrees from the requested tip angle a new iteration was performed with 
updated settings based on the last iteration: a maximum of 5 iterations was 
used to reach the desired tip angle. Regions with low signal can lead to an 
invalid signal ratio (ISTE2 / ISTE2 > 1) due to noise influences. These values were 
not accepted and the sequence was performed again with higher RF ampli-
fier power settings; in this way each region produced results consistent with 
equation [3]. 
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Figure 1: Sequence diagram of the volume selective RF calibration technique. 
A volume is selected using four RF pulses and gradients. Targeted angles for maximum signal 
intensity of STE2 are α0 = α1 = 90° and α2 = α3 = 45°. Two stimulated echoes are acquired (STE1 
and STE2) at times 2τ1+τ2 and 2τ1+τ3 respectively, while the spin-echo and free induction 
decay pathways are spoiled using crusher gradients on all three axes. The intervals between 
the RF pulses are: τ1 = 8 ms, τ2 = 15 ms and τ3 = 19.5 ms.
The sequence was performed twice, both before and after shimming and 
determination of the water resonance frequency (f0). Both shimming and f0 
determination were performed using adiabatic pulses, which are relatively 
insensitive to variations in RF power. Image based shimming (13) as provi-
ded by the manufacturer was used for regions where conventional shimming 
failed.
The conventional slice-selective calibration method was measured with the 
slice oriented along the slice selection direction of the VOI, which was, de-
pending on the exact orientation of the voxel, approximately perpendicular 
to the coil. 
Localized spectroscopy
The new calibration technique was evaluated in several stimulated echo ac-
quisition mode (STEAM) MR spectra of the calf muscle. The following scan 
parameters were used: 10x10x10 mm3 voxel, TR = 2000 ms, mixing time (TM) 
= 25 ms, echo time (TE) = 25 ms, 64 averages. The total scan duration inclu-
ding optimization of the water suppression was approximately 4 minutes, a 
clinically acceptable timeframe for patient studies. The coil was placed on 
the posterior side of the leg and positioned approximately at the location of 
the largest circumference of the calf. MR spectra were obtained at different 
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locations in the calf muscles, one set using the standard power calibration 
sequence over the entire slice, and the other set with the new four-pulse vo-
lume-selective calibration technique. In addition, for both scans a non-water 
suppressed scan with the same settings as the water suppressed scan was 
acquired to measure SNR using eight averages. The VOIs for the spectrosco-
py scans were positioned in the central zone of the soleus muscle (SOL), the 
medial side of the gastrocnemius muscle (GM) and in two different locations 
in the medial side of the soleus muscle (SM) based on a T1 -weighted anato-
mical image acquired with the following parameters: TR / TE / flip angle (FA) 
= 300 ms/ 5.2 ms/ 30°, voxel = 0.5 x 0.5 x 4 mm3, field-of-view (FOV) = 180 x 
180 x 66 mm3, 15 slices, scan duration is two minutes. 
The spectra were viewed in jMRUI (14) and the AMARES algorithm (15) was 
used to fit the water peak based on a Lorentzian line shape. The SNR of the 
spectra was measured by dividing the integrated area under the fitted water 
peak of the non-water-suppressed scans by the standard deviation of the 
last 200 points of the time-domain signal, which contained only noise. The 
water signal was chosen because the intensity is much larger than that of 
any metabolite and since residual dipolar couplings and bulk susceptibility 
effects can hamper accurate quantification of metabolite signals in muscle 
(16).
Figure 2: Coverage and B1-profile of coil.
The left image (a) shows a single slice from a low resolution 3D gradient echo sequence of 
the calf muscle. The right image (b) shows the corresponding B1 map scaled as a percentage 
of the target B1. There is substantial variation of B1 over the leg as would be expected for the 
partial volume Tx / Rx coil that was used in the experiments. Especially towards the medial 
side of the leg the B1 inhomogeneity is particularly pronounced as depicted by the arrow.
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B1 mapping
A B1 map was acquired using a 3D spoiled gradient echo sequence with two 
interleaved repetition times (TR1 and TR2) with the following parameters: TR1 
/ TR2 / TE / FA = 20 ms/ 100 ms/ 1.8 ms/ 30°, voxel = 2 x 2 x 4 mm
3, FOV = 180 
x 180 x 116 mm3, total scan duration is two-and-a –half minutes. The ratio of 
the resulting images with different TR yields a tip angle distribution map (7).
results
Figure 2 shows a single slice from the 3D B1 map illustrating that the tip angle 
varies considerably over the field-of-view, and that the excitation pattern is 
not symmetric. The latter observation is in line with several previous studies 
carried out at high field (17). The sensitive region of the coil is large enough 
to almost completely cover the soleus and gastrocnemius muscles, and the 
tip angle varies by more than a factor-of-two over this region. Toward the SM 
on the medial side of the leg there is a region where the B1 inhomogeneity is 
particularly pronounced. Differences were found in the result of the calibra-
tion sequence before and after f0 determination and shimming when the VOI 
was moved from the SOL to the SM.
Figure 3a shows the approximate locations of three volumes from which 
localized spectra were obtained. For all volunteers, the POvolume calibration 
sequence iteratively arrived at the desired  pulse angle for the selected vo-
lume. At the location of the SM conventional volume shimming failed due 
to the high B1 inhomogeneities, therefore image based shimming was used. 
MR spectra in the SM were acquired at two different locations within the 
same volunteer because of the high variability in B1 in that region. Increases 
in SNR were found in all locations when compared to the standard POslice 
technique. The amount of SNR increase was dependent on the location with 
respect to the coil. Representative spectra from the SOL are shown in figure 
3b and spectra from the SM are shown in figure 3c. The bottom spectrum is 
acquired with the POslice technique, whereas the one at the top is acquired 
with the POvolume technique. The POvolume technique results in an increase in 
SNR of 24% and 224% for SOL and SM, respectively, in this volunteer, based 
upon the unsuppressed water signal.
Figure 4 shows the SNR increases averaged over all volunteers for different 
regions in the calf muscles. The measured increases in SNR were 34 ± 5% in 
the GM, 22 ± 5% in the SOL and 166 ± 42% in the SM based upon the unsup-
pressed water signal. 
 |  55loCalized B1 CaliBration
Figure 3: Anatomic image and acquired MR spectra.
(a) T1-weighted anatomical image for reference showing the locations where the MR spectra 
were obtained. (b) Localized MR spectra of the SOL of a volunteer, top: POvolume , bottom: 
POslice. (c) Localized MR spectra of the SM, top: POvolume , bottom: POslice. Note the clear 
increase in SNR of the spectra from the new volume-selective power optimization method. 
Based on the signal intensity of the water peak (not displayed) an SNR increase of 24% was 
found in (b) and 224% in (c). Scan parameters: STEAM sequence, 10x10x10 mm3 voxel, TR/ 
TM / TE = 2000 ms/ 25 ms/ 25 ms, 64 averages. Volumes were placed in the central zone of 
the soleus muscle (SOL), the medial side of the gastrocnemius muscle (GM) and the medial 
side of the soleus muscle (SM).
discussion
Partial volume Tx/Rx coils are consistently used for studies at high field (18), 
particularly those aimed at very high spatial resolution and/ or reduced spe-
cific absorption rate. In addition to the intrinsic non-uniformity of the B1 
field from such coils, asymmetries in the transmit field are induced by the 
interaction of the RF field with the dielectric properties of the tissue. The 
resulting B1 fields are not easy to predict, and so experimental procedures 
for optimizing local tip angles are important. Since most MRS studies involve 
multiple-pulse localized spectroscopy experiments, sub-optimal pulse cali-
bration in the volume of interest can reduce signal intensities significantly. 
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This is particularly important in clinical studies, where total data acquisition 
times are typically limited both by institutional review boards and by pa-
tient comfort. Using a new four-pulse volume-selective optimization method 
consistent increases in SNR of the MR spectra were found compared to the 
standard slice-selective method (1, 2). When the tip angle is averaged over a 
large area the calibration is strongly biased toward the area with the highest 
B1, which is not necessarily near the VOI. This is particularly true for partial 
volume and surface Tx/Rx coils, which have a highly non uniform excitation 
profile. Using the four-pulse volume-selective optimization method we were 
able to locally measure the B1 field. In contrast to many other B1 mapping 
procedures (4–10) only signal originating from the VOI was acquired and the-
refore the calculations required for iterative convergence to the optimal tip 
angle are simple and can be performed real-time. The procedure was fast 
enough (less than 10 s) to be used as a calibration sequence before the ac-
tual MRS sequence. 
Figure 4: SNR comparisons of the unsuppressed water spectra. 
Spectra were acquired in different locations in the calf muscle, GM (n = 4), SOL (n = 5) and 
SM (n = 4) subjects. For the SM two different locations within the same volunteer were 
measured. A large variation in SNR increase was measured in the SM because of the very 
high B1 inhomogeneities at that location. The SNR was determined using the area under the 
water peak of a non-water suppressed spectrum divided by the standard deviation of the 
last 200 points of the time signal. Error bars represent standard error of the mean.
The technique is valid under the assumption that T1 decay between the two 
stimulated echoes can be neglected. This is usually valid in vivo where T1 
values of tissue are typically two orders of magnitude larger than the time 
between the first and second stimulated echo signal (12, 19). Therefore, the 
method is not only limited for use in the calf muscle but could also be used 
in the human brain. However if the technique is applied in tissues with very 
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short T1 values such as fat, it may be necessary to correct for the T1 decay 
during the calibration sequence. Both stimulated echo signals have identical 
T2 decay, and therefore no errors are introduced for tissues with different T2 
values. However tissues with very short T2 values will result in lower SNR and 
therefore increase the difficulty in obtaining a reliable tip angle estimation. 
The TE of the calibration sequence was 16 ms which was short enough to 
reliably measure signal in the human calf muscle. 
The first iteration of the volume-selective technique is performed using the 
f0 and shim settings of the previous scan. Therefore a large change in the lo-
cation of the VOI can lead to a large change in f0 and shim settings. This was 
the case when the VOI was moved from the SOL to the SM, and so it was ne-
cessary to repeat the POvolume sequence again after shimming and frequency 
adjustment
The SNR gain for the SOL was measured to be the smallest compared to the 
other two locations. This part of the muscle is located in a rather homoge-
neous sensitivity region of the coil and the difference between POslice and 
POvolume is therefore small, but nevertheless significant, corresponding to a 
reduction in scan time of approximately 40% to achieve a given SNR. The GM 
is located closer to the coil but within a more inhomogeneous region and 
consequently a larger SNR increase is both expected and measured when 
comparing the two techniques. The B1 inhomogeneity around the SM is very 
pronounced and therefore the largest SNR increases are found in this region 
because the slice-selective power calibration method is not able to accura-
tely measure the local B1 field. The increase in SNR in the SM is therefore also 
strongly dependent on the exact location of the VOI, but is typically substan-
tial. The reported SNR increases are measured using the unsuppressed water 
signals for improved accuracy: however, the metabolite SNR should increase 
proportionally given the similar relaxation properties of the metabolites and 
water (12). Visual inspection of the spectra in the figures does indeed show 
this increase.  
In summary, increases of up to 166% in SNR based upon the unsuppressed 
water signal were found in calf spectra of five healthy volunteers. This re-
sults in significant reduction in scan time, while maintaining the same SNR, 
an important factor when obtaining spectra in a clinical setting. Even with 
“homogeneous” transmit coils, the variation in tip angles is known to be pro-
nounced and patient-specific, and so simple experimentally-based power 
optimization schemes are valuable in realizing the full signal-to-noise poten-
tial of high field.
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AbstrAct
The altered iron concentration in many neurodegenerative diseases such as 
Alzheimer’s disease (AD) has led to the development of MRI sequences that 
are sensitive to the accompanying changes in the transverse relaxation rate. 
Heavily T2*-weighted imaging sequences at high magnetic field strength (7 
Tesla and above), in particular, show potential for detecting small changes in 
iron concentration. However, these sequences require a long echo time in 
combination with a long scanning time for high resolution and are therefore 
prone to image artifacts caused by physiological fluctuations, patient motion 
or system instabilities. Many groups have found that the high image quality 
that was obtained using high resolution T2*-weighted sequences at 7 T in 
healthy volunteers, could not be obtained in AD patients. In this study the 
source of the image artifacts was investigated in phantom and in healthy vo-
lunteer experiments by incorporating movement parameters and resonance 
frequency (f0) variations which were measured in AD patients. It was found 
that image degradation caused by typical f0 variations was a factor-of-four 
times larger than artifacts caused by movement characteristic of AD patients 
in the scanner. In addition to respiratory induced f0 variations, large jumps 
in the f0 were observed in AD patients. By implementing a navigator echo 
technique to correct for f0 variations, the image quality of high resolution 
T2*-weighted images increased considerably. This technique was succes-
sfully applied in five AD patients and in five subjective memory complainers. 
Visual scoring showed improvements in image quality in 9 out of 10 subjects. 
Ghosting levels were reduced by 24 ± 13%.
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introduction
Many neurodegenerative diseases, such as Alzheimer’s, Huntington’s and 
Parkinson’s disease are accompanied by local changes in iron concentration 
(1–3). In Alzheimer’s disease (AD) recent developments suggest that iron is 
bound to amyloid beta plaques in the grey matter (GM) (4, 5). Tissues with 
elevated iron concentration generate magnetic field inhomogeneities which 
can be visualized with MRI using, for example, heavily T2
*-weighted sequen-
ces. In samples from deceased AD patients it has been shown that the incre-
ased concentration of iron leads to significant signal loss on high resolution 
T2
*-weighted images (4, 6). The typical size of amyloid beta plaques ranges 
from 16 to 150 µm (7), which makes direct in-vivo visualization of indivi-
dual plaques within a clinically-acceptable scan time highly unlikely. Howe-
ver, whole body high field (7 T and above) MRI scanners might enable the 
indirect detection of small changes in iron concentration in vivo due both to 
the intrinsic higher signal-to-noise, which can be used to increase the reso-
lution, and the increased sensitivity to magnetic field inhomogeneities. Very 
high resolution (up to 0.2 mm in-plane resolution) T2
*-weighted images at 7 
T have been reported recently in young healthy volunteers (8–12), showing 
an increased contrast between GM and white matter (WM) regions compa-
red to lower field strengths. However, there are potential problems in ap-
plying these types of sequences in patients. Heavily T2
*-weighted sequences 
require a long echo time (TE) to generate sufficient T2
* contrast and, because 
of the high spatial resolution, the scan duration is typically long. As a result of 
these two factors the images are very sensitive to physiological fluctuations, 
patient motion and system instabilities, potentially causing blurring, signal 
cancellation and ghosting. Many of these effects are particularly pronounced 
at high magnetic field (13). Results obtained at our institution in normal he-
althy volunteers at 7 T are comparable to the high quality anatomical ima-
ges that have been reported by other authors using a similar sequence (10, 
11, 13). However, application of the same sequence in AD patients and in 
subjects with subjective memory complaints (SMC) showed a dramatically 
reduced image quality. 
This study is divided into two parts. First, the source of the image artifacts 
in AD patients was investigated. Using phantom and healthy volunteer scans 
the different contributions of translational motion, rotational motion, and 
time-dependent f0 variations to image artifacts were measured. Secondly, 
based on the results of the first part (which showed that f0 variations were 
dominant), a navigator-echo based correction technique was designed and 
implemented to improve the image quality in AD patients and SMC subjects. 
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Qualitative assessment of image quality was achieved using scoring by three 
observers and quantitative measures of the reduction in ghosting levels were 
reported.
MaTeRialS and MeThodS
Informed consent was obtained from all subjects and this study was appro-
ved by the local ethics committee. All experiments were performed on a 
whole body 7 T system (Philips Healthcare, Best, The Netherlands).
Synthesized motion and f0 variations
Among the factors that influence the image quality in brain exams, are phy-
siologically induced f0 changes (13–17) and patient motion (18–21). The 
influence of these factors on high resolution T2
*-weighted images was in-
vestigated using phantom and healthy volunteer scans. Experiments were 
performed in which the off-center position, angulations and f0 of the ima-
ging volume were changed for each acquired k-line during scanning to simu-
late the effects of respiration and motion. This was achieved by dynamically 
changing the demodulation frequency and phase for each k-space line via 
the software interface. This process was termed “synthesized” motion and 
f0 variations. The particular motion parameters used were taken from 4 AD 
patients that had previously participated in an unrelated resting-state func-
tional MRI (fMRI) study performed previously at 3 T in our institution. The 
motion parameters were interpolated to match the repetition time (TR) of 
the high resolution T2*-weighted sequence. Resonance frequency variations 
were measured in two healthy subjects and in two AD patients at 7 T using a 
navigator echo technique (see navigator echoes section). 
The effects of synthesized motion and f0 variations in phantom experiments
A manufacturer provided aqueous phantom consisting of different sized 
structures was used for the phantom experiments in combination with a 
quadrature transmit-receive birdcage coil. A T2
*-weighted sequence with 
scan parameters: TR / TE / flip angle = 796 ms / 25 ms / 45°, voxel size = 
0.24 x 0.24 x 1 mm3, FOV = 240 x 180 mm2, 3 slices and 2 averages was used 
for the following experiments: 1) a normal sequence with no synthesized 
motion or f0 variations, 2) synthesized translations in the frequency enco-
ding direction, 3) synthesized translations in the phase encoding direction, 4) 
synthesized rotations in all three directions, 5) the combination of both syn-
thesized translations and rotations, and 6) the combination of synthesized 
translations, rotations and f0 variations. The artifact power was quantified 
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by calculating the sum-of-squares differences (SSD) between the obtained 
image and a repeat of scan 1.
The effects of synthesized motion and f0 variations in healthy volunteers
To investigate the type of artifacts that resulted from motion and f0 variati-
ons on in-vivo images, several of the synthesized experiments described in 
the phantom experiments section were repeated in three healthy volunteers 
(2 females, age 24 ± 4 years). The sequence described in the previous section 
was used with 20 axial slices and no signal averages, resulting in a total scan 
duration of 9 minutes. Frequency and phase encoding direction were along 
the anterior-posterior (AP) and right-left (RL) axes, respectively. A Nova Me-
dical quadrature transmit, 16 channel phased array receive coil was used. 
The following experiments were performed, 1) no synthesized motion, 2) 
synthesized translation and rotation in both the frequency and phase enco-
ding direction, and 3) synthesized translation and rotation including f0 vari-
ations. To keep the total time for the in-vivo experiments within acceptable 
limits, we chose to only use a single motion parameter dataset (obtained 
in one AD patient as was described in the previous section), and a single f0 
parameter set (from another AD patient, also described in the previous sec-
tion).  In addition a respiratory belt was used to measure respiration-induced 
abdominal movements.
Navigator echoes:
Based on the results from the phantom and healthy volunteer experiments 
(see results section) it was found that f0 variations had the greatest contribu-
tion to the image artifacts. Therefore, a navigator echo correction technique 
was designed to measure and correct for f0 variations (22–24). A navigator 
echo was acquired through the center of k-space before the phase encoding 
gradient but after flow compensation gradients in the frequency encoding 
and slice selective dimensions. No flow compensation on the phase encod-
ing axis was applied to limit eddy current induced phase variations resulting 
from the temporally-varying flow compensation gradients. The phase of the 
navigator signal is given by (15):  
      [1]
where τ is the time after excitation, and φsystem is an TE independent phase 
term which is caused by system instabilities such as eddy currents. The phase 
was calculated after Fourier transformation (20) and was weighted by the 
signal magnitude.
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The phase difference (Δφj) was measured using the difference between the 
first navigator echo and the jth navigator. ∆f0,j can then be calculated:
 [2]
where ∆f0,j  is the difference in resonance frequency between the j
th naviga-
tor and the first navigator. It was assumed that the f0 does not change during 
the time between excitation and acquisition of a single k-space line, and also 
that no motion takes place during this time. Therefore Δφj(τ) increases lin-
early with time and each phase encoded (ky) imaging echo can be corrected 
by:
    [3]
where Scorr(x, ky) and S(x, ky) are the corrected and acquired signal, respecti-
vely, after Fourier transform along the frequency direction and TE is the echo 
time of the acquisition echo. 
In vivo experiments:
Five AD patients (79 ± 4 years) and five SMC subjects (62 ± 10 years) were 
scanned using a flow compensated T2
*-weighted sequence with the follow-
ing parameters: TR / TE / flip angle = 796 ms / 25 ms / 45°, voxel size = 0.24 
x 0.24 x 1 mm3, FOV = 240 x 180 mm2, 20 axial slices with a gap of 0.1 mm. 
The bandwidth per pixel was 46 Hz, corresponding to a readout length of ap-
proximately 22 ms. Frequency and phase encoding direction were along the 
AP and RL axes, respectively. A navigator echo was acquired along the same 
direction as the read out gradient at time TEnav = 9.5 ms, before the phase 
encoding gradient was applied. The navigator was sampled at an increased 
bandwidth to reduce the TE of the acquisition: the duration of the acquisi-
tion window for the navigator echo was 4.3 ms. The total scan duration was 
approximately 10 minutes. Shimming up to third order was performed using 
an image based shimming approach (25). The images were reconstructed 
with and without navigator echo correction. Qualitative visual grading of the 
images was performed by three observers blinded to which dataset was re-
constructed with or without navigator echo correction. Each pair of images 
was evaluated based on the appearance of artifacts and the image with the 
highest image quality was selected. Interobserver agreement was calculated 
using the kappa-statistic (26). Ghosting levels for each pair of corrected and 
uncorrected images were determined by calculating the average signal in-
tensity outside the brain anatomy.
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results
Figure 1 compares the image quality obtained from a healthy volunteer and 
an AD patient. It is clear that the image quality from the AD patient is consi-
derably poorer than that obtained in the healthy volunteer. In addition dif-
ferences in image contrast, ventricular size and brain morphology can be ob-
served which can be attributed to the disease and aging process.
Figure 1: Comparison of T2*-weighted images.
Images obtained in a 22 year old healthy volunteer (a) and in a 86 year old AD patient (b) 
using the same sequence. Image quality is reduced considerably in the image on the right. 
Scan parameters: TR / TE / flip angle = 796 ms / 25 ms / 45°, voxel size = 0.24 x 0.24 x 1 mm3, 
FOV = 240 x 180 mm2, 20 slices with a gap of 0.1 mm.
Figures 2a and (b) show the estimated time-series of translational and ro-
tational motion measured in an AD patient in the separate study at 3T. The 
maximum translational motion for the four AD patients was found to be less 
than 1.5 mm and rotations were typically less than 1 degree. Figure 2c shows 
the time-dependent f0 variations measured in one AD patient at 7 T. The am-
plitude of respiration-induced f0 variations was considerably different bet-
ween subjects but was typically about 6 Hz, which was larger than previously 
reported values (13, 15, 23) at 3T (about 1.25 Hz) and at 7 T (about 1.5 – 3.5 
Hz). The reported f0 changes were calculated with respect to a reference na-
vigator signal for each slice. The displayed f0 fluctuations include f0 changes 
from all slices (2.2 cm coverage in the feet-head direction). Based on these 
calculations it is not possible to measure the spatial dependency of the am-
plitude of f0 changes, which was shown to be present for respiratory f0 chan-
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ges (15). The temporal resolution of each individual slice is too low (TR = 796 
ms) to adequately sample the respiration pattern on a slice by slice basis.
Figure 2: Translational and rotational motion and f0 fluctuations in an AD patient.
(a) and (b) show typical time-series of translational and rotational motion as  measured in 
AD patients in a separate study at 3T. (c) Shows the time-dependent f0 variations measured 
in an AD patient at 7 T.
The time-dependent motion and f0 values were incorporated into the 
phantom studies, with motion and f0 effects being synthesized via changes 
in the transmit and receive offset frequency and phase for each acquired 
k-space line. The results are shown in Figure 3a, which illustrates that there 
is a linear relationship between the artifact power and the degree of linear 
motion and that the contribution to the artifact level of rotational motion is 
much less than translational motion. It can also be seen that translational 
motion in the AP and RL direction had a very similar effect on the amount 
of artifacts. When the translational motions in the AP and RL direction are 
combined the artifact power is approximately the sum of both directions in-
dividually. Figure 3b shows that the contribution of f0 fluctuations is the most 
important factor in the value of the artifact power. The SSD increases from 
64 ± 22 % when only translational motion and rotations are considered, to 
193 ± 14 % when f0 variations from healthy volunteers are included, to 376 ± 
15 % when f0 variations from AD patients are included. It can be concluded 
that the f0 variations had the largest effect on the amount of artifacts com-
pared to translation or rotations. In addition, the increase in the SSD scales 
linearly with the amount of motion and f0 variations (p<0.0003). 
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Figure 3: Relative contributions to amount of artifacts.
(a) The effect of translation and rotation on the artifact power for synthesized motion in a 
phantom. A motion factor of 1 corresponds to the motion parameters from Figure 2(a), a 
motion factor of 2 doubles these values and so on. It can be seen that there is a linear rela-
tionship between the artifact power and the motion factor. (b) Shows the artifact power for 
translational motion and rotation combined (light gray line), when f0 variations of healthy 
volunteers are included (medium gray line) and when f0 variations of AD patients are inclu-
ded (black line).  Note the different scale y-axis of a) and b), error bars display standard error 
of the mean.
The effect of translational, rotational and f0 variations on in-vivo images was 
investigated using the same approach. A single slice is shown from a 28 year 
old volunteer without any visible motion corruption in figure 4a. When the 
data are acquired with added synthesized motion and rotation parameters 
(figure 4b) the image quality is slightly decreased. When f0 variations from 
an artifact corrupted scan acquired in an AD patient are added in addition 
to the translation and rotation parameters severe artifacts occur (figure 4c). 
The f0 variations measured during the complete sequence are displayed in 
figure 5, for a healthy volunteer (a) and for two AD patients (b,c). Correspon-
ding zoomed regions are shown in (d-f). The relation between respiration 
and the phase of the navigator was evaluated using a respiratory belt, figure 
5 (d), in a healthy volunteer. Both AD patients show large jumps in f0 in ad-
dition to the sinusoidal respiratory induced f0 variations. 
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Figure 4: Images acquired from a young healthy volunteer at 7 T.
 (a) Standard T2*-weighted imaging sequence. (b) Imaging sequence with the translational 
and rotational values from figure 2(a) and (b) incorporated by varying the demodulation 
frequency and phase for each k-space line. (c) As for (b) but with the f0 fluctuations shown in 
figure 2(c) incorporated into the imaging sequence for each k-space line.  Scan parameters: 
TR / TE / flip angle = 796 ms / 25 ms / 45°, voxel size = 0.24 x 0.24 x 1 mm3, FOV = 240 x 180 
mm2, 20 slices with a gap of 0.1 mm.
Figure 5: Resonance frequency fluctuations during acquisition.
The top row shows the f0 variations measured during the complete sequence for a healthy 
volunteer (a) and two AD patients (b and c). The bottom row shows corresponding zoomed 
in regions (d-f). The signal from the respiratory belt and the f0 variations combined for a 
healthy volunteer is shown in (d). In addition to the sinusoidal respiratory fluctuation jumps 
(e), or spikes (f) in the f0 are visible for scans in AD patients.
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Figure 6: Images reconstructed with and without navigator correction.
The top row shows slices without navigator echo correction. The bottom row shows the 
same slices reconstructed with navigator echo correction. Four sections from one SMC sub-
ject (a) and two sections including corresponding zoomed in regions from an AD patient (b) 
are shown. The black arrows point to regions with artifacts. The reduction in ghosting level 
was 38 % for (a), and 28% for (b).
Figure 6 shows examples from one SMC subject (a) and one AD patient (b) 
without and with navigator echo correction (top and bottom row for each 
subject, respectively). A clear reduction of the artifacts was visible when nav-
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igator echo correction was applied. The amount and severity of many of the 
artifacts decreased (represented by the black arrows) and ghosting artifacts 
were reduced. In addition, areas close to regions with a high magnetic field 
inhomogeneity, such as frontally in the brain also showed improvements. 
Image quality improvements were found in 9 out of 10 subjects, based on 
the results of the visual grading. An excellent interobserver agreement was 
found (κ = 0.86). Average ghosting levels were reduced with 24 ± 13% (range 
8-46%) when navigator echo correction was applied. No images reconstruct-
ed with navigator echo correction were of poorer quality than those without 
correction. The cases, which showed low reductions in ghosting levels, cor-
responded to images that already had little artifacts before application of the 
navigator echo correction. 
discussion
The most important findings of this study were threefold. First the contribu-
tions of translational motion and rotation to the amount of artifacts in a T2
*-
weighted sequence were found to be minimal. Second, the decreased image 
quality in AD patients and SMC subjects results mainly from fluctuations in f0 
during the acquisition. Third, using navigator echoes it is possible to correct 
for these f0 fluctuations resulting in a substantial increase in image quality.
The amount of artifacts in many AD and SMC subjects was found to be se-
vere, as is shown in figure 1, making it difficult to interpret the resulting 
images. Using synthesized motion and f0 variations in phantom experiments 
the origin of the artifacts was investigated. It was found that f0 variations 
were causing the majority of the image artifacts. In fact, the degree of sub-
ject translation and rotation could have been multiplied by a factor-of-three 
compared to normal AD patient movement before it would have generated 
the same amount of differences as normal f0 variations, as indicated in fi-
gure 3. This supports the assumption that head motion is not likely to be 
the main cause of the typical artifacts seen in high resolution T2
*-weighted 
sequences of AD patients and SMC subjects. No motion in the foot-head 
direction was synthesized, but since the slice thickness is much larger than 
the in-plane resolution it is not likely that these movements will produce 
significant image artifacts (19). When the same synthesized motion and f0 
parameters were applied to a scan of a healthy volunteer, comparable arti-
facts occurred as were observed in AD patients (figure 4c). However, when 
synthetic motion without f0 variations was included, the image quality was 
only slightly degraded (figure 4b). Hence the effect of translational motion 
and rotation can be considered to be minimal. It is, therefore, highly proba-
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ble that f0 variations play the most important role in the artifacts found in AD 
patients. Previous reports have shown that respiration leads to f0 changes in 
the head (13, 15, 23, 27) that are most likely due to volume changes of the 
chest (16). It is well-documented that the effect that respiration and other 
susceptibility-related changes have on the phase of MRI signal increases 
with magnetic field strength (13). In this present study, the measured sinus-
oidal phase variations in healthy volunteers were found to correspond well 
with the signal from the respiratory belt (figure 5d). However the large dif-
ference in image quality between healthy volunteers and AD patients is not 
likely to be caused simply by differences in respiration. This is confirmed by 
the f0 patterns of two AD patients shown in figure 5, where the most notable 
differences between a healthy volunteer and two AD patients are the jumps 
in f0 during acquisition. A possible explanation for the large variations in f0 is 
subject motion (although this was not apparent during the experiment): for 
example, arm movements or swallowing can lead to substantial f0 variations 
in the brain (14, 17).
The findings of our investigations led to the implementation of a navigator 
echo to correct for f0 variations. By acquiring a navigator echo separately for 
each slice it is possible to measure the f0 per slice for each k-space line. A 
necessary assumption of this approach was that f0 variations within a slice 
are minimal. It has been shown previously that the spatial extent of the f0 
variations due to arm movements within a transverse slice in the brain is 
relatively small (14), which was also shown earlier for respiratory induced 
f0 changes (15). A reduction in the amount and severity of artifacts is visible 
when performing the navigator echo correction (figure 6). Even though some 
remaining artifacts are still visible after navigator correction, the image quali-
ty is considerably improved. This is supported by the results of the visual eva-
luation, which showed an image quality improvement in 9 out of 10 subjects 
with excellent interobserver agreement and the reduction in ghosting levels 
of 24%. A potential confounding factor of using ghosting levels as a quantita-
tive measure is that the reconstruction algorithm of the scanner masks areas 
outside the brain automatically, effectively reducing the absolute amount 
of visible ghosting. However, the relative measures of ghost-level reduction 
remain valid and these are reported.
Possible explanations for incomplete correction are spatially varying f0 chan-
ges within the slice, or variations that occur between navigator acquisition 
and image acquisition: the latter is not very likely because of the small se-
paration of approximately 16 ms between the two acquisitions. Future work 
will focus on measuring and correcting for the spatial distribution of f0 chan-
ges.
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Recently, a technique has been introduced that is able to correct for spatially 
varying f0 variations within a slice and between slices (13). This technique, 
which is called “real-time shimming”, uses a calibration scan that relates the 
motion from the chest wall to the spatially varying magnetic field. During 
acquisition the shim and f0 settings are updated dynamically and this tech-
nique has been applied successfully in high resolution T2
*-weighted images 
at 7 T (9, 13). An advantage of this technique is that it also corrects for spa-
tially varying f0 differences within a slice, in contrast to the navigator echo 
technique presented here. However, the temporal behavior of the navigator 
signal in AD patients (see figure 5) showed that not all f0 variations were 
caused by respiration alone. The heavily corrupted scans, in particular, show 
large jumps in f0 that are not caused by respiration, which makes adequate 
suppression of the artifacts in these scans using the dynamic shimming ap-
proach unlikely.
Due to the long TE and small readout bandwidth of the acquisition window 
in most T2
*-weighted sequences, the time that is needed to acquire a navi-
gator echo is a small fraction of the total scan duration. In the sequence that 
was used in this study the inclusion of a navigator echo resulted in a scan du-
ration increase of 30 s, which was small compared to the total scan duration 
of approximately 10 minutes.
In summary, this study has shown that the major source of artifacts in high 
resolution T2
*-weighted images at 7 T in AD patients and SMC subjects is 
caused by variations in f0. These f0 variations are a combination of sinusoidal 
respiratory induced fluctuations and jumps in f0. With the latter causing the 
majority of the image artifacts. Based on these experiments we have imple-
mented a T2
*-weighted sequence with navigator echo correction to measure 
and correct for f0 variations during scanning. In 9 out of 10 subjects image 
quality improvements were found using visual scoring.
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AbstrAct
Spatio-temporal magnetic field changes in the brain caused by breathing or 
body movements can lead to image artifacts. This is especially a problem in 
T2
*-weighted sequences. With the acquisition of an extra echo (navigator) it 
is possible to measure the magnetic field change induced frequency offset 
for a given slice during image acquisition. However, substantial local varia-
tion across a slice can occur. This work describes an extension of the con-
ventional navigator technique that improves the estimation of the magnetic 
field distribution in the brain during strong field fluctuations. This is done 
using the combination of signals from multiple coil elements, the coil sensi-
tivity profiles and frequency encoding; termed sensitivity encoded (SENSE) 
navigator echoes. In vivo validation was performed in subjects who perfor-
med normal breathing, nose touching and deep breathing during scanning. 
The SENSE navigator technique leads to an error reduction in estimating the 
field distribution in the brain of 73 ± 16% compared to 56 ± 14% for con-
ventional estimation. Image quality can be improved via incorporating this 
navigator information appropriately into the image reconstruction. When 
the SENSE navigator technique was applied to a T2
*-weighted sequence at 7 
Tesla a ghosting reduction of 47 ± 13% was measured during nose touching 
experiments compared to no correction.
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introduction
Magnetic resonance imaging (MRI) is ideally performed in a spatially and 
temporally stable and homogeneous magnetic field, especially when using 
gradient echo sequences in which magnetic field inhomogeneities lead to 
loss of phase coherence. It has been shown previously that body move-
ments and respiration lead to substantial variations of the magnetic field 
in the brain (1–6). These effects are significantly more pronounced at high 
magnetic field strengths. One of the sequences frequently used at 7 Tesla is 
a strongly T2
*-weighted gradient echo, because of the high intrinsic contrast 
in both magnitude and phase which allows differentiation of cortical layers, 
as well as detection of diffuse depositions of iron associated with various 
neurodegenerative diseases (7–10). Due to the sensitivity of this sequence 
to spatial and temporal variations in both T2
* and phase (through changes in 
the resonance frequency), changes in these parameters that are not related 
to tissue properties can have a large detrimental effect on image quality. 
Variations in the local magnetic field can be separated into static inhomogen-
eities, i.e. those that remain constant during the experiment, and dynamic 
inhomogeneities, i.e. those that fluctuate throughout the experiment. On 
most current systems up-to-third order shimming is available to compensate 
at least partially for static inhomogeneities. In contrast, dynamic magnetic 
field changes, such as caused by respiration and body movements cannot be 
corrected using static shimming approaches. 
Several methods, either prospective or retrospective, exist to measure and 
correct partially for these dynamic field variations. It has been shown that a 
reference scan can be used to relate field changes caused by normal respi-
ration to the chest motion (1). By measuring the chest motion during image 
acquisition prospective correction was possible by dynamically switching the 
shim values.  Using this approach, however, only periodic field fluctuations 
due to respiration can be corrected while non-periodic fluctuations due to 
cardiac pulsations and body movements, for example, lead to fluctuations 
that are not corrected. Others have used external magnetic field probes to 
sample the magnetic field changes at several spatial locations during image 
acquisition, an approach that is also capable of measuring non-periodic fluc-
tuations, but requires dedicated hardware (11, 12). 
Another approach to compensate for dynamic field variations is to sample an 
extra navigator echo before phase encoding (6, 13–17), or to use special se-
quences capable of self-navigation (18–20). Based on the difference between 
successive navigator signals the temporal magnetic field disturbance can be 
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estimated and corrected during image reconstruction. An advantage of the 
navigator echo approach is that it does not require dedicated hardware. So 
far this technique has mostly been used to correct for zeroth order temporal 
changes in the magnetic field. This can be sufficient to correct for magnetic 
field changes induced by normal respiration when axial images through the 
brain are considered (2, 4). Substantial improvements in image quality of 
high resolution T2
*-weighted images have been shown in Alzheimer’s disease 
patients, where the changes in the magnetic field were measured for each 
axial slice separately and used to correct the phase of each acquired k-space 
line retrospectively (6). However, residual image artifacts still remain, which 
were hypothesized to arise from spatio-temporal magnetic field fluctuations 
within a slice. 
The aim of this work is to address and correct for the artifacts that are cau-
sed by these within-slice dynamic magnetic field fluctuations. A prerequisite 
for this approach is that information about the magnetic field distribution 
must be available at a sufficiently high temporal and spatial resolution. In this 
work the field map information is derived by integrating frequency-encoded 
navigators with the intrinsic spatial information from the coil sensitivity pro-
files of the individual elements of the receive array (21–23). Subsequently 
this information was used to correct retrospectively the corrupted images. 
To test the robustness of this correction approach strong spatio-temporal 
magnetic field inhomogeneities were produced by having subjects perform 
nose touching and deep breathing tasks during image acquisition. This was 
used to model the worst case fluctuations that can occur during patient exa-
minations. Additionally, the method was evaluated in cooperative subjects 
instructed to remain still and breathe normally.
MaTeRialS and MeThodS
All experiments were performed on a 7 T whole body system (Philips He-
althcare, Best, The Netherlands), equipped with a quadrature transmit and 
32-channel phased array head coil (Nova Medical, USA). All subjects gave 
written informed consent prior to the study in compliance with local ethics 
regulations.
This study is divided into two parts, in the first part the accuracy of the spatial 
field estimations is investigated using very fast imaging as a ground truth. In 
the second part a reconstruction framework is developed to correct retros-
pectively the data using the measured dynamic field fluctuation information.
Spatial field estimations
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The navigator echo was acquired immediately after each RF excitation using 
32 receive channels; see Figure 1 for more details. A complex difference sig-
nal was calculated between the first and the successively acquired navigator 
echoes, which is subsequently converted to a frequency shift for each chan-
nel (f0,nav). The navigator echo was acquired once for every excitation, and a 
phase correction was applied to all k-space lines following the same excita-
tion, either one gradient echo, or the entire echo planar imaging (EPI) train.
Four different methods were investigated for spatial field mapping based on 
this one-dimensional navigator. The first method consists of a complex sum-
mation over the individual channels and temporal sampling points, result-
ing in a global estimation of the frequency shifts: this is the zeroth order 
approach outlined in ref. (6) and is used as a reference. The second method 
consists of a coil sensitivity weighted summation over the channels and sum-
mation over all temporal sampling points: this is termed the sensitivity en-
coded (SENSE) navigator approach. The third method is similar to the second 
method but in addition includes the spatial information of the frequency 
encoding gradient in the anterior/ posterior direction: this is termed the fre-
quency encoded SENSE navigator. The fourth method includes the frequency 
encoding gradient after averaging all channels, this is called the frequency 
encoded navigator. 
Figure 1: SENSE navigator sequence details. 
(a) The acquisition of the navigator is shown schematically in a sequence diagram. The na-
vigator echo is acquired after slice selection prior to phase encoding and is followed by 
an imaging module. GRO is the navigator readout gradient, and ADC is the analog-to-digital 
converter. (b) Multiple coil elements with different coil sensitivities are used to sample the 
navigator echo simultaneously (depicted schematically as c1 – cn ).  Four different naviga-
tors have been studied. In the first a complex summation of all temporal sampling points 
is performed and all coil signals are simply added before evaluation. Also in the second the 
sampling points are summed, but all coil signals are added including spatial coil sensitivity 
weighing, while the third is equal to the second one, but taking into account the spatial fre-
quency encoding gradient (GRO) along the x direction to increase the spatial definition. The 
fourth approach only uses the GRO after adding all individual coil signals.
All four types of field map reconstruction (zeroth order, frequency encoded 
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and both SENSE navigator estimations) use exactly the same acquired data, 
allowing the results for the different approaches to be compared. 
For the SENSE navigator field techniques the individual field estimations 
(f0,nav) were weighted according to a separately acquired coil sensitivity map 
(CSM) that describes the spatially varying sensitivity of each receive coil ele-
ment, to produce a dynamic low resolution two dimensional field distribu-
tion map (f0,nav(x,y,t)) (22):
  [1]
Where x and y are the frequency- and phase encoding directions, respecti-
vely and ch denotes the receive coil element. The CSM was calculated on the 
scanner using a manufacturer provided method that uses the ratio between 
an image acquired with the 32 channel receive array and the quadrature 
transmit-receive coil as receive coil in order to limit the effect of T2 differen-
ces on the CSM.
The amplitudes of the CSMs are normalized voxelwise such that each voxel 
location, when summed over the channels, adds up to unity. For the fre-
quency encoded SENSE navigator, first a Fourier transform was applied along 
this direction to resolve the spatial dependence. The phase difference signal 
in the frequency encoding direction was fitted using a polynomial of 2nd or-
der to reduce the effects of noise, after which the previously described steps 
were performed.  This was empirically found to be the lowest polynomial or-
der that matched the observed magnetic field distribution patterns adequa-
tely. For the SENSE navigator f0,nav(x, t, ch) reduces to f0,nav(t, ch) and for the 
frequency encoded navigator to f0,nav(x, t). The zeroth order navigator results 
in a single frequency change value for each time point: f0,nav(t).
To estimate and assess the accuracy of these four navigator-based field es-
timations the following experiment was conducted. A fast single shot EPI 
sequence was run with the following parameters: repetition time (TR) /echo 
time (TE)/flip angle (FA) = 65 ms/ 25 ms/ 25°, EPI factor = 27, SENSE factor 2.3, 
voxel size = 3.3x3.3x3 mm3, bandwidth per pixel = 23 Hz. Before image ac-
quisition the navigator echo was acquired using 32 coil elements at TEnav=2.1 
ms. A total of 4000 images were acquired resulting in 4’20’’ scanning time. 
Four subjects performed the following tasks during scanning: touching their 
nose, moving one arm, touching their neck, and taking deep breaths. The 
first image was taken as a reference and the phase difference with respect to 
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subsequent images was calculated. These measurements were considered 
the ground truth and were compared to the navigator based estimations of 
the spatio-temporal field variations. Head motion was minimized using foam 
padding and was visually monitored.
To assess the error for each of the three approaches sum-of-square diffe-
rence (SSD) maps were generated between the ground truth measurements 
and the navigator based estimations. The maps were summed over all voxels 
and timepoints to yield a single number indicating the accuracy of the speci-
fic navigator approach. A reduction in the SSD (RSSD), defined as (SSDnavigator 
– SSDno correction) / SSDno correction will be reported.
Image artifact correction
The second component of the study consists of using the different navigator 
field estimation approaches for image artifact correction in a T2
*-weighted 
sequence. The following sequence was used to demonstrate the effects 
that magnetic field variations can have on image quality. Six subjects were 
scanned using a 2D gradient echo sequence with the following parameters: 
TR/TE/FA = 400 ms/20 ms/ 30°, the navigator was acquired at TEnav=10 ms, 
voxel size 0.42x0.42x3 mm3, and data matrix size of 480x480. Three separate 
scans were acquired: 1) subject lying still, 2) subject touching nose at ap-
proximately 10 s intervals, and 3) subject taking deep breaths. The first scan 
is considered as a reference image and is used to compare the performance 
of the navigator based reconstructions of images acquired during intentional 
magnetic field variations. For each acquired k-space line an estimation of the 
magnetic field change was made using the previously described navigator 
techniques. The resulting phase errors can be incorporated in the image en-
coding equation (11, 24), written in matrix form:
       [2]
Where k is the k-space data, m is the image space data, both stored as a co-
lumn vector of size [NxNy], where Nx is the number of frequency encodings 
and Ny is the number of phase encodings, or voxels along the respective di-
mensions. E is the encoding matrix, containing both the Fourier encoding 
terms as well as the derived phase errors for each shot and location. If paral-
lel imaging is not considered E is of size [NxNy x NxNy] and becomes prohibi-
tively large even for moderate imaging resolutions. Therefore an iterative 
approach based on a conjugate gradient solver was used that calculates only 
the relevant parts of E and the complex conjugate EH to solve this problem 
efficiently (24–26). Equation 2 can be rewritten as:
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 [3a]
and,
       [3b]
Where equation 3a calculates E m and equation 3b calculates EH m. Mi is a 
diagonal matrix of size [NxNy x NxNy] that selects the data for the i
th shot. F is 
the Fourier transformation, F-1 is the inverse Fourier transformation and Pi is 
a diagonal matrix of size [NxNy x NxNy] that contains the phase variations for 
the ith shot. The summation is performed over the number of shots. Based 
on visual inspection the maximum number of iterations was set to 3, to limit 
reconstruction times. Data for multiple coils were reconstructed separately 
and combined using the coil sensitivity maps (27). Images were reconstruc-
ted both with and without navigator echo correction. Phase images were 
unwrapped using k-space based high-pass filtering, as detailed in ref. (28)
Overall reconstruction times were 1 minute per channel for a single slice on 
an 8 core Intel 2.27 GHz processor with 12 GB internal memory, using Matlab 
2009a (Mathworks, USA).. 
To assess image quality, difference images were generated between the se-
parately acquired non-corrupted image (where the subject was asked to lie 
still in the scanner) and the images where movements were intentionally 
made. A large percentage reduction in the difference image corresponds to 
a small difference between the reference image and the retrospectively cor-
rected image, which is a measure for how well the navigator reconstruction 
performed. In four subjects the reference scan was repeated while the sub-
ject was lying still, in order to assess the stability of the navigator based ap-
proaches with respect to very small magnetic field fluctuations. 
results
Figure 2 is an example of a single time frame of the spatial magnetic field 
distribution and illustrates the performance of the different approaches du-
ring touching of the nose. Figure 2a displays the “ground truth” magnetic 
field distribution. The corresponding estimated field change maps using the 
navigator echo based approaches are shown in Figure 2b for zeroth order, 
Figure 2c for SENSE navigator estimation without frequency encoding, 2d 
for frequency encoded navigator estimation and in 2e for SENSE navigator 
estimation with frequency encoding information. In Figure 2a a spatially in-
homogeneous magnetic field distribution is observed with a spread of up to 
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20 Hz between the anterior and posterior regions. The zeroth order naviga-
tor measured a global frequency offset of -6.5 Hz, approximately the average 
frequency offset over the entire slice. Visually it can be appreciated that both 
SENSE navigator approaches and the frequency encoded estimation lead to 
an improved field estimation compared to the zeroth order technique. The 
low bandwidth of the EPI sequence leads to geometric distortions on the 
order of 1 to 2 pixels in the phase encoding direction for the observed field 
variations during the nose touching experiments. 
Figure 2: Magnetic field changes during nose touching.
Field changes in an axial brain slice during nose touching measured using an EPI sequence 
(a) which is considered to be the ground truth field change measurement.  b-e) show the 
navigator based field change estimations. b) is the result of the conventional zeroth order 
navigator, a global frequency offset of -6.5 Hz is estimated for the entire slice with no spatial 
resolution. c) is estimated using the SENSE navigator. (d) is estimated using only frequency 
encoding, and (e) is estimated using the frequency encoded SENSE navigator. The magnetic 
field varies substantially over the slice between -20 Hz frontally to +5 Hz posterior. Table 1 
shows a quantitative summary of the results.
To assess the accuracy of the different approaches quantitatively, SSD maps 
are generated over the complete time course. The RSSD for the different 
navigator estimations compared to no estimation is calculated. The zeroth 
order navigator results in a reduction of 56 ± 14% (p = 0.02). Further reduc-
tions are found for SENSE navigator estimation: 70 ± 14% (p = 0.02), for the 
frequency encoded navigator estimation: 70 ± 16 % (p=0.02) and 73 ± 16% (p 
= 0.02) is found for the frequency encoded SENSE navigator estimation (see 
table 1 for details).
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Table 1: Reduction in sum of squared difference (RSSD) values.
Zeroth order navigator 56 ± 14% †
SENSE navigator (no FE) 70 ± 14% †,‡
FE navigator 70 ± 16 % †,‡
SENSE navigator (with FE) 73 ± 16% †,‡
RSSD values for each navigator echo based approach compared to no navigator correction. 
(no FE): no frequency encoding gradient information is used; (with FE): frequency encoding 
information of the navigator echo is used. P-values are calculated using a paired t-test, com-
paring RSSD values between no correction and the different navigator techniques. † denotes 
significantly different from no correction; ‡ denotes significantly different from zeroth order 
navigator correction, p<0.05.
The application of the navigator based field estimations for retrospective 
image correction is shown in Figure 3. Images from the T2
*-weighted sequen-
ce are shown for two slice locations in the brain during nose touching at an 
interval of approximately 10 s. Figures 3a and 3f show the results when no 
correction is applied. Severe image artifacts are observed, resulting from the 
strong dynamically varying magnetic field changes during acquisition. When 
the image is corrected using a single phase offset for each acquired k-space 
line (Figures 3b and 3g, zeroth order correction) the image quality is impro-
ved, but artifacts still remain. When coil-based SENSE navigator correction is 
applied image quality is further improved. Figures 3c and 3h show the cor-
responding results for SENSE navigator correction. Figures 3d and 3i show 
the resulting images for the frequency encoded navigator correction and 
Figures 3e and 3j show the results for frequency encoded SENSE navigator 
correction.  Most image quality improvements are observed in the anterior 
part of the brain. Visually the best image quality is obtained for frequency 
encoded navigator field estimation and frequency encoded SENSE navigator 
estimation. The bottom row shows the difference images compared to an 
artifact free image when no intentional subject motion was introduced. A 
reduction of differences is visible when navigator correction is applied. Histo-
grams of the difference image values are shown in Figure 3 as an inset on the 
difference maps. The histograms corresponding to the SENSE and frequency 
encoded navigator corrected data show a narrower distribution compared to 
no correction, or zeroth order correction histograms. 
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Figure 3: Navigator corrected T2*-weighted imaging during nose touching.
Different reconstructions are shown for two slice locations in the brain (a-e) and (f-j), respec-
tively, Below each image the difference image is shown between the corresponding recon-
structions and an artifact-free image (no nose touching). Histograms of the difference values 
are displayed as an inset in the bottom left corner of the difference images. a,f) the original 
dataset without correction. b,g) Image corrected using conventional (zeroth order) naviga-
tor correction. Artifacts in the frontal part of the brain are reduced (see zoomed in sections), 
c, h) image after SENSE navigator correction. d, i) Image using the frequency encoded navi-
gator correction, without using coil sensitivity information, e, j) image after frequency en-
coded SENSE navigator reconstruction., The histograms of the difference values show that 
the distribution of values becomes narrower when navigator correction is applied. Results 
are summarized in table 2
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With the proposed reconstruction methods the complex MRI signal is pre-
served and therefore both magnitude and phase images can be reconstruc-
ted. Unwrapped phase images for a single subject are shown in Figure 4 
during a nose touching experiment. The image quality improves when navi-
gator correction is applied (Figures 4a – e), with the most pronounced reduc-
tion in image artifacts for frequency encoded SENSE navigator correction. In 
addition improved phase unwrapping is observed, depicted by the arrow in 
the zoomed in sections of the anterior part of the brain. This is particularly 
apparent in Figures 4d and 4e.
Figure 4: Navigator corrected phase images during nose touching.
Unwrapped phase images during nose touching. a) no correction, b) zeroth order correction, 
c) SENSE navigator correction, d) frequency encoded navigator correction and e) frequency 
encoded SENSE navigator correction. Similar to the results of figure 3 much improved image 
quality is visible for the frequency encoded and SENSE navigator approaches, resulting in 
clearer phase images. Phase images were unwrapped using a homodyne high-pass filter 
with a kernel size of 80. The top row shows a zoomed section of the anterior part outlined 
by the white box. The arrow points to an area that significantly improves. Images are scaled 
between –π/5 and π/5.
Figure 5 shows images of a different subject while performing deep breathing. 
Again the best results are obtained for frequency encoded and SENSE navi-
gator correction, however in this case the improvements compared to the 
other approaches are less pronounced. The middle row shows a zoomed 
section of the posterior part, the arrow points to one of the artifacts that is 
resolved only when SENSE navigator correction is applied. The bottom row 
shows the difference images compared to an artifact free image. The diffe-
rence images are scaled differently compared to Figure 3. Histograms of the 
difference images show a narrower distribution of values when navigator 
correction is applied compared to no correction. The differences in histo-
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grams between the zeroth order correction and other navigator techniques 
are less pronounced.












Nose touching 22 ± 9% † 36 ± 13%  †,‡ 46 ± 14%  †,‡ 47 ± 13%  †,‡
Deep breathing 11 ± 12% 13 ± 12%  †,‡ 14 ± 12%  †,‡ 15 ± 12%  †,‡
Normal breathing 15 ± 14% 15 ± 14% 15 ± 15% 15 ± 15%
Percentage reduction in difference between image acquired when subjects (n=6) were lying 
still and when subjects were performing nose touching, deep breathing or normal breathing 
for the different navigator correction approaches. P-values are calculated using a paired 
t-test, comparing absolute SSD maps between the artifact free image and the different na-
vigator techniques. † denotes significantly different from no correction; ‡ denotes signifi-
cantly different from zeroth order navigator correction; p<0.05.
The improvement in image quality was quantified by taking the difference 
between the corrupted image of a single slice and the separately acquired 
reference image when the subject was asked to lie still in the scanner. A 
percentage reduction in the difference image of up to 47 ± 13% (p = 0.01) is 
obtained for nose touching experiments and up to 15 ± 12% (p = 0.04) for the 
experiments consisting of deep breathing (see table 2 for details). When no 
artificial field fluctuations were introduced navigator correction resulted in a 
reduction in the amount of differences of 15 ± 14 % (p=0.08), irrespective of 
the navigator correction technique used, compared to when no correction is 
performed. 
92  | ChaPter 6
Figure 5: Navigator corrected T2*-weighted imaging during deep breathing.
Different reconstructions are shown. a) Uncorrected image, b) image using zero order cor-
rection, c) using SENSE navigator correction, d) using frequency encoded correction and 
e) using frequency encoded SENSE navigator correction. The bottom row shows difference 
images between the corresponding reconstructions and an artifact-free image. Histograms 
of the difference values are displayed as an inset in the bottom left corner of the difference 
images. Compared to nose touching experiments the increase in image quality between the 
zero order approach and the SENSE navigator approaches is less pronounced. The arrow 
points to an artifact at the posterior side of the brain that is reduced by SENSE navigator 
correction. Data are summarized in table 2 showing that frequency encoded and SENSE 
navigator correction leads to the best results. 
discussion
The most important findings of this study are twofold. First, the use of sen-
sitivity encoded and frequency encoded phase navigators leads to an impro-
ved estimation of inhomogeneous spatio-temporal magnetic field disturban-
ces in the human brain compared to a conventional zeroth order navigator 
approach when strong field distortions are introduced. Second, it was shown 
that the image quality of heavily T2
*-weighted acquisitions can be improved 
considerably by correcting for these inhomogeneities, caused primarily by 
patient motion outside of the imaging region. 
The field map obtained during nose touching, see Figure 2 shows that the 
magnetic field disturbance is not homogeneous over the slice. There is a 
large variation between the anterior and posterior part of the brain. Conse-
quently a global frequency estimate for the complete slice, as is obtained by 
a conventional zeroth order navigator, does not describe this magnetic field 
distribution adequately under this particular type of experiment. All the sig-
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nals from the different receive coil elements that might reflect local changes, 
are effectively averaged in this case. Since the individual coil elements of 
the receive array sample only a small part of the brain, temporal changes in 
magnetic field can be detected and spatially resolved. If the coil elements are 
weighted according to their spatial sensitivity profile, low resolution spatio-
temporal field change maps can be obtained, resulting in a more realistic es-
timation of the inhomogeneous field. When, in addition, frequency encoding 
of the navigator echo is used, field change estimations can be further impro-
ved. The field fluctuations introduced by nose touching are mainly oriented 
in the anterior-posterior direction. Therefore a frequency encoded navigator 
along that same direction without using coil sensitivity information already 
results in substantial improvements in estimating the magnetic field. In the 
present work significant improvements in the RSSD have been demonstrated 
for the SENSE and frequency encoded navigators. It should be noted that 
the EPI based method used to serve as a “ground truth” cannot be used for 
measuring magnetic field fluctuations in practical imaging studies because of 
the amount of time it takes to acquire the extra data. In addition the intro-
duction of an extra RF pulse needed for the EPI readout also influences the 
magnetization, which is unwanted in most experiments. A navigator echo, 
on the other hand, can be used in a variety of imaging experiments through 
minor sequence adaptations. In the imaging experiments that are perfor-
med in this study, the navigator echo is acquired before the actual frequency 
encoding readout because of the long TE of the sequence and is part of a 
pre-phaser gradient already present in the sequence (see Figure 1). It does 
however limit the total time available for the imaging acquisition, therefore 
resulting in a signal-to-noise penalty. The time needed for the navigator can 
be minimized by sampling the navigator echo at a higher bandwidth (6) or 
by reducing the number of samples when no frequency encoding is required 
(19, 23). Due to the long imaging time needed for the EPI readout the TEnav of 
the ground truth measurements is different from the imaging experiments 
The artificially-induced changes in magnetic field distributions in this study 
were used to mimic (and amplify) spatio-temporal magnetic field fluctuati-
ons within a slice that have been observed in previous studies and serve as 
a worst case (2, 5, 6). Nose touching experiments result in substantial image 
degradation, as is shown in Figure 3 and 4, which result from the large vari-
ations in resonance frequency (up to 20 Hz). The image quality is considera-
bly improved when zeroth order navigator echo correction is applied in line 
with previous findings in Alzheimer’s disease patients using a comparable se-
quence (6). However, some artifacts still remain after zeroth order navigator 
correction, which is indicative of a spatial distribution of the magnetic field 
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changes that is not captured accurately using the zeroth order navigator ap-
proach. The remaining artifacts are substantially reduced when a SENSE na-
vigator or frequency encoded navigator correction technique was employed. 
The best performance was observed when frequency encoding of the coil 
sensitivity navigator was included. The artifacts caused by deep breathing 
were, in general, less severe than during nose touching and the improve-
ments between SENSE navigator correction and zeroth order correction are 
less pronounced. This is likely due to the relatively homogeneous magnetic 
field distribution that is induced by breathing for transverse slices through 
the brain (1, 2, 5) and smaller amplitude of the magnetic field changes (typi-
cally less than 10 Hz). In the absence of artificially introduced magnetic field 
fluctuations, such as nose touching or deep breathing, small image quality 
improvements were observed for navigator correction compared to no cor-
rection: however, no differences were found between the performance of 
the different navigator techniques. Another advantage of the improved na-
vigator approaches is that the unwrapped phase images, also show fewer 
artifacts when correction is applied and in addition improved performance 
of the phase unwrapping algorithm is observed. When navigator correction 
is applied, artifacts arising from rapid spatial phase variations are reduced 
and fewer remaining phase wraps are observed. These improved phase ima-
ges can be particularly helpful in applications such as susceptibility weighted 
imaging. 
It should be noted that, in order to enable the direct comparison of the dif-
ferent navigator techniques the zeroth order and SENSE navigator have been 
acquired in a suboptimal manner in the sense that although no frequency 
encoding information is required, all data are actually acquired using a fre-
quency encoding gradient followed by complex summation in the spatial-
temporal or temporal domains respectively, resulting in a reduction in SNR 
and increased sensitivity to motion. 
The concept of acquiring navigator echoes using multiple receive channels 
is not entirely new. Non-phase encoded free induction decay signals, similar 
to navigator echoes have been used in recent publications for high temporal 
imaging, or B0 shimming (21–23). Others have shown that by using multi-coil 
navigators, improvements in image quality could be obtained by retrospecti-
vely discarding and re-measuring k-space lines that contain signal corruption 
exceeding a certain threshold (29). In this case the navigator echoes were 
acquired using a dedicated RF excitation pulse interleaved with the imaging 
sequence. In our approach, rather than discarding and re-measuring data, 
the navigator based spatial field estimations are used for retrospective ima-
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ge correction and therefore require no extra scanning time. It is expected 
that an even higher number of elements will result in further improvements 
in estimating the spatial magnetic field distribution. 
Methods other than navigator echoes can be used to measure dynamic mag-
netic field fluctuations. External field probes positioned around the subject 
can be used to sample dynamically magnetic field changes using free induc-
tion decay signals (11, 12). These field probes can operate at a different re-
sonance frequency (e.g. fluorine) than the imaging sequence, limiting the 
interaction with the imaging sequence and therefore requiring no additional 
scanning time (11). However the phase changes are measured outside of the 
brain and data are fitted to provide the field changes within the head (11, 
12), leading to a possible reduction in accuracy. Furthermore, the hardware 
effort needed to support these field probes is substantial potentially limiting 
wide applicability. An advantage of the proposed navigator approach is that 
the phase changes are measured within the brain and that no additional 
hardware components are necessary.
Another method to measure dynamically fluctuations in the magnetic field 
is to relate the phase of the respiratory cycle to a certain magnetic field 
distribution. A calibration scan is used to measure the magnetic field dis-
tribution at different phases of the respiration cycle using an external belt. 
During imaging the shim settings are adjusted according to the respiration 
cycle (1). However, using this approach non-periodic field changes, such as 
body movements, yawning and coughing cannot be corrected. Our proposed 
method differs in that it does not make an assumption of the periodicity or 
origin of the magnetic field fluctuations since it measures the field distribu-
tion for each RF excitation. Furthermore, no additional calibration scan is 
needed. Care needs to be taken that the echo time of the navigator (TEnav) 
is sufficiently small such that, given the amplitude of the expected magnetic 
field variations, no phase wraps occur. However, for very small values of TEnav 
the sensitivity to magnetic field variations is reduced. The maximum detec-
table range of magnetic field variations corresponding to TEnav = 10 ms is ± 
50 Hz, conservatively set to be approximately twice  the estimated/observed 
magnetic field changes.
The proposed reconstruction framework is similar to the technique descri-
bed by Liu et al. (24) in the “extreme” form where each shot comprises the 
acquisition of only a single k-space line. Their technique has been implemen-
ted for self-navigated sequences, such as spiral or PROPELLOR (30), whereas 
in our case a separate navigator echo is acquired. The approach that is used 
in this study incorporates the spatial sensitivity information of multiple coils 
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in a receive array to improve the spatial reconstruction of a magnetic field 
distribution map. This has been shown using a similar acquisition approach 
with FID navigators before, but without using the application in retrospec-
tive image correction and without using frequency encoded navigators (23). 
Future work will focus on implementing this method to include a frequency 
encoding gradient to further increase the accuracy of the dynamic field es-
timations.  Most sequences can be modified to allow for the inclusion of a 
navigator echo, especially when only a limited number of points are sampled 
(19), whereas only certain sequences can be modified to be self-navigated. 
Instead of using Cartesian navigators, spiral navigators have been used to 
dynamically measure low resolution field maps either by self-navigation 
through oversampling of the center of k-space (20, 24), through the sepa-
rate acquisition of a spiral navigator echo (16, 31), or orbital navigators (32). 
These techniques have been applied successfully in diffusion weighted ima-
ging to correct for phase errors or in structural imaging to correct for subject 
motion. However in these cases the spatial dependency of the individual coil 
elements is not taken into account and the proposed Cartesian navigators 
can be acquired in a shorter amount of time, especially when no frequency 
encoding gradient is required.
So far, most applications of phase correction have been in the field of diffu-
sion weighted imaging (15, 16, 20, 31) or functional imaging (13, 14, 17, 18). 
Both applications are very sensitive to magnetic field induced phase changes 
or motion. However, as was shown previously, high field (i.e. 7 Tesla) causes 
more sequences to be sensitive to magnetic field induced phase changes (1, 
6) because the amount of phase change is directly related to the magnetic 
field strength. Therefore, correction for magnetic field induced phase chan-
ges becomes important also for structural imaging at high field.
In principle the proposed technique is not limited to simple gradient echo 
sequences, but can easily be extended to other types of data acquisition. 
The reconstruction framework can be used with any method that estimates 
dynamic field changes. Although in this study the actual imaging sequence 
was not accelerated by parallel imaging, the iterative image reconstruction 
approach is also applicable to undersampled k-space data as was shown pre-
viously (24, 33)
conclusion
Changes in the magnetic field distribution in the brain, caused by physio-
logical and/or patient motion can seriously affect high field image quality. 
Correcting for these artifacts is important to obtain consistent image quality 
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in patient studies performed at high field. By intentionally introducing strong 
magnetic field distortions the performance of different navigator techniques 
was investigated. It was found that the combination of frequency encoded 
navigator echoes and coil sensitivity information (SENSE navigator echoes) 
improved the spatial and temporal estimation of the magnetic field distri-
bution under these exaggerated conditions, such as nose touching and deep 
breathing, compared to conventional zeroth order navigator estimation. 
Prior information about the expected direction of strongest field gradients 
was used for the frequency encoded techniques. Under normal conditions in 
cooperative subjects all investigated navigator correction approaches wor-
ked equally well.
Therefore, the proposed SENSE and frequency navigator based image cor-
rection techniques are particularly valuable in T2
*-weighted sequences at 
high magnetic field strengths acquired in non-cooperative subjects. 
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AbstrAct
Magnetic susceptibility based (T2*-weighted) contrast in MRI at high mag-
netic field strength is of great value in research on brain structure and cor-
tical architecture, but its use is hampered by the low signal-to-noise ratio 
(SNR) efficiency of the conventional spoiled gradient echo sequence (GRE) 
leading to long scan times even for a limited number of slices. In this work, 
we show that high resolution (0.5 mm isotropic) T2*-weighted images of the 
whole brain can be obtained in 6 min by utilizing the high SNR efficiency of 
echo-planar imaging (EPI). A volumetric (3D) EPI protocol is presented and 
compared to conventional 3D GRE images acquired with the same resolu-
tion, amount of T2*-weighting, and imaging duration. Spatial coverage in 3D 
EPI was increased by a factor of 4.5 compared to 3D GRE, while also the 
SNR was increased by a factor of 2. Image contrast for both magnitude and 
phase between gray and white matter was similar for both sequences, with 
enhanced conspicuity of anatomic details in the 3D EPI images due to the 
increased SNR. Even at 7 T, image blurring and distortion is limited if the EPI 
train length remains short (not longer than the T2* of the imaged tissue). 3D 
EPI provides steps (speed, whole brain coverage, and high isotropic resolu-
tion) that are necessary to utilize the benefits of high field MRI in research 
that employs T2*-weighted imaging.
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introduction
Magnetic resonance imaging (MRI) with susceptibility-based contrast at high 
magnetic field strength has allowed the visualization of human brain ana-
tomy in vivo with exceptional detail. Variations in magnetic susceptibility 
of tissue (manifested as T2* and frequency variations) yield clear contrast 
between different anatomical structures in T2*-weighted magnitude images 
both in white matter (e.g. fiber bundles (1)) and gray matter (e.g. basal gan-
glia (2)). The phase of T2* weighted images is even more sensitive to magne-
tic susceptibility variations. Using the phase, it is possible to depict exquisite 
details of cortical structure and substructure, including the line of Gennari in 
the visual cortex (3–5). The magnetic susceptibility of tissue depends on the 
presence and arrangement of, amongst others, lipids, proteins and (non-he-
me) iron in the tissue (6, 7). T2*-weighted imaging at high field is, therefore, 
sensitive to the tissue composition at a cellular level, yielding a powerful tool 
to study normal and pathological tissue (8–11).
T2*-weighted imaging is conventionally performed using a spoiled gradient 
echo (GRE) sequence (12). At the high resolutions employed to image struc-
tural detail (<<1 mm3 voxel volume), however, imaging time is long, even 
for a limited number of slices (3). As a result, the imaging volume is typically 
limited since full brain coverage requires excessively long scan times of 1 h 
or more for a single acquisition. This hampers the practical use of T2*-weigh-
ted imaging for fundamental research of normal physiology or disease. Long 
imaging times are also problematic because they increase the possibility of 
subject motion during the scan duration resulting in blurring or unusable 
images (13). The long imaging times are due to the relatively low signal-to-
noise ratio (SNR) efficiency of the spoiled GRE sequence. For sufficient T2* 
weighting, a long echo time (TE) is needed, which leads to ‘dead’ time in the 
sequence during which no signal is acquired.
In this work, we show that high resolution T2*-weighted images of the whole 
brain can be obtained in 6 min based on volumetric (3D) echo-planar ima-
ging (EPI) by utilizing the high SNR efficiency of EPI (14). By using a multi-shot 
approach with short EPI train lengths, the common artifacts related to EPI 
(distortion and blurring) are limited, and images with a considerable gain in 
both SNR and coverage as compared to GRE imaging can be obtained within 
a given amount of scan time. The contrast in the phase and magnitude 3D 
EPI images and the distortion are compared with 3D GRE images, acquired 
with the same acquisition parameters in terms of resolution, amount of T2*-
weighting, and imaging duration.
104  | ChaPter 7
MaTeRialS and MeThodS
Imaging was performed on 8 healthy subjects (4 male, 4 female, age 
27 ± 4 years) who gave written informed consent, in accordance to the In-
stitutional Review Board of the University Medical Center Utrecht. Images 
were acquired using a 7 T MRI system (Philips Healthcare, Cleveland, USA) 
with a 16 channel receive coil and a volume transmit coil (Nova Medical, Wil-
mington, MA). Maximum gradient strength and slew rate were 33 mT/m and 
166 T/m/s, respectively. For all sequences 3rd order B0 shimming was per-
formed using an image based approach with an adapted version of the tool 
developed by (15). The amplitude of the RF transmit field (B1) was measured 
with actual flip angle imaging in the pulsed steady state (16) in order to as-
sess the spatial variations in the RF transmit field across the brain, using the 
following parameters: TR1/TR2/TE 25/125/2.5 ms, flip angle 50°, voxel size 
3.8 × 3.7 × 4 mm3, 20 slices, field of view 240 × 195 mm2. For good T2* con-
trast, the TE of the T2*-weighted sequences was chosen to be equal to the 
average T2* of white matter at 7 T: 27 ms (17), which is in between the (on 
average longer) T2* of cortical gray matter and the (on average shorter) T2* 
of the iron containing nuclei of the basal ganglia.
3D EPI protocol
A 3D T2*-weighted protocol was set up with 0.5 mm isotropic resolution 
(125 nl voxel volume) and whole brain coverage, with a total scan duration of 
less than 6 min. Multi-shot 3D EPI was used with a conventional Cartesian in-
terleaved k-space trajectory. During each EPI shot, the y gradient (left–right 
(LR) encoding) was stepped, for a given kz (linearly increasing phase encoding 
step in the feet–head direction). The EPI factor was set to 13, leading to an 
EPI train length of 23 ms, below the average T2* for gray and white matter 
(17). Fat-suppression was applied to avoid possible artifacts that may arise 
from a shifted fat signal in combination with sensitivity encoding (SENSE) 
with the small receive coils, which have a rapidly varying sensitivity at the 
location of the subcutaneous fat. For fat-suppression Spectral Presaturation 
Inversion Recovery (SPIR) was applied with a non-selective RF pulse of 110 ° 
flip angle, 679 Hz BW and a frequency offset of 1.1 kHz. The flip angle of the 
imaging sequence was set to a value which was 33% larger than the Ernst an-
gle for gray matter given the TR (see Table 1). This choice was made to partly 
compensate for the fact that the actual B1 as assessed from the B1 maps was 
about 80% of the nominal value (20 μT) in the center of the brain, and even 
less elsewhere. The Ernst angle was computed using the T1 value for cortical 
gray matter at 7T, T1 = 2132 ms (18). The flip angle was optimized for gray 
matter (GM), as GM has a longer T1 and thus less signal, relative to white 
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matter (WM). The imaging parameters are shown in Table 1.
Table 1: Imaging parameters.
3D EPI 3D GRE 2D EPI 2D GRE
FOV (mm2) 240 × 192 240 × 192 240 × 190 240 × 190
Matrix (AP × RL) 480 × 381 480 × 384 300 × 234 300 × 237
Resolution (mm2) 0.5 × 0.5 0.5 × 0.5 0.8 × 0.8 0.8 × 0.8
Slice thickness (mm) 0.5 0.5 2 2
Nr slices 300 66 1 1
Coverage (FH direction, mm) 150 33 2 2
Flip angle 19° 13° 15° 15°
TR/TE (ms) 70/27 32/27 70/27 70/27
BW readout direction (Hz/pixel) 677 203 997 1080
BW phase encoding direction 
(Hz/pixel)
41 – 57 –
EPI factor 13 – 13 –
Repetitionsa – – 26 2
Slice-oversampling factor 1.28 1.28 – –
k-space shutter (sampled frac-
tion of k-space)
1.0 0.78 1.0 1.0
SENSE (LR) 2.3 2.3 1.0 1.0
Fat suppression SPIR None SPIR SPIR
Scan time (s) 350 354 33.3 33.9
          
FOV: field-of-view, AP: anterior–posterior, RL: left–right, FH: feet–head, TR: repetition time, 
TE: echo time, BW: bandwidth, SENSE: parallel imaging acceleration factor (sensitivity en-
coding), SPIR: spectral presaturation by inversion recovery. a Last repetition is performed 
without applying any RF or gradient pulses in order to measure the noise.
3D GRE protocol
As a reference for image quality, a GRE imaging protocol was set up with 
the same resolution, TE and scan duration as the EPI protocol (Table 1). The 
bandwidth was chosen to obtain optimal SNR for the GRE images, and was 
equivalent to that used for the combined time-of-flight/susceptibility weigh-
ted clinical imaging protocols in our hospital (19). Given the scan duration, 
coverage for the GRE protocol was maximized by choosing the shortest pos-
sible repetition time (TR), and adapting the flip angle accordingly. Fat sup-
pression was omitted to further shorten the TR within the specific absorp-
tion rate (SAR) constraints. A vendor supplied elliptical shutter in k-space was 
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applied with GRE, which means that approximately 22% of the data in the 
edges with both high ky and high kz values were not sampled. Given the scan 
duration, this allows to further increase the coverage with a limited cost in 
resolution.
Quantitative comparison between 3D EPI and 3D GRE images
The 3D EPI and GRE images were reconstructed with image homogeneity 
correction, using the standard reconstruction software of the scanner. Both 
magnitude and phase images were stored. Phase images were high-pass fil-
tered by subtracting a 2nd order polynomial fit from the phase data in or-
der to remove large length-scale fields over the whole image. Varying fields 
toward the edge of the image were filtered by modeling these fields with 
dipole point sources parallel to the main field (B0) and subtracting a least-
squares fit from the phase data, as described in Wharton et al. (20) The 3D 
EPI images were compared to the GRE images to assess the image quality 
and contrast, for both magnitude and phase.
Figure 1: Magnitude images of the 3D EPI protocol 
(A: transverse, B: sagittal, C: coronal orientation), showing the gain in coverage and SNR as 
compared to the 3D GRE imaging protocol (D, E and F). Note that the EPI and GRE images are 
acquired with the same scan duration and resolution. The dotted lines indicate the perpen-
dicular cross-sections of the different orientations. Some blurring can be seen for the GM 
just above the nasal cavity in panel B.
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The contrast between GM and WM in the two sequences was compared for 
regions of interest (ROIs) in three different regions (GM vs. WM): cingulate 
gyrus vs. corpus callosum, putamen vs. internal capsule, and GM vs. WM in 
the primary visual cortex. The contrast in the magnitude images was defined 
as the signal of GM divided by the signal of WM. This signal ratio was chosen, 
because the conventional measure of contrast, SNRGM − SNRWM is directly 
affected by the overall difference in SNR between the two sequences. The 
contrast in the phase images was quantified as the frequency difference in 
Hz, which was obtained by dividing the phase in radians by 2π TE.
The distortion in the EPI images was assessed by overlaying the outer con-
tour of the GM in the 3D GRE image over the corresponding 3D EPI image. 
To remove any contribution from head motion between the scans, the 3D 
GRE images were registered to the 3D EPI images with rigid body registration 
using the FSL software package (FSL 4.1, FMRIB’s Software Library, Oxford 
(21). After registration, the maximum mismatch between the GRE contour 
and the EPI image was measured in the phase encoding (LR) direction for 
both the lowest and the highest slice in the GRE dataset.
To confirm that the EPI and GRE performance is equivalent if all imaging 
parameters are the same, we performed a 2D experiment where the only 
difference was the scan duration (due to the EPI factor). The imaging para-
meters are given in Table 1. The noise level was measured by repeating the 
data acquisition with the same receiver gain and bandwidth for data sam-
pling, without applying any RF or gradient pulses. The EPI scan was repeated 
multiple times in dynamic mode, in order to obtain a steady state signal for 
correct comparison of the SNR level between EPI and GRE imaging. The 2D 
EPI and GRE images were used to measure the SNR in an ROI covering the 
complete brain. The noise level was quantified as the standard deviation in a 
corresponding ROI in the image with sampled noise.
results
The image quality was consistent for all volunteers for both the 3D EPI and 
the 3D GRE protocol. The remarkable improvements in both coverage and 
SNR that are obtained with the 3D EPI protocol are illustrated in Fig. 1. Note 
the clear depiction of the cerebellum, and the clear visualization of the hip-
pocampus in the 3D EPI images. The contrast in both the magnitude and 
phase images between GM and WM was similar between 3D EPI and 3D GRE, 
as shown in Table 2. Fig. 2 and Fig. 3 illustrate the improved image SNR with 
3D EPI, for sample areas in the basal ganglia and the visual cortex. The higher 
SNR in the 3D EPI magnitude images yields improved visualization of tissue 
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borders, for example between white matter and the putamen, hippocampus 
and substantia nigra (Fig. 2). Also the optic radiations are delineated more 
clearly as they fuse into the primary visual cortex (Fig. 3). In analogy to the 
magnitude images, the higher SNR obtained with 3D EPI yields clearer phase 
images, which allows enhanced visualization of subtle details such as the 
line of Gennari in the visual cortex (Fig. 3). Artifacts from incomplete phase 
unwrapping are similar between both protocols, e.g. posteriorly around the 
edges of the cortex (Fig. 2 and Fig. 3).
Figure 2: Detail of transverse 3D EPI vs. 3DGRE images.
Visible are many anatomical structures,including the putamen (Pt) and globus pallidus (GP) 
in the lentiform nucleus, the anteriorcommissure (black arrow heads), substantia nigra (long 
black arrow), the nucleus ruber (short black arrow) and the hippocampus (white arrow). 
Left: 3D EPI magnitude (A) and phase (C). Right: 3D GRE magnitude (B) and phase (D).
Maximum image distortions measured in the 3D EPI images, were 
2.2 ± 0.5 mm and 1.1 ± 0.2 mm for the slice corresponding to the lowest and 
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highest slice in the 3D GRE volume, respectively. The maximum distortion 
was usually observed as a very localized distortion (as illustrated in Fig. 4). In 
many cases, particularly away from bone/air-tissue interfaces, the distortion 
(if present) was less than 0.5 mm (pixel size). An example of the distortion is 
given in Fig. 4. In the slices close to the skull base, the border between GM 
and WM appeared less sharp in the EPI images, as can be seen in the frontal 
area above the nasal cavities in Fig. 1.
Figure 3: Detail of transverse 3D EPI vs. 3D GRE images, showing part of the visual cortex. 
Left: 3D EPI magnitude (A) and phase (C). Right: 3D GRE magnitude (B) and phase (D). The 
black arrows in the EPI phase image (C) indicate the line of Gennari, and the arrow heads 
point to the clear delineation of the optic radiations.
The 2D EPI images had similar SNR (15.8 ± 0.6) as the 2D GRE images 
(14.9 ± 0.5) (mean ± standard deviation across subjects, n = 8), despite the 
fact that they were acquired 13 times faster. Hence, the SNR efficiency of the 
2D EPI protocol was approximately √ 13 larger than that of 2D GRE protocol, 
as expected.
discussion
The high SNR efficiency of EPI was used to develop a fast 3D T2*-weighted 
anatomical imaging protocol, providing whole brain coverage with 0.5 mm 
isotropic resolution in less than 6 min. Given a fixed amount of scan time, the 
3D EPI protocol yields more than a four-fold increase in coverage (150 mm 
vs. 33 mm for 3D GRE imaging), and also higher SNR. The higher SNR allows 
enhanced visualization of fine anatomical detail ( Fig. 2 and Fig. 3), while the 
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isotropic resolution allows reformatting of the data in any desired orienta-
tion (Fig. 1).
Figure 4: Amount of distiortions on GRE and EPI dataset.
Example data showing the highest and lowest slices of a 3D GRE data set (panels A and C, 
respectively) and the corresponding slices in the 3D EPI data set (panels B and D, respecti-
vely). The outer contours of the brain as drawn on the GRE images are superimposed on the 
EPI images to assess the amount of distortion. The arrows indicate the location of maximum 
distortion in the phase encoding direction (1.4mm for the highest slice, B, and 2.7 mm for 
the lowest slice, D).
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To date, the high SNR efficiency of EPI is almost exclusively used for func-
tional MRI (fMRI), to capture the dynamic signal changes associated with 
brain activity. Recently, it was shown that 3D EPI imaging is more efficient 
than multi-slice (2D) EPI, in the context of fMRI applications (22). The current 
results show that the high SNR efficiency of 3D EPI is also valuable for appli-
cation in structural imaging, an application for which the use of EPI seems to 
be underappreciated.
Table 2. Contrast between GM and WM for both 3D EPI and 3D GRE images.




3D EPI phase 
(Hz)
3D GRE phase 
(Hz)
CG vs.CC 1.7 ± 0.2 1.7 ± 0.2 − 0.3 ± 0.7 − 0.2 ± 0.5
Pt vs. IC 0.8 ± 0.1 0.8 ± 0.1 − 2.6 ± 0.4 − 2.4 ± 0.5
GMvc vs. WMvc 1.2 ± 0.2 1.1 ± 0.1 − 3.4 ± 1.0 − 3.5 ± 1.2
CG: cingulated gyrus, CC: corpus callosum, Pt: putamen, IC: internal capsule, GMvc/WMvc: 
gray matter/white matter of visual cortex. For magnitude: ratio of gray matter signal over 
white matter signal, for phase: difference in phase, expressed as a frequency difference 
(using TE = 27 ms).
SNR efficiency, point spread broadening and distortion
The SNR efficiency of the 3D EPI protocol presented here (Table 1) resulted 
in a gain in SNR by a factor of 2 relative to the 3D GRE protocol. The relative 
SNR was calculated by S = (1 − E1) E2 sinα / (1 − E1cosα) (23) and the depen-
dency of the SNR on voxel volume (∆xyz), number of samples acquired (Nx-
NyNz) and bandwidth (BW): S∆xyz √((NxNyNz)/BW), where E1 = exp(− TR/T1), 
E2 = exp(− TE/T2*) and α is the flip angle.
The main reason why GRE imaging has a much lower SNR efficiency than 
EPI, is that GRE imaging performs data sampling only during a fraction of the 
‘lifetime of the signal’, T2*, while EPI samples the signal over a much longer 
duration. The limiting factor for imaging speed with EPI is, therefore, the T2* 
of the tissue. We chose an EPI factor of 13, leading to an EPI train length of 
23 ms, which is just below the T2* for most brain tissues. Long echo trains 
will reduce the efficiency of EPI, because in the extreme case, only noise is 
sampled, while shorter echo trains are still sub-optimal. There is a trade-off 
between EPI train length and image blurring or point spread widening, due 
to T2* decay during the readout. Using an EPI train length equal to the T2* of 
the imaged tissue, the broadening of the point spread function is less than 
5% (24). For longer train lengths, or for tissues with shorter T2*, for example 
as may occur in regions with poor shimming such as above the nasal cavities 
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(Fig. 1), blurring can become noticeable.
The 3D GRE bandwidth could be reduced to such extent that the SNR ef-
ficiency of the 3D GRE protocol would become equal to that of the 3D EPI 
protocol (3). However, the total scan time for whole brain coverage would 
still be long, as the increased SNR efficiency obtained in this way cannot be 
traded off directly against imaging speed, as is the case for EPI.
The 3D EPI images showed only limited distortion, with a maximum observed 
distortion of 2.5 ± 0.5 mm for the lowest slice of the 3D GRE volume. This 
might be counter-intuitive, as EPI is well known to suffer from distortion. Ho-
wever, the amount of distortion depends strongly on the echo train length. 
With the echo train length used in this study, the BW in the phase enco-
ding direction is 41 Hz, which corresponds to a displacement of 2.5 pixels 
(1.25 mm) per 100 Hz off-resonance. In our experience, using image based 
shimming at 7 T, the standard deviation of the off-resonance frequency dis-
tribution in the shimmed brain volume is around 60 Hz after shimming. In 
regions close to the nasal cavity and petrous bones, distortion will be stron-
gest, and local gradients will lead to an apparently shorter T2* and hence 
to noticeable blurring, which can be problematic for studies involving these 
regions.
The lower bandwidth for EPI sequences in the phase encoding direction re-
sults in larger water–fat shifts, which can be a disadvantage. However, be-
cause of the increased TR and the acquisition of multiple lines with each RF 
excitation, it is possible to include fat suppression or saturation slabs while 
still remaining within the SAR constraints, which are more easily reached at 
higher magnetic field strengths.
Implications
T2*-weighted imaging provides valuable information in the study of both 
normal brain physiology and disease, as these images reflect brain tissue 
microstructure (4, 6, 25, 26). Neurodegenerative diseases in particular are 
associated with elevated iron depositions to which T2*-weighted imaging is 
extremely sensitive (8–11). Unfortunately, patients with neurodegenerative 
diseases often have difficulties lying still for more than a few minutes, while 
T2* weighted imaging is prone to motion artifacts (13). The proposed proto-
col is fast and will, hence, allow increased coverage in acceptable scanning 
time, or fast scanning of a limited brain area with lower chance of motion 
artifacts. Further reduction in scan time is expected from coils with more re-
ceive elements, which will allow for higher acceleration factors from parallel 
imaging. 3D EPI allows fast mapping of phase contrast and can hence con-
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tribute to research on the origins of this contrast (27), as well as to accurate 
susceptibility mapping (20). 3D EPI using non-isotropic voxel sizes may prove 
beneficial for venography based on susceptibility-weighted imaging (28).
conclusion
Fast T2*-weighted anatomical imaging with high resolution and full brain co-
verage was obtained with 3D multi-shot EPI imaging. Spatial coverage and 
image signal to noise ratio is markedly improved compared to conventional 
3D GRE imaging, given a fixed scan time and resolution, while image blurring 
and distortion are limited if the EPI train length remains short (not longer 
than the T2* of the imaged tissue). 3D EPI provides steps (speed, whole brain 
coverage, and high isotropic resolution) that are necessary to utilize the be-
nefits of high field MRI in research that employs T2*-weighted imaging.
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AbstrAct
Background
Post mortem studies have indicated the potential of high-field magnetic re-
sonance imaging (MRI) to visualize amyloid depositions in the cerebral cor-
tex. The aim of this study is to test this hypothesis in patients with Alzhei-
mer’s disease (AD). 
Methods
T2
*- weighted MRI was performed in 15 AD patients and 16 control subjects. 
All MRI scans were scored qualitatively by visual assessment and quantitati-
vely by measuring phase shifts in the cortical gray matter and hippocampus. 
Statistical analysis was performed to assess differences between groups.
Results
Patients with AD demonstrated an increased phase shift in the cortex in tem-
poroparietal, frontal, and parietal regions (p<0.005) and this was associated 
with the individual Mini Mental State Examination (r = -0.54, p<0.05). 
Discussion
Increased cortical phase shift in AD patients demonstrated on 7 Tesla T2
*-
weighted MRI is a potential new biomarker for AD, which may reflect amy-
loid pathology in the early stages.  
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introduction
Alzheimer’s disease (AD) can only be diagnosed with certainty at autopsy, 
based on the histological detection of senile plaques containing fibrillary 
amyloid-β (Aβ) and neurofibrillary tangles. Currently, due to the absence of 
validated sensitive and specific tests, the clinical diagnosis of AD can only be 
made at a late stage of disease progression and with a considerable degree 
of uncertainty, “probable AD” at best, and is based on criteria from the Diag-
nostic and Statistical Manual of Mental Disorders (DSM-IV) and the National 
Institute of Neurologic, Communicative Disorders and Stroke-AD and Related 
Disorders Association (NINCDS-ADRDA). Nevertheless, the histological hall-
marks of AD pathology, comprising amyloid plaques and neurofibrillary tan-
gles, are known to occur up to 10 to 20 years before the objective detection 
of cognitive decline (1). Recently, positron emission tomography (PET) using 
Pittsburgh compound-B (PiB) has been introduced as a diagnostic tool to de-
tect cerebral amyloid in-vivo (2–8). The major disadvantages of PiB-PET are 
the need to use a radioactive tracer, the relative scarcity of institutions that 
can perform such scans due to the requirement for an on-site cyclotron, the 
inability to acquire anatomical and functional information in the brain during 
the same examination and the high prevalence of positive amyloid scans in 
asymptomatic individuals, especially in the elderly which hampers the use of 
this method as a diagnostic tool in the elderly (9). 
Earlier research demonstrated the potential of high-field (7T) magnetic res-
onance imaging (MRI) in the diagnosis of AD by showing distinct intensity 
changes in the cortex on T2
*-weighted images of post mortem brain speci-
mens of AD patients. These features included hypointense foci and diffuse 
granular patterns of less distinct hypointense foci in the cerebral cortex (10). 
Similar patterns have been described in studies of AD transgenic mice and 
post mortem human AD, and were attributed to the presence of amyloid 
plaques using histological confirmation (11–19). It has been proposed that 
the visualization on MRI of plaques in humans and mice is based on the fact 
that these deposits co-localize with iron, which gives rise to magnetic sus-
ceptibility effects on T2
*-weighted images over volumes that are much larger 
than the actual size of amyloid plaques (17, 19–24). An alternative method 
to measure these susceptibility changes in the brain is to measure the rela-
tive phase in regions of interest, since it has been shown that this is a reliable 
indicator of the iron content in the brain (25–28). Although previous studies 
have demonstrated the potential of this approach in high-field MRI (29, 30), 
no clinical studies have been performed yet on AD patients in-vivo for the 
detection of AD pathology. 
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The overall aim of the present study is to confirm previous post mortem 
findings, by detecting AD pathology in the cerebral cortex and hippocampus, 
using a novel in vivo 7T high-field MR approach. 
MaTeRialS and MeThodS
Participants
This study was approved by the local institutional review board. In all cases, 
informed consent was obtained according to the declaration of Helsinki (31). 
In total 16 AD patients with a mean age of 76.9 years (range 68 to 86 years, 
10 male/6 female) and 15 control subjects with a mean age of 75.1 years 
(range 69 to 80 years, 10 male/5 female) were included. 
The AD patients were recruited from the memory clinic of the Leiden Univer-
sity Medical Center. Memory clinic patients were referred to the hospital by 
their general practitioner or a medical specialist. Prior to the 7T study these 
patients all underwent a routine clinical protocol, comprising a whole brain 
MRI (3 Tesla), a battery of neuropsychological tests, and a general medical 
and neurological examination performed by a neurologist, psychiatrist or in-
ternist-geriatrician. The diagnosis was made in a multidisciplinary consensus 
meeting using the NINCDS-ADRDA criteria for diagnosing probable Alzhei-
mer’s disease (32). Participants with the diagnosis ‘probable AD’, who were 
capable of giving informed consent (Mini Mental State Examination (MMSE) 
≥ 19) with late onset dementia (age > 67 year) were selected for inclusion in 
the 7T study either retrospectively within one year after attending the me-
mory clinic, or prospectively. 
Healthy control subjects were recruited by focussed advertisement. Subjects 
with an age between 69-80 years, who were living independently, had an 
MMSE ≥ 25 and a Geriatric Depression Scale (GDS) ≤ 4 were selected for 
inclusion. Subjects with the following diseases were excluded; stroke, mor-
bus Parkinson, dementia, diabetes mellitus, rheumatoid arthritis, polymy-
algia rheumatica, cancer, heart failure, and chronic obstructive pulmonary 
disease. 
Image acquisition
MRI was performed on a whole body human 7 T MR system (Philips He-
althcare, Best, the Netherlands) using a quadrature transmit and 16-channel 
receive head coil (Nova Medical, Wilmington, MA, USA). Participants were 
scanned using a 2D flow-compensated transverse T2
*-weighted gradient-
echo scan which included the frontal and parietal regions for amyloid detec-
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tion with a total imaging duration of 10 minutes. Imaging parameters were: 
repetition time (TR)/echo time (TE) 794/25 ms, flip angle 45°, slice thickness 
1.0 mm with a 0.1 mm interslice gap, 20 slices, 240 x 180 x 22 mm field of 
view, 1000 x 1024 matrix size – resulting in an in-plane nominal spatial re-
solution of 0.24 x 0.24 mm2. Figure 1 shows a typical positioning of these 20 
slices. The bandwidth per pixel was 46 Hz, corresponding to a readout length 
of approximately 22 ms. The frequency and phase encoding directions were 
along the anterior-posterior and right-left axes, respectively. Additionally, a 
coronal 2D flow-compensated T2
*-weighted gradient echo scan covering the 
hippocampus with a total imaging duration of 6 minutes was performed. 
Imaging parameters were: TR/TE 624/14 ms, flip angle of 40°, slice thickness 
of 3.0 mm with no interslice gap, 32 slices, 240 x 180 x 96 mm field of view, 
480 x 480 matrix size - resulting in a nominal in-plane spatial resolution of 
0.5 x 0.5 mm2. These sequences are very sensitive to image artifacts arising 
from resonance frequency fluctuations within the brain caused by slight pa-
tient movements, even in areas significantly away from the head. A navi-
gator echo was included to correct for these artifacts (33). Shimming up to 
third order was performed using an image based shimming approach (34). 
The phase images were subsequently unwrapped by highpass filtering with 
a 92x92 kernel size (35).
Image analysis
First, the T2
*-weighted gradient-echo images were evaluated, blinded for di-
agnosis, for hypointense foci by SvR and checked by MvB as described in a 
previous ex-vivo study (10). 
Image phase values in the cortex were determined using the transverse 2D 
T2
*-weighted gradient echo scans. Based on the visual observation on un-
wrapped phase images of a higher contrast between gray and white matter 
in AD patients than in controls, due to a higher signal intensity within the 
gray matter, the phase values of the cortical gray matter were determined in 
regions of interest (ROIs) in four different areas of the brain: temporoparietal 
left, temporoparietal right, frontal and parietal. Because of the laminar varia-
tion in the cortical areas (29), histograms perpendicular to the cortex within 
these regions were created to measure peak gray matter phase values, over 
at least 10 cortical regions per slice and per region. To correct for local mac-
roscopic magnetic field inhomogeneities subcortical white matter phase val-
ues were measured and used as an internal reference value. Phase values for 
gray and white matter were measured in these four areas per MRI slice for 
every other slice (ten in total), resulting in 40 phase values for gray and white 
matter separately per subject. Phase values of the different ROIs of the four 
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regions were averaged. Per subject, the overall phase shift between cortical 
gray and subcortical white matter (cortical phase shift) was calculated for 
each region and expressed in radians. 
Phase values of the hippocampus were determined using the coronal 2D T2
*-
weighted gradient echo scans. The hippocampus was manually segmented 
and phase values were determined on 5 consecutive slices, starting at the 
head of the hippocampus, for the right and left hippocampus separately. For 
each subject, these five measurements were averaged for each hippocam-
pus. Phase values of the white matter were determined in three neighboring 
areas of subcortical white matter on each of the five slices and averaged 
per subject. The phase shift of the hippocampus was calculated by the dif-
ference in phase value of the hippocampus and white matter (hippocampal 
phase shift) and expressed in radians. Analysis of the hippocampus was only 
performed in 12 of the 16 AD patients and in 14 of the 15 controls, because 
of severe motion artifacts that could not be completely corrected for (three 
subjects) or because participants were not able to finish the whole scan pro-
tocol (two subjects).
Statistics
A Mann-Whitney U-test was used to assess differences in age, gender, MMSE 
and phase measurements between AD and control groups. Logistic regres-
sion analysis was used to assess the association between diagnosis and inter-
tissue phase shifts in the cortex and hippocampus, corrected for age and 
gender. To assess the interaction between cortical gray matter/hippocampal 
and white matter phase values, both were also entered as covariates in one 
model. Receiver operating characteristic (ROC) analysis was performed to 
determine the area under the ROC curve and to assess the optimal cut-off 
phase shift in the cortex and hippocampus to detect AD with its correspon-
ding sensitivity, specificity, positive predictive value, and negative predictive 
value. To determine the association between MMSE and phase shift in the 
cortex and hippocampus, a linear regression analysis including a Pearson 
correlation corrected for age and gender was performed. All statistical ana-
lyses were performed with the Statistical Package of Social Sciences (SPSS, 
version 17.0.1; SPSS, Chicago, Ill).
results
The characteristics of the participants are shown in Table 1. No difference in 
age or gender was found between patient and control groups. Scores for glo-
bal cognitive functioning (MMSE score) were significantly higher in controls 
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(29.0 points) than in patients with AD (22.5 points), p<0.001.
Table 1: Characteristics of AD patients and control subjects.
AD (n = 16) Controls (n = 15)
Mean age, years (range) 76.9 (68–86) 75.1 (69–80)
Male/female 10/6 10/5
Median MMSE, points (range) 22.5 (19-26) 29.0 (27-30)
AD = Alzheimer’s Disease, MMSE = Mini Mental State Examination.
Figure 2 shows representative transverse T2*-weighted magnitude and phase 
images of the parietal region of a subject with AD (a and b) and a control 
subject (c and d). Figure 3 shows coronal T2*-weighted magnitude and phase 
images of the hippocampus of a subject with AD (a and b) and a control sub-
ject (c and d). In none of the subjects were small focal hypointensities found 
in either the cortex or hippocampus.
Table 2: Mean phase differences and SDs of the cortical and hippocampal 
subregions in AD patients and control subjects.
AD (rad) (n = 16) Control (rad) (n = 15) p-value
Temporoparietal left 0.90 + 0.08 0.79 + 0.08 0.001
Temporoparietal right 0.97 + 0.10 0.85 + 0.09 0.001
Frontal 0.70 + 0.08 0.62 + 0.07 0.004
Parietal 0.87 + 0.10 0.74 + 0.08 0.000
Hippocampus right 0.09 + 0.04 0.07 + 0.03 0.18
Hippocampus left 0.10 + 0.04 0.08 + 0.02 0.14
AD = Alzheimer’s Disease, rad = radians.
Table 2 shows the mean phase shifts of the temporoparietal, frontal, parietal 
cortex and the right and left hippocampus. For the temporoparietal, fron-
tal, and parietal cortex, a larger cortical phase shift (p <0.005) was found in 
the AD patients compared to control subjects (adjusted for age and gender). 
For both hippocampi no difference in phase shifts between groups was ob-
served. Analysis in which both gray and white matter values were entered in 
the logistic regression model showed that only the cortical gray matter phase 
value, and not the white matter phase value, was associated with diagnosis. 
For the hippocampus, both gray and white matter phase values were not as-
sociated with diagnosis.
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Figure 1: Sagittal survey image.
The stack position of the 2D T2*-weighted gradient-echo scan including the frontal and pa-
rietal regions for amyloid detection is shown. Image shows sagittal plane.
To determine the diagnostic value of the phase measurements in differen-
tiating AD from control subjects, ROC analysis was performed for each re-
gion. Table 3 shows the area under the curve (AUC), cut-off value, sensitivity, 
specificity, positive and negative predictive values of all regions selected. 
For the temporoparietal, frontal, and parietal cortex an AUC between 0.79 
and 0.85 was found, with the regions all having a high specificity (90-100%) 
and a moderate-to-high sensitivity (50-70%). Of these regions, the parietal 
cortex demonstrated the highest AUC (0.85) with a sensitivity of 69% and a 
specificity of 93%. The corresponding positive predictive value and negative 
predictive value were 92% and 74%. Both hippocampi demonstrated a lower 
AUC; right hippocampus 0.66 and left hippocampus 0.67. This resulted in a 
relatively lower specificity and positive predictive value. The sensitivity and 
negative predictive values were comparable with the regions in the cortex.
There was a significant negative correlation (adjusted for age and gender) 
between MMSE and phase shift in the left temporoparietal cortex, r = -0.47 
(β = -0.464, p<.05), the right temporoparietal cortex, r = -0.41 (β = -0.473, 
p<.05), frontal cortex, r = -0.44 (β = -0.404, p<.05) and parietal cortex, r = 
-0.54 (β = -0.501, p<.05) (all: P < 0.05). For the right and the left hippocampus 
there was no correlation between MMSE and phase shift (right hippocam-
pus, r = -0.25, p = 0.21 (β = -0.168, p = .404), left hippocampus, r = -0.27, p = 
0.19 (β = -0.190, p = .336)).
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Figure 2: Cortex T2
*-weighted images obtained in AD patient and control subject.
Representative 0.24 x 0.24 mm2 2D T2*- weighted gradient echo images show an AD patient 
(A and B) and a control subject (C and D). Image A and C show magnitude images and image 
B and D phase images of the parietal region. No hypointense foci are seen on the magni-
tude images. The phase images show that the contrast between gray and white matter is 
enhanced in the AD patient in comparison to the control subject, indicating a larger cortical 
phase difference. Images show transverse planes.
discussion
This study shows that using a novel high-field imaging approach at 7T, pa-
tients with clinical symptoms of AD demonstrate an increased cortical phase 
shift on T2
*-weighted images. These phase shifts between AD patients and 
control subjects have a high specificity, independent of age and gender. 
Moreover, these phase shifts correlated with individual MMSE scores. Of 
all cortical areas studied, the parietal cortex shows the highest specificity 
combined with the highest sensitivity for the diagnosis AD and the strongest 
correlation with MMSE. On the other hand, phase shifts in the hippocampus 
were not significantly increased in AD patients and did not correlate with 
MMSE.
High-field T2
*-weighted MRI sequences are highly sensitive for iron depos-
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its in the brain (36). In autopsy material of AD patients amyloid deposition 
and neurofibrillary tangles as well as tau deficiency were found to co-local-
ize with neuronal iron accumulation (37–39). Therefore, it is likely that the 
increased cortical phase shift found on high-field T2
*-weighted MRI in pa-
tients with AD indirectly reflect AD pathology. Our data also show that the 
particular distribution of the phase changes in the brain follows the known 
cerebral distribution of amyloid deposition in AD. In our data the neocortex, 
and more specifically the parietal lobes, allowed much better differentiating 
of AD patients from control subjects based on phase shift as compared to 
the hippocampus. In histological studies it was demonstrated that the neo-
cortex is the first structure in the brain that is affected by amyloid deposi-
tions whereas the hippocampus is not only more mildly affected by amyloid 
plaques but also affected at a later stage of AD than the neocortex (40–42). 
This sequence of events has been confirmed by PiB-PET studies, showing 
high amyloid loads in the parietal and frontal lobes and not in hippocampus 
(5–7, 43, 44). 
Phase measurement on T2
*-weighted MRI at 7 Tesla has a high specificity 
for AD as compared to the reported specificity of the methods that are cur-
rently considered state of the art, such as cerebrospinal fluid (CSF) assay of 
the amyloid peptide or PiB PET imaging (9). Previous studies indicated that 
AD patients have reduced levels of Aβ1-42 and increased levels of t-tau and 
p-tau181p in CSF compared to control subjects of which Aβ1-42 is the most 
sensitive biomarker for AD of CSF samples. 7T MRI had lower sensitivity than 
these CSF analyses of Aβ1-42 (69% vs. 96%) but had a higher specificity (93-
100% vs. 77%) (45). PET studies using [11C] Pittsburgh Compound-B (PiB-
PET) have shown the possibility of detecting cerebral amyloid accumulation, 
although the diagnostic utility is limited (46) and numbers on sensitivity and 
specificity are sparse. Mormino and coworkers (47) showed high sensitivity 
(90%) and specificity (90%) in differentiating AD patients from controls. How-
ever, within the group of healthy subjects the specificity drops with increas-
ing age, because the percentage of positive PiB-PET scans increases rapidly 
with 12% of the people in their 60s, 30% in their 70s and 50% in their 80s 
giving “false positive” results (44, 48, 49). Our data show that measurement 
of phase shift using T2
*-weighted MRI might improve the specificity of AD 
diagnosis.
Our study could not replicate the ex-vivo finding of hypointense foci, that 
might represent amyloid plaques (10). Although we corrected for resonance 
frequency variations, which are the main contributor to decreased image 
quality in AD patients, with a navigator echo (33) it is highly likely that even 
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sub-voxel degrees of motion blur the hypointense foci.
Figure 3: Hippocampus T2
*-weighted images obtained in AD patient and control subject.
Representative 0.5 x 0.5 mm2 2D T2*- weighted gradient echo images show an AD patient (A 
and B) and a control subject (C and D). Image A and C show magnitude images and image B 
and D phase images of the hippocampal region. No hypointense foci are seen on the magni-
tude images. The phase images show no difference between the AD patient and the control 
subject in terms of image contrast between hippocampus and white matter.
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Table 3: differentiating betw
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A limitation of the present study is that phase measurements might also be 
influenced by the geometry and orientation of the scans (28). We limited 
these effects as much as possible by carefully positioning every participant in 
the same manner. Moreover, phase values were measured in the exact same 
way by using a standardized method. Furthermore, we averaged multiple 
measurements of phase values to cancel out the possible effects of geome-
try and orientation. A second limitation is that white matter phase values, 
which were used to correct for magnetic field inhomogeneities, might have 
an influence on the results. However, our data show that the observed phase 
changes were mainly caused by phase shifts in the gray matter. A third limita-
tion is that we only included AD patients and healthy controls and therefore 
the diagnostic accuracy of our method in a group of memory clinic patients 
is unclear. The specificity of the presented method should be examined tho-
roughly by assessing different categories of neurodegenerative diseases to 
evaluate the ability to differentiate between different forms of dementia. 
Moreover, the value of our method should be investigated in the preclinical 
stages of AD in future studies to evaluate the possibility of detecting early AD 
pathology and to be used as an early treatment marker.
In conclusion, in this study we introduced a novel approach to detect cortical 
changes in AD patients exploiting the increased sensitivity of 7T MRI for iron 
in brain tissue. Our current data demonstrate that cortical phase changes are 
a potential new biomarker for AD.
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AbstrAct
High field magnetic resonance imaging is showing potential for imaging of 
neurodegenerative diseases. 7 T MRI is beginning to be used in a clinical re-
search setting and the theoretical benefits, i.e. higher signal-to-noise, sensi-
tivity to iron, improved MRA and increased spectral resolution in spectrosco-
py are being confirmed. Despite the limited number of studies to date, initial 
results in patients with multiple sclerosis, Alzheimer’s disease and Hunting-
ton’s disease show promising additional features in contrast that may assist 
in better diagnosis of these disorders.
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introduction
The increase in static magnetic field strength (B0) for clinical MRI scanners 
has resulted in significant improvements in image quality. There is almost 
universal improvement in the diagnostic value of 3 T vs. 1.5 T clinical neu-
rological MRI scans and 3 T scanners are routinely used for a broad range of 
applications. The need for increased sensitivity to early indicators of neuro-
degeneration with the goal of identifying potential biomarkers for diagnosis 
and the monitoring of treatment is one of the driving forces behind the in-
terest in increasing further the magnetic field strength. The well-characteri-
zed signal-to-noise ratio (SNR) increase with field strength can be used for 
reduced acquisition times or higher spatial resolution. The increased sen-
sitivity of image contrast (particularly in T2*-weighted sequences) to tissue 
iron levels has great potential for detecting early diffuse depositions that 
may lead to neurotoxic effects. The longer T1 value of both blood and tissue 
results in higher quality MR angiography (MRA) with improved background 
suppression. Furthermore, the increased chemical shift difference between 
the proton signals of different metabolites has an advantage for magnetic 
resonance spectroscopy (MRS) in quantifying more metabolites than previ-
ously possible (1, 2). 
Initial imaging studies of multiple sclerosis (MS) patients at 7 T appear promi-
sing in detecting more lesions with higher structural detail (3–5), especially 
in gray matter. In addition to the improved spatial resolution and signal-to-
noise, the increased contrast in MR angiography (6) and cortical layer con-
trast in T2*-weighted imaging (7) have already demonstrated the potential of 
7 T MRI. However, many intrinsic challenges remain to obtaining high quality 
MR data at field strengths of 7 T and above. 
Challenges
The main challenges are related to creating a homogeneous magnetic field 
(B0) and  radiofrequency (RF) field B1 over the entire brain. A higher magnetic 
field strength results in increased sensitivity to magnetic susceptibility indu-
ced field variations. On a microscopic scale this effect enhances the contrast 
within cortical layers (7, 8), basal ganglia (9), small venous structures (10–12) 
and results in greater white matter heterogeneity (13). However large-scale 
magnetic field variations induced by e.g. air-tissue interfaces (static) or res-
piration (dynamic) can lead to undesired signal loss and image deformations. 
Most modern high field MRI scanners are equipped with higher order shim 
gradients to improve the static field homogeneity. Careful optimization of 
sequence parameters and image correction algorithms has shown that it is 
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possible to acquire high quality images even from sequences such as echo 
planar imaging, which are particularly susceptible to static magnetic field 
inhomogeneities. Equally problematic, the amplitude of dynamically fluctua-
ting magnetic fields caused by respiration or body movements also increases 
with field strength. It has been shown that corrections for these dynamic 
effects are possible both prospectively and retrospectively. Using dedicated 
hardware or sequences (14–16) image quality can be restored reasonably 
well.
Another fundamental challenge at 7 T is producing a highly homogeneous RF 
field, B1, with high efficiency in order to minimize tissue heating. B1 inhomo-
geneities are due primarily to the dielectric properties of tissue, which result 
in partial constructive and destructive interactions from RF wave behavior 
(17). Tissue conductivity produces conduction currents in tissue, which dam-
pens the electromagnetic (EM) field as it penetrates through tissue, produ-
cing a phase shift in the travelling RF. This not only results in significant image 
inhomogeneity and areas of signal loss but may also give rise to local heating, 
expressed as the specific absorption rate (SAR) from interaction with the 
electric field. The dielectric properties of tissue produce displacement cur-
rents in tissue, as well as inductive losses caused by eddy currents, and also 
alter the RF wavelength in tissue. The effective wavelength of electromagne-
tic energy in tissue is ~13 cm at 7 T. The brain has dimensions on the same 
order as the wavelength. This limits the applicability of conventional volume 
coils, such as the birdcage (18) and transverse electromagnetic (TEM) reso-
nator (19), which produce homogeneous transmit fields at 1.5 T and 3 T, but 
cannot produce the same homogeneous fields at 7 T (17). The inhomogene-
ous RF field in combination with increased tissue heating leads to important 
sequence considerations. SAR intensive protocols involving sequences such 
as fast spin echo and fluid attenuated inversion recovery (FLAIR) cannot sim-
ply be copied from lower field strengths. Solutions will be discussed in the 
section “Future prospects and challenges”.
Despite these challenges 7 T MRI is beginning to be used in a clinical setting 
and the theoretical benefits of 7 T, i.e. higher signal-to-noise, sensitivity to 
iron, improved MRA and spectroscopy are being confirmed. Although, so far 
only a limited number of patient studies have been performed at 7 T and 
many of the proposed techniques still need further validation. Initial ima-
ging studies of multiple sclerosis (MS) patients at 7 T appear promising in 
detecting more lesions with higher structural detail (3–5), especially in gray 
matter. In addition to the improved spatial resolution and signal-to-noise, 
the increased contrast in MR angiography (6) and the detection of cortical 
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layer contrast in T2*-weighted imaging (7) have already demonstrated the 
potential of 7 T MRI. 
neURodegeneRaTive diSeaSeS
This section describes some of the clinical studies with 7 T MRI that have 
performed so far in patients suffering from neurodegenerative diseases. 
CADASIL
Cerebral autosomal dominant arteriopathy with subcortical infarcts and leu-
koencephalopathy (CADASIL) is a hereditary form of small vessel disease that 
is caused by a mutation in the Notch3 gene. Pathologically, degeneration of 
the small smooth vessels is observed together with fibrous thickening of the 
small vessels. Clinical characteristics of the disease comprise cognitive loss, 
migrainous headaches, stroke-like episodes and dementia. In addition, cere-
bral blood flow is known to be reduced in CADASIL patients. However, the 
exact mechanism remains unclear and most findings regarding vessel wall 
pathology come from ex vivo studies. In vivo MRA can potentially provide 
valuable information on the hemodynamic changes in CADASIL patients. The 
most affected vessels are the leptomeningeal arteries supplying the white 
matter and the lenticulostriate perforating arteries supplying the deep gray 
nuclei. At lower field strengths MRA has been unable to visualize these ar-
teries because of its small diameter. However, recent studies performed at 
7 T show sufficient enhancements in resolution and contrast enabling visu-
alization of the lenticulostriate arteries (6, 20, 21). The method that is most 
suited is time-of-flight (TOF) MRA, where the contrast is generated by the 
fresh inflow of blood with a gradient echo sequence that is relatively SAR 
friendly. The prolonged T1 relaxation times at 7 T result in improved back-
ground saturation compared to lower field strengths, increasing the contrast 
between the vessel lumen and surrounding tissue. In addition the increase 
in SNR can be traded for a very high spatial resolution. In a recent study this 
was confirmed by visualization of significant lengths of the lenticulostriate 
arteries (22) in patients with CADASIL and control subjects. Figure 1 shows 
an example of a coronal maximum intensity projection of the lenticulostriate 
arteries in a healthy control subject and in a patient with CADASIL. The ar-
rows point towards the lenticulostriate arteries. A small field of view (FOV) 
3D TOF MRA technique was used with an isotropic resolution of 0.23 mm 
and 161 slices, resulting in a scan duration of 11 minutes. From these da-
tasets, the number of visible arteries at different locations with respect to 
the middle and anterior cerebral artery, the cross-sectional area and length 
of the arteries were determined. No significant differences were found bet-
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ween patients and controls in any of the measures. In addition no associa-
tion was found between the luminal diameters and lacunar infarct load in 
the basal ganglia and basal ganglia hypointensities on separately acquired 
T2-, T2
*- or T1-weighted scans (22). These results suggest that basal ganglia 
damage in CADASIL is likely not caused by vascular mechanisms. The lack of 
association between age and disease duration with these vascular measu-
rements further supports the finding that generalized narrowing of luminal 
diameters of lenticulostriate arteries does not play a significant role in the 
pathophysiology of CADASIL.
Figure 1: MRA of lenticulostriate arteries.
Coronal maximum intensity projections of a 32 year old healthy control (left) and 32 year 
old patient with CADASIL (right). The arrows point towards the lenticulostriate arteries. Ex-
cellent visualization of large portions of the lenticulostriate arteries was possible due to the 
high spatial resolution and contrast between the artery and surrounding tissue. No signifi-
cant differences in length, diameter and number of lenticulostriate arteries was found, sug-
gesting that basal ganglia damage in patients with CADASIL is not due to luminal narrowing 
of these vessels.
Another common MRI finding in patients with CADASIL are hypointensities 
on T2*-weighted images (22, 23) caused by iron containing hemosiderin de-
posits in cerebral microbleeds (CMBs). Figure 2 show CMBs observed bilate-
rally in the thalamus of a 35 year old patient with CADASIL on a T2*- and T1-
weighted image. Initial results have shown diffuse areas of T2* hypointensity 
in the basal ganglia, most commonly caused by diffuse iron deposition in 
CADASIL (24). Such diffuse areas have been described in other neurodege-
nerative diseases such as Alzheimer’s disease (AD) as well. Still, it is unsure 
whether iron deposition is exclusively a neurodegenerative process, or if it 
can also be caused by vascular mechanisms. High field T2*-weighted MRI 
is extremely sensitive to changes in the local magnetic field, such as those 
generated by iron-rich regions. These changes in local magnetic field lead to 
decreased signal intensity on magnitude images and an increased frequency 
shift (relative to non-iron containing brain tissue) on phase images. Prelimi-
nary data of high resolution T2*-weighted images using a 2D gradient echo 
sequence obtained with a resolution of 0.24x0.24x1 mm3 (24), demonstra-
ted increased iron deposition in the globus pallidus and the caudate nucleus. 
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These findings were based on both magnitude images and unwrapped phase 
images. Both approaches gave similar results but the phase shift measure-
ments showed larger differences, emphasizing the sensitivity of phase to 
iron induced changes in the brain. 
Figure 2: Microbleed detection in CADASIL.
Cerebral microbleeds (CMB) observed bilaterally in the thalamus of a 35 year old patient 
with CADASIL, visualized on a T2*-weighted (left) and T1-weighted (right) scan. The arrows 
point to the CMB. Accurate visualization of CMB is possible at high magnetic field strengths 
due to the induced susceptibility effect of haemosiderin deposits in the microbleeds. The 
sensitivity to detect CMB is highest on T2*-weighted scans.
In summary, high field MRI can provide useful additional information in un-
derstanding CADASIL pathology given the high resolution TOF images, sensi-
tivity to CMBs (25) and diffuse iron deposition. 
Huntington’s Disease
Huntington’s disease (HD) is a neurodegenerative autosomal dominant dis-
order caused by a gene mutation on the short arm of chromosome 4. A 
repeat expansion of the cytosine-adenine-guanine gene leads to an abnor-
mally increased synthesis of huntingtin, a protein causing neuronal damage 
and brain atrophy. Ultimately, the disease leads to functional disturbances of 
motor function, cognition and behavior. Brain atrophy measurements, parti-
cularly of the striatum, are considered the MRI hallmark of the disease, sho-
wing changes up to a decade before clinical manifestations of the disease oc-
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cur. The exact disease mechanism underlying these volume changes remains 
unclear. Several proposed theories include impaired energy metabolism and 
the degeneration of neurons due to neuronal overstimulation (excitotoxi-
city). MRS offers additional insight into which processes may play a role in 
these volume changes, by measuring, for example, N-acetylaspartate (NAA), 
creatine and glutamate concentrations. If the neuronal integrity were to be 
compromised, NAA would be expected to be reduced. Changes in energy de-
position may be reflected in total creatine signals. In contrast, an increase in 
glutamate levels would reflect overstimulation of neurons. Lower field MRS 
studies have shown conflicting results, especially for findings in glutamate 
concentrations (26). Higher field provides improved spectral resolution al-
lowing more metabolites to be quantified (1, 2). This can be done with bet-
ter spatial localization (smaller volumes) due to increased SNR. In a study by 
Van den Bogaard et al. (26) localized MRS was performed using a stimulated 
echo acquisition mode (STEAM) sequence in the caudate nucleus, putamen, 
thalamus, hypothalamus and frontal lobe in patients with manifest and pre-
manifest HD. Using 7 T MRS six metabolites could be identified in all of these 
nuclei: choline, creatine, glutamine + glutamate, total NAA, myo-inositol and 
lactate, despite the significant brain atrophy, which lead to reduced SNR. 
Figure 3 shows MR spectra in the caudate nucleus and putamen of control 
subjects and manifest patients. Lower concentrations of creatine and NAA 
were found in the caudate nucleus and the putamen, and a reduction of 
glutamate in the putamen, of manifests HD patients. Secondly an association 
between disease severity and metabolic levels of NAA, creatine and gluta-
mate was demonstrated. The results from this study indicate affected  ener-
gy metabolism in HD patients reflected in lower creatine concentrations, and 
a decrease in neuronal integrity reflected in lower NAA concentrations. In 
contrast to other studies a lower concentration of glutamate was found in 
the putamen of manifest patients. This study showed that 7 T allows measu-
rement of reliable glutamate concentrations, thereby obtaining additional 
insight in the disease process.
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Figure 3: Representative MR spectra from the caudate nucleus and putamen in a control 
subject and manifest HD patient. 
In total six metabolites could be identified in the hypothalamus, thalamus, caudate nucle-
us, putamen and the prefrontal region. In the caudate nucleus and putamen a significant 
decrease in NAA and creatine levels was found in manifest HD patients. Glutamate levels 
were found to decrease significantly in the putamen. Significance changes are depicted by 
asterisks (*), p < 0.05. Cho choline, Cr creatine, NAA N-acetylaspartate, mI myo-inositol, Glx 
glutamate + glutamine, Lac lactate, PPM parts per million.
In summary, the increased spectral and spatial resolution of 7 T MRS offer 
capabilities that are not possible at lower field strengths. It allows for the 
examination of metabolites in small anatomical structures in clinically accep-
table scanning times, e.g. such as the caudate nucleus and putamen, which 
are important in many neurodegenerative diseases. 
Multiple sclerosis
The field of MS research has been the most active since the introduction of 
7 T MRI scanners. MS manifests itself through demyelinating lesions that can 
be detected by MRI. Conventional protocols use fluid attenuated inversion 
recovery (FLAIR) and dual inversion recovery (DIR) sequences to suppress 
signal from cerebrospinal fluid (CSF) or from both CSF and white matter, res-
pectively, to highlight white matter (WM) lesions. In addition, gadolinium 
contrast agents can be administered to distinguish active lesions from older 
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lesions on T1-weighted images. Histology has revealed that lesions not only 
occur in WM but also frequently affect gray matter (GM) and that MS lesions 
have a preference for a perivenular location. The high spatial resolution and 
sensitivity of high field facilitates the detection of GM lesions and the peri-
venous location of lesions, which is more difficult at lower field strengths. 
To make effective use of the high contrast generated by venous blood and to 
circumvent the difficulties implementing B1-sensitive and SAR-intensive se-
quences such as FLAIR and DIR, many studies have focused on T2*-weighted 
sequences. Using this type of contrast it was found that between 50% and 
87% of lesions contain a central vein (4, 5, 27–29). Compared to lower field 
strengths, a significantly lower number of lesions containing a central vein 
was found. At 1.5 T no central venous structure was observed in any of the 
detected lesions (4), whereas twice as many lesions with a central vein were 
detected at 7 T compared to 3 T (5). Figure 4 shows a large WM lesion visu-
alized using T2*-weighted MRI, comparing 7 T and 3 T (5). It is immediately 
apparent that the contrast within the lesion is enhanced at 7 T and that the 
perivenous location of the lesion can be appreciated.
Figure 4: 7T T2*-weighted MRI shows more detail of central veins in MS lesions than 3T. 
T2* images of a patient with MS showing a large lesion with a perivenous orientation. On the 
7T image (A) the vein can be seen in more detail than on the equivalent 3T image (B). Image 
courtesy of Dr. Emma Tallantyre.
The presence of a central vein in WM lesions may be an imaging characte-
ristic that helps differentiating MS-related lesions from other WM lesions. 
This may be important for designing therapies targeted at MS lesions and 
monitoring disease progression, and also it may help providing insight into 
the mechanisms of lesion formation (27). It was found that the presence of 
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a central vessel is highly indicative of MS specific lesions. In a comparison 
between MS patients and subjects having WM lesions that were non-specific 
to MS, 80% of MS lesions had a perivenous location compared to only 19% 
in WM lesions not related to MS (29). The high sensitivity of 7 T in detec-
ting perivascular signal changes is due to the susceptibility effect of venous 
blood. The effect of induced local magnetic field changes scales linearly with 
the applied magnetic field strength. Therefore the use of a sensitive method 
such as a T2*-weighted sequence at high field greatly improves the contrast 
generated by venous blood. 
Apart from WM lesions, GM lesions are also a frequent finding in MS. GM 
MS lesions, however, can be very difficult to detect at lower field strengths. 
The increased spatial resolution at 7 T increases the number of visible GM 
lesions. Figure 5 shows an example of an MS patient with a cortical GM le-
sion (30). The arrow in the zoomed in section points towards the cortical 
GM lesion. In one study no GM lesions could be detected in patients at 1.5T, 
while 44% of the lesions detected at 7T showed cortical involvement (4). This 
was confirmed by other studies at 7 T (30, 31). In line with other neurodege-
nerative diseases higher iron deposition is expected in patients with MS. The 
high sensitivity to iron of 7 T has lead to the investigation of MS lesions using 
phase images (3, 31, 32). However initial studies find that phase images have 
a lower sensitivity in detecting MS lesions (31) than the magnitude images. 
However between 8% and 21% of WM lesions show a characteristic ring 
around the lesion that is not readily visible on magnitude images (3, 31). This 
is thought to occur due to iron-rich macrophages and as such may provide 
information about the extent of inflammation around the MS lesion (4, 31). 
T2*-weighted sequences were identified as being the most sensitive in de-
tecting lesions compared to other sequences (31) and lower field strength 
(4). Recently, progress has been made in reducing the SAR requirements of 
FLAIR and DIR sequences at 7 T while maintaining comparable or improved 
contrast and spatial resolution (33, 34). Preliminary results have shown the 
applicability in MS patients (35), although no systematic comparison of using 
high field FLAIR and DIR sequences has been published to date.
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Figure 5: Axial T2*-weighted image (195x260μm) of an MS patient with a cortical GM 
lesion at 7 T.
Right: Enlarged image of the region around the GM lesion demonstrating fine detail within 
the cortical lesion at this high magnetic field and fine spatial resolution.  Image courtesy of 
Drs. Vigneron, Metcalf and Pelletier.
In summary, MS research at 7 T is promising. The difficulty in designing FLAIR 
and DIR sequences at 7 T has to date resulted in the use of T2*-weighted se-
quences to detect MS lesions. The high contrast and spatial resolution of this 
sequence provides an additional type of sequence to investigate MS lesions, 
especially suited for high magnetic field strengths. 
Other neurodegenerative diseases
There have been a number of other clinical studies in the field of neurode-
generative diseases at 7 T. Most studies use the same contrast mechanisms 
as mentioned in the previous sections. In amyotrophic lateral sclerosis (ALS) 
patients 7 T MRI was used to investigate the presence of CMBs. In animal 
models of this disease deposits of hemosiderin and CMBs were found, in 
contrast no CMBs were found in sporadic ALS patients (36). In patients with 
Alzheimer’s disease (AD) a limited number of studies has been published. 
One of the hallmarks of AD is the presence amyloid beta plaques, a protein 
thought to be associated with iron. The small size of these plaques (typi-
cally smaller than 150 µm) (37) makes direct in vivo visualization difficult, 
although not impossible. Using localized coils and a limited FOV a resolution 
of the same order of magnitude as individual plaques has been obtained in 
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a reasonable scan time (38). Susceptibility weighted imaging (SWI) post pro-
cessing was performed to enhance the sensitivity to susceptibility changes 
(39), such as induced by iron. The results of this study suggest that plaques 
can be visualized using this technique. Still, it remains unclear whether the 
observed signal voids represent individual plaques or not. In addition to the 
presence of plaques, early in the process of the disease brain atrophy occurs. 
One of the first brain regions affected by AD is the hippocampus; however 
not all subsections of the hippocampus are affected in a similar way. These 
different subregions can be distinguished using high resolution T2*-weighted 
imaging sequences. One study has shown that in the very early stage of AD 
changes can be observed in the hippocampal subregion CA1 apical neuro-
pil (40). From post mortem studies this region is known to be among the 
earliest affected in the brain. Interestingly at 7 T this was confirmed in vivo. 
Along the same line are findings in patients with hippocampal sclerosis (HS) 
where accurate visualization of subregions within the hippocampus is impor-
tant for diagnosis. HS leads to atrophy of the intrahippocampal cortical fields 
CA1 to CA4 regions and to disruption of the internal hippocampal structure. 
In a study of focal epilepsy patients with HS, the intrahippocampal cortical 
fields could well be visualized on T2- and T2*-weighted sequences (41). Re-
gional differences in hippocampal atrophy were shown between patients. 
In a different study similar findings were reported using T1- and T2-weighted 
imaging. In all patients hippocampal abnormalities were observed. Using 7 
T MRI localized atrophy in the Ammon horn was observed in temporal lobe 
epilepsy patients (42).  
A small number of patients with Parkinson’s disease (PD) has been studied at 
7 T. The symptoms of PD can sometimes be reduced by deep brain stimula-
tion. This is a neurosurgical technique that relies on the accurate placement 
of electrodes. Using high-resolution susceptibility weighted imaging (SWI) 
high contrast can be generated between the iron rich basal ganglia. It has 
been shown that high quality images can be obtained that help guiding the 
placement of these electrodes (43, 44). 
FUTURe PRoSPeCTS and ChallengeS
In general, the theoretical gain in SNR and sensitivity of high field MR to, 
for example, diffuse iron accumulation have been shown to be achievable 
in practice. Transmit RF field inhomogeneity is still a major concern, but by 
using dedicated sequences that are less sensitive to these inhomogeneities 
some of these effects can be circumvented (45, 46). By placing high dielectric 
materials close to the brain the transmit field becomes more homogeneous 
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(2, 47). The coverage towards the cerebellum in particular is improved and 
the effect of high signal centrally in the brain is reduced. The ultimate “solu-
tion”, although currently only in the technical development phase, is the use 
of multiple transmit channels to improve the transmit homogeneity. Prelimi-
nary results already show the added value and one can anticipate that it will 
not take long before this technique is used in a clinical setting.
Figure 6: T2*-weighted images before and after correction
A healthy subject (a), showing the high image quality and contrast that can be obtained. 
Application of the same sequence in patients with AD leads to frequent image degradation 
(b and d) caused by fluctuating magnetic fields during image acquisition. Using a navigator 
echo correction technique it is possible to measure and correct for these dynamic fluctu-
ations and improve image quality significantly (c and e). Correction techniques like these 
improve image quality at high field.
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Sequence adaptations have not been trivial, the increased RF deposition and 
inhomogeneous transmit field preclude the simple translation from lower 
field strength protocols to 7 T. However, all conventional image contrasts (T1-
, T2-, T2
*-weighted and FLAIR) are currently available with high image quality. 
To limit the need for additional lower field strength scans, it is important to 
have these image contrasts available. 
Magnetic susceptibility induced field changes scale linearly with the applied 
field strength. This leads to an increased sensitivity to iron accumulation in 
the brain (8, 9) and WM heterogeneity (13) detected in T2
*-weighted sequen-
ces. An adverse effect is that the sensitivity to unwanted field changes is also 
increased. Air tissue interfaces at the edge of the brain or near the sinuses 
generate a static inhomogeneous magnetic field. Shim gradients up to third 
order are used to compensate for these changes. However the effects of 
dynamic susceptibility changes are also enhanced, leading to ghosting and 
image blurring. It has been shown that breathing (14, 48) and body move-
ments (49) can lead to substantial magnetic field changes in the brain. In 
a study in AD patients image artifacts were observed that were related to 
dynamic magnetic field changes (15). Figure 6 shows a transverse slice from 
a T2*-weighted sequence in a healthy subject and an AD patient. The image 
quality is severely reduced in the AD patient. After navigator-based image 
correction for the effects of the magnetic field changes most image artifacts 
are suppressed. Still more advanced is to measure the field changes in real 
time using separate field probes that are positioned around the brain (16, 
50), but this may not be clinically practical.  
There has been rapid development of sequences and hardware since the 
introduction of 7 T MR systems. As a result most conventional sequences are 
available and high quality images are obtained in the brain. Based on the ini-
tial results so far, 7 T MRI is showing potential to be valuable in investigating 
neurodegenerative diseases. In patients with MS an increased number of 
lesions can be detected and more importantly, there is greater sensitivity to 
detect GM lesions.   In addition to the increased sensitivity, also the pathop-
hysiology of these lesions can be studied more extensively at high field. It 
was shown that most MS lesions have a clear vascular component. However, 
some lesions also showed up on phase images surrounded by a hypointense 
rim, possibly reflecting the area of inflammation or potentially a susceptibi-
lity effect. In patients with HD it was possible to quantify metabolite levels, 
including glutamate in very small regions of interest, providing valuable in-
formation about possible disease mechanisms. The sensitivity to iron and 
the high spatial resolution leads to a clearer depiction of the substantia nigra 
150  | ChaPter 9
and other deep gray matter nuclei in PD. 
Even though limited clinical studies have been performed thus far, it is expec-
ted that the contribution of 7 T MRI especially in the field of neurodegenera-
tive diseases will increase over time. Many of the initial problems related to 
magnetic and RF field inhomogeneities and the lack of optimized sequences 
have been solved or improved.
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AbstrAct
Purpose: To determine the subjective experiences and the sources of dis-
comfort for subjects undergoing 7 Tesla MRI examinations on a whole-body 
7 Tesla system within a hospital setting 
Materials and Methods: A post-scan survey was filled out by 101 healthy 
subjects who participated in a 7 Tesla examination. All participants answered 
questions regarding different potential sensations of discomfort including 
dizziness, claustrophobia, and scanner noise. 
Results: Dizziness was reported most frequently with 34% of subjects expe-
riencing dizziness while moving into the scanner and 30% while moving out 
of the magnet. Scanner noise was also frequently mentioned as uncomforta-
ble (33% of the subjects). In 11% of the cases a metallic taste was reported. 
The overall experience was rated by 3% as unpleasant, 51% as neutral and 
46% as pleasant.
Conclusion: The reported side effects are larger than previously reported for 
lower field strengths. However, overall 7 Tesla examinations are well tolera-
ted, with only 3% of subjects rating it as unpleasant. These results agree well 
with previous in-depth studies, and provide further evidence that 7 Tesla 
MRI would be accepted by patients in clinical practice. 
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introduction
There has been a rapid increase in the number of whole body 7 Tesla MRI 
scanners in research centers and hospitals worldwide; at the end of 2011 
more than 30 systems were in operation. For 7 Tesla MRI to fulfill the  pro-
mise of increased spatial resolution and increased sensitivity for the iden-
tification of pathologies in the clinical setting, it is important to assess how 
well examinations are tolerated by subjects and what adverse side effects, if 
any, are reported and whether they can be easily mitigated. The subjective 
perception of 7 Tesla examinations is important for local institutional review 
board (IRB) approval and for acceptance of 7 Tesla MRI as a true “medical 
device” by the regulatory bodies as opposed to the “investigational status” 
it has currently. 
A number of studies have been performed on high field systems that have 
examined the possible effects of MRI on human subjects. Earlier studies at 
different field strengths of up to 9.4 Tesla have shown no effect of the static 
magnetic field on vital signs, such as blood pressure and heart rate (1–3) and 
very limited (2, 4) or negligible effects (5, 6) on cognitive function, such as 
short term memory have been found. A small effect on eye-hand coordina-
tion and the visual sensory domain was reported in the stray field of a 7 Tesla 
magnet, where subjects experienced a maximum of 1.6 Tesla (7). Perceived 
side effects occur most commonly when the subject moves through a high 
magnetic field gradient, with a metallic taste reported in 50% of subjects who 
shook their heads in the stray field of a 7 Tesla magnet (8). Vertigo can be 
induced by the induction of currents through the vestibular hair cells (9), but 
most reported side effects are acute and disappear rapidly after the expo-
sure ended (10) and the United States Food and Drug Administration (FDA) 
has therefore classified MR systems of up to 8 Tesla to be non-significant risk 
devices for subjects above one month of age (11). 
There have been two previous studies performed in subjects undergoing a 
7 Tesla examination by the Essen group on a whole-body Siemens system to 
assess the subjective experience of a large number of both healthy volun-
teers and patients (12, 13). Their results indicated that feelings of dizziness 
and general discomfort were more pronounced at 7 Tesla than at 1.5 Tesla, 
but that overall the general acceptance was high with only ~12% of subjects 
rating the experience as unpleasant. Since results from subjects undergoing 
a 7 Tesla MRI exam from only one geographical site and one specific magnet/
vendor configuration have so far been reported, it is important to assess 
whether these findings are similar at other sites and on scanners of other 
vendors for general acceptance of clinical 7 Tesla MRI. Specifically we report 
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from experiences on a Philips 7 Tesla scanner which has a slightly smaller 
diameter than the Siemens scanner in Essen, and which is also geographi-
cally located in a clinical hospital environment. Given the somewhat subjec-
tive nature of subjects reactions, one other important difference is that the 
siting-plan of the Philips scanners indirectly “obscures” the long length of 
the scanner bore (compared to 1.5 and 3 Tesla scanners) by having plastic 
side-planes which connect to the inside of the shielded room, in contrast to 
general siting for Siemens systems in which the volunteer can see the entire 
magnet bore. However the result on the perception of subjects is not clear.  
MeThodS
101 healthy subjects with mean age of 27 years (range is 18 – 57 years) un-
derwent a 7 Tesla MRI examination on a human Philips Achieva scanner with 
a clear bore diameter of 58 cm and length of 340 cm. The diameter of 58 cm 
is slightly smaller than the 59.5 cm for the Siemens scanner used in previous 
studies: although this difference is small it is likely to have some effect on the 
experience of patient comfort. Many different scanning protocols were used, 
incorporating both imaging and spectroscopy, with individual scans ranging 
in duration from less than a minute to approximately 10 minutes. The types 
of sequences that were performed have not been recorded, but it has been 
estimated based on vendor supplied reports that highest noise levels are 
around 105 dB.  In all cases the total scanning period was limited to one hour. 
All brain examinations were performed using a close fitting 16 channel Nova 
Medical (Wilmington, MA, USA) phased array receive-coil with a diameter of 
29.2 cm and length of 26 cm, other examinations of the knee and calf muscle 
were performed using various custom built coils. For examinations of the calf 
muscle and knee, subjects were positioned feet first in the magnet, for exa-
minations of the brain, subjects were head first in the magnet. Subjects were 
moved manually inside and outside the scanner bore at a constant pace of 
approximately 7 cm/s. No attempt was made to reduce the table speed in 
the vicinity of the highest gradient of the magnetic field. Noise protection 
was provided (3M Ear Classic) with a reported average noise reduction of 
28 dB. When space within the coil allowed a custom adapted version of the 
manufacturer provided headphone was used for additional protection.  
In conjunction with our local medical ethics committee a questionnaire was 
created to assess the experience of the participants in 7 Tesla MRI studies. 
Participants were recruited using advertisements in public spaces of our hos-
pital and near the lecture rooms for medical students, and received a small 
compensation in the form of a gift certificate. Similar to examinations per-
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formed on the clinical 1.5 Tesla and 3 Tesla scanners in our hospital, before 
scanning all subjects were informed of possible side-effects: claustrophobia, 
dizziness, metallic taste, noise and possible muscle twitching. No mention 
was made that these effects might be more intense than experienced at the 
lower field systems. 
Immediately after the examination was finished the subjects were asked to 
fill in the questionnaire (see table 1) under supervision of a researcher to 
ensure accurate understanding of the questions. All questions were answe-
red on the scale: yes, a little, or no except for the final question (overall ex-
perience), which was rated: unpleasant, neutral, or pleasant and the open 
question regarding additional comments of the subjects. The total duration 
of the examination was also recorded. Differences in side effects between 
subjects that were head first in the scanner versus feet first were addressed 
with a χ2 test (SPSS 17.0, Chicago, US).
Because the primary purpose of the questionnaire was to comply with IRB re-
gulations, additional details regarding scanning protocol, weight and height 
of subjects and history of previous MRI examinations were not recorded.
results
The responses to the questionnaire are summarized in figure 1; the findings 
are shown in descending order according to the number of participants ans-
wering yes, except for the last two questions, which were answered mostly 
positive. The total duration of the examination was approximately one hour 
(58 ± 8 minutes). The three most frequently reported negative findings (ans-
wers yes and a little) were, in descending order, dizziness moving in to the 
magnet (34%), scanner noise (33%) and dizziness moving out of the magnet 
(30%). 11% of subjects reported a metallic taste during the examination. Diz-
ziness during scanning was mentioned in a similar number of cases (14%), 
which was significantly  less frequent compared to dizziness while moving 
into or out from the magnet. This is an indication that both effects are likely 
to be caused by moving through the strong static magnetic field gradients, as 
also found in the previous studies (8, 9). Out of the 101 subjects included in 
this survey only two could not undergo the examination due to severe claus-
trophobia. One subject reported seeing light flashes during the first 10 mi-
nutes inside the scanner and one subject reported sensations of peripheral 
nerve stimulation. These remarks were reported in the additional comments 
section of the questionnaire and were not directly targeted as such. Of all 
cases, 78% were brain examinations, 9% knee examinations and 3% were 
examinations of the calf muscle, in 10% of the cases it was not possible to re-
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trieve retrospectively what body part was imaged. A statistical trend towards 
more remarks of dizziness was  reported by subjects that were head first in 
the scanner when they were moved outside the bore (χ2 test, p = 0.054). No 
other differences were found. Whether subjects were well informed prior 
and during the examination was answered with yes by almost all subjects 
(98% and 97%, respectively). The large majority of the participants rated the 
examination as pleasant or neutral, with only 3% of subjects rating the exa-
mination as unpleasant, 51% as neutral and 46% as pleasant. 
Table 1: Questionnaire
Did you experience dizziness when moving in the scanner?
Did you experience dizziness during scanning?
Did you experience dizziness when moving out the scanner?
Did you experience nausea during the examination?
Did you experience a metallic taste during the examination?
Was it too cold during the examination?
Was it too warm during the examination?
Were you feeling claustrophobic?
Did you suffer from the scanner noise?
Are there any additional comments?
What was your overall experience?
Were you informed well prior to the examination?
Were you informed well during the examination?
All questions were answered on the scale: yes, a little, no except for the last question (over-
all experience), which was rated: unpleasant, neutral, pleasant and the open question about 
additional comments.
discussion
The most important finding of this short survey is that 7 Tesla examinations 
in a hospital setting were tolerated well by healthy subjects. The most com-
mon experience was dizziness while moving inside the scanner bore, which 
was mentioned more frequently than previously reported at 1.5 Tesla (12), 
therefore it might be advantageous to inform subjects when they are being 
moved into the scanner of possible feelings of dizziness. In most cases diz-
ziness was reported to disappear rapidly once inside the scanner. It has been 
hypothesized that the dizziness during movement is induced by magnetic 
susceptibility differences between the vestibular organs and the surrounding 
 |  163suBjeCt toleranCe oF 7 tesla
fluid and induced currents acting directly on the vestibular hair cells (9). 
Figure 1: Results of the questions listed in table 1 in 101 subjects. 
The most mentioned unpleasant remarks were dizziness when moving in and out of the 
magnet and the amount of scanner noise.
In terms of direct comparison of the results of this survey compared to 
the two previous studies in Essen, there is a strong general agreement for 
many of the either neutral or negative effects. For example, in Theyson et 
al. (13) approximately 25% of the subjects scanned at 7 Tesla reported diz-
ziness during manual table movement, while our findings show slightly lar-
ger numbers (34% and 30% while moving in to and out from the scanner, 
respectively). More people reported a definite (rather than slight) sense of 
dizziness moving into the magnet as opposed to moving out, and this can 
be explained both by initial trepidation at the start of a scan as compared to 
a more relaxed feeling at the end of the scan in terms of heightened awa-
reness to possible side-effects. Because the table had to be moved manu-
ally at the time of this study by different operators, there were variations 
in table speed between subjects, resulting in corresponding differences in 
sensations of dizziness. The larger number of subjects reporting dizziness 
when moving out of the scanner when they were positioned head first in 
the scanner compared to feet first is likely to be caused by movement of the 
head through the highest magnetic field gradient. However it must be noted 
that the number exams performed outside the brain was very limited (12%). 
Scanner noise is also mentioned frequently as unpleasant, which for studies 
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of the head could be explained by the limited space available for noise pro-
tection. The small size of the receive head coil frequently prevented the use 
of head phones in addition to ear plugs. This was especially the case for 
subjects with larger head sizes. A metallic taste was reported by 11% of the 
subjects, which is more than twice as frequent as previously reported (13) 
and is thought to be induced by moving through the static magnetic field 
(8). In contrast to previous studies, the length of the examination was not 
mentioned specifically by any volunteer as being a problem. There can be 
several reasons explaining this difference. First, the subjects were explicitly 
told that the maximum scan duration allowed by our IRB was one hour. Se-
cond, throughout the examination the subject was told how long each scan 
would take (shortest ~1 minute, longest ~10 minutes), and asked after every 
scan if they were comfortable. Thus full information was available to the sub-
ject throughout the examination – in accordance with recommended clinical 
procedures. A potential bias in the subject recruitment can exist because it 
was not recorded whether subjects had undergone any previous MRI exami-
nations at lower field strengths, which can influence reported numbers on 
claustrophobia and other side effects.
Previous literature studies have focused on the effects of (moving through) 
the static magnetic field and have reported relatively mild effects in line with 
these findings. The most frequently mentioned effects are caused by moving 
through the magnetic field, similar to subjects being positioned in the scan-
ner bore in this study and include a metallic taste, dizziness or concentration 
problems (2, 8–10). However these studies did not include an actual MRI 
examination, which is likely to influence the overall perception of possible 
side effects.  Operating conditions, such as matching table speed to the po-
sition of the head within the magnetic field gradient (slowest speed through 
the highest gradient) could be adapted to minimize dizziness.
Overall the 7 Tesla MRI examinations were tolerated well, which is confirmed 
by only 3% of subjects rating the examination as unpleasant. Claustrophobia 
was only mentioned in a very small number of cases and resulted in only two 
subjects not being able to participate.
In conclusion, this report supports previous literature in showing that in 
general 7 Tesla MRI examinations are tolerated well. Very similar reactions 
were obtained from this current study in a clinical setting with a Philips 58 
cm bore diameter magnet as reported previously from a Siemens scanner of 
59.5 cm bore diameter. The similarities in two completely different settings, 
with different manufacturers, provide further evidence that patient accep-
tance of clinical 7 Tesla is not likely to be problematic. 
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The development of magnetic resonance imaging (MRI) systems with incre-
asing field strengths is driven by the promise of higher signal-to-noise ratios 
(SNR) resulting in imaging structures that could not be visualized before. Ho-
wever it is not trivial to obtain the improvements that can be theoretically 
expected. The transition from a conventional 3 Tesla MRI scanner to a re-
search 7 Tesla system creates intrinsic challenges, such as radiofrequency 
(RF) inhomogeneity, B0 inhomogeneity and increased tissue heating that can 
negate the expected improvements. In this thesis several new techniques 
have been developed and applied to 7 Tesla MRI to optimally benefit from 
the expected improvements in SNR, and contrast.
inTRinSiC ChallengeS oF 7 TeSla MRi
RF field inhomogeneities
Creating a highly homogeneous RF field (B1) is of great importance for many 
MR applications. In addition to the homogeneity it needs to be created with 
high efficiency to reduce the tissue induced heating. However this is not eas-
ily achieved. The short wavelength (approximately 11 cm in human tissue) 
and as a result deconstructive interference of the RF field (1) prohibits, or 
at least seriously limits the application of conventional RF coils (2, 3) used 
at lower field strengths. Almost all recently developed pulse sequences and 
system calibration sequences for 1.5 Tesla and 3 Tesla systems assume a ho-
mogeneous B1 field, therefore a simple translation of protocols will not work 
at 7 Tesla. There are two ways to mitigate these issues, the first is to develop 
different coils which are sufficiently homogeneous within a certain region-
of-interest (ROI), and the second approach is to develop sequences which 
are robust to variations in the B1-field. Since the introduction of 7 Tesla MRI 
systems a range of different coils has been developed. When the ROI is suffi-
ciently small, such as for imaging leg muscles, the eye lens, or even the heart 
or spine, a relatively simple local transmit-receive (Tx/Rx) coils can provide 
adequate coverage and homogeneity (4–7). This thesis has shown the devel-
opment of a local Tx/Rx coil for cardiac imaging, which was used to visual-
ize the lumen of the right coronary artery (8). For larger anatomies, or for 
improved homogeneity more sophisticated design is required using multiple 
independently driven RF coils simultaneously (B1-shimming) to create con-
structive addition of B1-fields (9–11), or using “traveling wave” antennas (12, 
13). Concurrently pulse sequences can be adapted to provide robustness 
for variations in the B1-field while staying within the specific absorption rate 
(SAR) limits for tissue heating. SAR intensive protocols involving turbo spin 
echo and fluid attenuated inversion recovery sequences have been adapted 
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to cope with these issues (14). For small targeted areas, such as in single 
voxel MRS the B1 field can be considered homogeneous, relatively indepen-
dent from the used coil configuration. This thesis has shown that a volume 
specific RF calibration can accurately establish the relation between RF am-
plifier power and generated B1 field in a small localized region, resulting in an 
increased SNR of single voxel spectra obtained in the calf muscle (6). 
Although the RF field inhomogeneities of 7 Tesla MRI will likely continue to 
be a challenge, several techniques, both in hardware and pulse sequences 
have been developed to overcome some of the issues.
Static magnetic field inhomogeneities
Inhomogeneities in the main magnetic field (B0) become increasingly larger 
for higher magnetic field strengths. These inhomogeneities can be separated 
into static distortions and dynamically fluctuating distortions. The former are 
created by transitions in magnetic susceptibility between different types of 
tissue and particularly by air cavities and produces on MR imaging local areas 
of deformation or signal drop out. The latter can create an overall degrada-
tion of image quality, especially for sensitive protocols, such as T2
*-weighted 
gradient echo sequences. Higher order shimming is used to counteract the 
static B0 inhomogeneities and is available on most 7 Tesla systems. Additional 
improvements in compensating for static inhomogeneities have been shown 
using slice specific shim settings, however this requires dedicated hardware 
(15). Correcting for dynamically fluctuating magnetic fields, which can sub-
stantially degrade image quality becomes increasingly important for long 
scan durations. These fluctuations can be introduced by breathing, coughing 
or involuntary body movements (16, 17). Solutions have been proposed that 
prospectively change the shim settings depending on the respiratory cycle 
(18), by the  additional placement of field probes (19, 20) or that retrospec-
tively correct the images using an additionally acquired navigator echo (17, 
21). Ultimately when the magnetic field distortions are known in real time it 
is possible to pro-, or retrospectively correct for the image artifacts, resulting 
in robust imaging. This thesis has shown that correcting for these artifacts is 
important for patient studies, which typically are more restless than healthy 
young volunteers. Similarly the frequent use of high resolution scans with a 
long scan duration lead to an increased chance of motion induced artifacts.
The (CliniCal) valUe oF 7 TeSla MRi: CURRenT STaTUS
Following the technical advancements and solutions to many of the initial 
problems, 7 Tesla MRI is gradually being used in a clinical setting. To date 
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the number of pure patient studies is still very limited. By far, the majority 
of studies have been performed in patients with neurological diseases, likely 
because the techniques for brain imaging are most developed. Patients with 
a variety of neurological disorders have been studied. To name a few, in pa-
tients with Multiple Sclerosis (MS) enhanced lesion detection and location of 
lesions was obtained (22–24). In patients suffering from Huntington’s disease 
(HD) single voxel MRS could be obtained from small brain structures, such as 
the caudate nucleus and putamen known to be affected by the disease. Due 
to the increased chemical shift and SNR accurate metabolite concentrations 
were obtained showing a decrease of NAA, creatine and glutamate levels 
in patients (25). The visualization of small arteries using time-of-flight (TOF) 
angiography benefits both from the higher SNR and from the increased back-
ground suppression of static tissue due to prolonged T1 relaxation times. This 
technique has been applied to visualize the small perforating lenticulostriate 
arteries in stroke, vascular dementia and in cerebral autosomal-dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) 
patients (26–28). Studies from this thesis have shown the applicability of 7 
Tesla MRI in patients with AD (chapters 5 and 8). Based on the phase ima-
ges from a high resolution T2
*-weighted sequence, which is very sensitive 
to changes in the magnetic field homogeneity differences were found bet-
ween patients and controls. This difference is ascribed to local increases in 
iron concentration co-localized with Amyloid-β, one of the hallmarks of the 
disease. This technique benefits from an increased contrast caused by the 
increased sensitivity to magnetic field inhomogeneities in addition to the 
higher SNR. 
Overall, more clinical studies are expected to be performed in the future, 
especially because subject tolerance for 7 Tesla examinations is high, as was 
shown in this thesis (chapter 10) and by others (29). Currently, 7 Tesla brain 
imaging is the most widely applied, for other anatomies of the human body 
it is still mainly an experimental system requiring more technical develop-
ment for use in a clinical environment. Some initial studies using 31P MRS in 
breast cancer or 23Na imaging in patients after cartilage repair surgery (30, 
31) have been performed, but numbers are very limited so far.
FUTURe diReCTionS and oUTlook
In the near future, 7 Tesla MRI is not likely going to replace lower field streng-
th MRI for a broad range of applications. The number of problems arising 
from the transition from 3 Tesla to 7 Tesla is more complicated than the pre-
vious transition from 1.5 Tesla. For many applications merely an increase in 
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SNR does not make up for much increased inhomogeneity, complexity and 
increased number of contra-indications (e.g. implants). Therefore research 
efforts need to focus on types of contrast that benefit from the higher mag-
netic field strength in addition to the higher SNR. The most promising ap-
plications, such as the detection of microbleeds, measuring disease related 
changes of iron in AD, single voxel MRS in small structures and native contrast 
angiography of small vessels all benefit from increased contrast in addition 
to SNR. In a more research setting is the potential for arterial spin labeling, 
or blood oxygen level dependent (BOLD) functional MRI.
Combining increased contrast with high resolution scans, often results in 
long scan durations making scans susceptible to subject induced artifacts. 
For the robust introduction of 7 Tesla MRI in clinical routine it is important 
to be able to correct for these artifacts. Proper subject fixation can be used 
to limit involuntary motion, however fluctuations of the magnetic field due 
to breathing, coughing or movement of other body parts is more difficult to 
avoid. A further complicating factor is that the amplitude of the magnetic 
field fluctuations scales with field strength. Navigator echo based measure-
ment and correction of these fluctuations has already shown to substantially 
improve image quality (this thesis). Some very promising approaches measu-
re real time field changes using magnetic field probes placed around the 
body or use multiple receive coil elements to sample the spatial distribution 
of the magnetic field (this thesis). In conjunction with the ability to prospec-
tively switch higher order gradient shim terms in real time, this would allow 
for highly robust imaging even for scans with long scan duration. On the lon-
ger term with adequate hardware to individually drive multiple RF coils and 
modified sequences, other anatomies are likely to benefit from similar im-
provements in contrast and resolution, ultimately leading to improved and 
earlier diagnosis.
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The aim of this thesis was to develop methods to enable the use of 7 Tesla 
MRI in clinical practice. Since the installation of the first whole body 7 Tesla 
magnet, less than 15 years ago, research in this field has seen a rapid incre-
ase, with over 40 human in vivo studies published in 2011 (PubMed). Howe-
ver to date, the number of clinical studies has been rather limited. One of 
the reasons is that translating existing techniques from lower field strengths 
to 7 Tesla is far from trivial in many cases. Intrinsic properties related to the 
high field, such as increased sensitivity to magnetic field inhomogeneities 
and reduced homogeneity of transmit and receive fields require specific se-
quence and hardware modifications. A simple translation of protocols from 
lower field strength to higher field is likely to deliver sub optimal results, or 
even worse results than obtained at lower field strengths.  In this thesis a 
number of technical developments have been performed to facilitate clinical 
studies and to achieve the full potential that high field has to offer in terms 
of increased signal-to-noise, contrast and spatial resolution. 
The first part describes techniques to improve MR applications in the heart 
and calf muscle. 
Chapter 2 describes the development of a local transmit-receive coil to facili-
tate cardiac imaging. Different coil configurations have been tested to achie-
ve a B1 transmit field without tissue induced signal voids, caused by des-
tructive B1 interference due to the small RF wavelength. Empirically different 
coils were optimized, using a single loop configuration and a quadrature dual 
loop configuration. It was shown that using a relatively simple quadrature 
local transmit-receive coil sufficient coverage to image a large part of the 
heart could be obtained without introducing any signal voids in this region. 
RF safety validations were performed to ensure imaging experiments stayed 
within specific absorption rate (SAR) limit. Several applications of this coil 
were shown to be feasible, including functional cine moving heart imaging 
and morphological imaging of the right coronary artery (RCA)
The coil and techniques described in the previous chapter are used in chap-
ter 3 to image the RCA and to compare the results with a similar protocol at 3 
Tesla. Ten healthy volunteers were included and images of the RCA were ob-
tained at 3 Tesla and at 7 Tesla, while keeping the protocols as comparable as 
possible. The following measurements were performed at both field streng-
ths to quantify the visualization of the coronary artery. Contrast-to-noise ra-
tio between blood and epicardial fat, signal-to-noise ratio of the blood pool, 
RCA vessel sharpness, diameter, and length; and navigator efficiency. Incre-
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ased vessel sharpness and signal-to-noise ratio were found at 7 Tesla. Overall 
in young healthy volunteers the image quality at 7 Tesla was equal or better 
than obtained at 3 Tesla.
In chapter 4 a new calibration method is introduced that measures the B1 
transmit field in a small region of interest. To achieve a certain flip angle the 
RF amplifier needs to be calibrated depending on location, coil positioning 
and subject size. Conventionally this is done over a large region, because 
at lower field strengths the flip angle can be considered constant to a high 
degree. At 7 Tesla this assumption does not hold, because of the smaller 
wavelength of the RF field and the frequent use of local intrinsically inhomo-
geneous transmit coils therefore a new calibration method was developed. 
Because this method needs to be performed before each scan, it should be 
very fast without user interaction. The method that was developed used the 
ratio of two stimulated echoes to derive the actual flip angle. The power set-
ting of the RF amplifier was subsequently iterated to reach the desired flip 
angle. Using this method an increased signal-to-noise ratio was obtained for 
localized spectroscopy scans acquired from the calf muscle compared to the 
conventional calibration method. The exact increase was dependent on the 
location with respect to the partial volume transmit-receive coil.  Generally 
increases were larger for regions where the local B1 field was more inhomo-
geneous.
The second part is concerned with technical developments for high resolu-
tion brain imaging.
In chapter 5 high resolution T2
*-weighted imaging is performed in Alzheim-
er’s disease (AD) patients. One of the hallmarks of this disease is the aggre-
gation of a protein (amyloid β) that is co-localized with iron. High resolution 
T2
*-weighted imaging is a promising technique to image these deposits espe-
cially at high magnetic field strengths. However the image quality was found 
to be severely reduced in AD patients compared to previously acquired imag-
es in healthy volunteers. It was hypothesized that the images were degraded 
due to dynamic fluctuations of the static magnetic field (B0 fluctuations). 
This was subsequently confirmed in healthy volunteers where comparable 
artifacts were observed when similar magnetic field fluctuations were syn-
thetically added to the acquisition. These B0 fluctuations are introduced by 
respiration and coughing, but also likely due to body movements not related 
to head motion. In addition, it was shown that the effect of typical transla-
tional and rotational head motion had a much smaller effect on the resulting 
image-quality. The T2
*-weighted sequence was modified to include a naviga-
tor echo to dynamically estimate magnetic field changes during image acqui-
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sition. Retrospectively this information was used in image reconstruction to 
substantially improve image quality in all cases enabling high quality imaging 
in AD patients.
An extension of this technique is described in chapter 6. Even after correc-
tion using the navigator echo technique, the images remained typically of lo-
wer quality than images obtained in healthy volunteers. It was hypothesized 
that the magnetic field fluctuations observed in AD patients had a spatial 
distribution within an acquired slice, whereas the previously proposed na-
vigator technique was capable of only measuring a global B0 offset in a slice 
for each RF excitation. In this chapter a sensitivity encoded (SENSE) navigator 
was introduced that samples the magnetic field using the 32 receive chan-
nels that were available.  Because each element sampled signal from a small 
location of the head only, a spatial estimation of the underlying magnetic 
field could be obtained by combining the navigator with separately acquired 
coil sensitivity profiles. This approach was extended to include a frequency 
readout gradient to improve the magnetic field estimation further. High re-
solution T2
*-weighted images were acquired in volunteers while they were 
intentionally touching their nose or taking deep breaths, to mimic the worst 
case magnetic field fluctuations seen in AD patients. It was found that the 
SENSE navigator technique could accurately estimate the induced B0-fluctu-
ations. In the second part of this chapter a reconstruction framework is in-
troduced that uses the spatially and dynamically fluctuating magnetic fields 
to retrospectively correct the images. The complexity of the reconstruction 
scales to the fourth power of the acquisition matrix, therefore an iterative 
solver was used based on conjugate gradient minimization to limit memory 
requirements and reconstruction times. Results show a much improved ima-
ge quality. The approach using the SENSE navigator including frequency en-
coding yielded optimal results. Future patient studies are needed to validate 
this technique in clinical practice.
The long scan duration of most high resolution T2
*-weighted sequences li-
mits whole brain coverage, in chapter 7 a new fast volumetric 3D echo pla-
nar imaging (EPI) protocol is introduced. By employing the high efficiency of 
EPI, typically used for fast low resolution functional brain imaging an impro-
ved SNR efficiency was obtained. The proposed sequence was compared to a 
conventional 3D T2
*-weighted protocol, with the same resolution, amount of 
T2
* weighting and scan duration. The spatial coverage of the EPI based proto-
col was a factor of 4.5 larger, while also the SNR was a factor of 2 increased. 
This effectively enabled whole brain acquisition of 0.5 mm isotropic resolu-
tion in less than 6 minutes of scanning time. The longer readout train in the 
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EPI protocol inevitably results in more spatial distortion and possibly areas of 
signal voids. However with the chosen parameters there were no apparent 
regions of signal voids and the distortion was less than 3 mm for the lowest 
slices. Due to magnetic field inhomogeneities these slices are most prone 
to distortion; the amount of distortion for the slices higher in the brain was 
therefore much less. The new sequence provides the necessary steps, such 
as resolution and coverage to utilize the high T2
* contrast of high field MRI.
The third part of the thesis is focused on the current clinical applications of 
7 Tesla MRI.
In chapter 8 T2
*-weighted imaging has been performed in AD patients to im-
age changes occurring in the cortex related to the deposition of Amyloid-β 
and iron. The phase of the complex MRI signal of a T2
*-weighted sequence is 
very sensitive to changes in iron deposition. Therefore T2
*-weighted images 
were acquired in 15 mild to moderate AD patients and 16 control subjects. 
Phase measurements were performed in the cortex of different regions of 
the brain and in the hippocampus. It was found that the phase shift between 
gray and white matter in the cortex was increased in AD patients and that 
these differences were strongly associated to the Mini Mental State Exami-
nation, which tests basic cognitive functions. No differences were found in 
the hippocampus phase values. Therefore the increased cortical phase val-
ues on T2
*-weighted images might provide a new biomarker that measures 
early changes related to amyloid pathology.
Chapter 9 reviews the current status of studies performed in patients with 
neurodegenerative diseases performed at 7 Tesla. Some of the technical 
challenges and solutions are discussed. Despite the limited number of purely 
clinical studies to date promising additional features in contrast can be ob-
tained that may assist in better diagnosis of these disorders. High field MRI 
allowed to visualize the lenticulostriate arteries with great detail in patients 
with cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL). In patients with AD and hippocampal scle-
rosis anatomical changes were observed using high resolution imaging. The 
increased contrast and resolution allowed visualizing the perivenous locati-
on of multiple sclerosis lesions and the frequent cortical involvement. Given 
the rapid progress over the last years it is expected that the contribution of 
7 Tesla MRI especially in the field of neurodegenerative diseases will incre-
ase over time. Many of the initial problems related to magnetic and RF field 
inhomogeneities and the lack of optimized sequences have been solved or 
improved.
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The acceptance of 7 Tesla MRI examinations by subjects is discussed in chap-
ter 10. In order to fulfill the promise of increased spatial resolution and in-
creased sensitivity for the identification of pathologies in the clinical setting, 
it is important to assess how well examinations are tolerated by subject and 
to identify potential adverse side effects. A total of 101 healthy subjects fil-
led out a post scan survey with questions related to potential sensations of 
discomfort, such as nausea, vertigo and scanner noise. The most frequent 
(34% of subjects) mentioned negative finding was dizziness while moving 
in the scanner, followed by scanner noise (33%) and dizziness moving out 
(30%), also a metallic taste was reported in about 1 in 10 cases. Although the 
sensations of discomfort are mentioned more frequently than at lower field 
strength, overall the examinations were tolerated very well. Only 3% of the 
subjects rated the examination as unpleasant. These results provide further 
evidence that 7 Tesla MRI would be accepted by patients as with lower field 
strength examinations.
conclusions
This thesis has shown that in order to fully benefit from the expected incre-
ase in signal-to-noise ratio and improved contrast of 7 Tesla specific sequen-
ce and hardware adaptations are necessary. Many standard techniques from 
lower field strength require to be redesigned taking into account the specific 
constraints of 7 Tesla MRI, such as inhomogeneous RF fields (chapters 2, 
3 and 4) and increased sensitivity to B0 artifacts (chapters 5 and 6). With 
proper adjustments it is possible to perform studies in almost all anatomies 
including difficult regions, such as the heart. The promises of 7 Tesla: higher 
SNR, resolution and faster scanning can be (partly) fulfilled. This has resulted 
in improved visualization of the right coronary artery, compared to 3 Tesla. 
With specific calibration sequences that take into account the inhomoge-
neous RF distribution the SNR of spectra obtained in the calf muscle could 
be improved.  The high magnetic field strength results in very high contrast 
of T2
*-weighted images; however the sensitivity to B0 fluctuations can de-
teriorate the image quality substantially when applied in patients, who are 
typically more restless than healthy subjects. A correction technique was de-
veloped to reduce these artifacts, which allowed imaging of Alzheimer’s di-
sease patients with high image quality (chapters 5, 6 and 8). Improvements 
in the efficiency of T2
*-weighted sequences resulted in whole brain acquisi-
tions within acceptable scanning times (chapter 7), which is of great impor-
tance for the clinical introduction. Over the years the number of studies has 
steadily increased, however there is still only a limited number of pure clini-
cal patient studies performed. The diagnostic added value of 7 Tesla MRI is 
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beginning to be demonstrated in patients with neurodegenerative diseases, 
which is also a large part of the patient studies performed so far (chapter 
9). The largest advances are mainly seen in increased resolution resulting in 
more accurate visualization of Multiple sclerosis lesions, or visualization of 
small vessels that were previously not visible at lower field strengths. Visu-
alization of microbleeds and changes in iron deposition, common to many 
neurodegenerative diseases, such as Alzheimer’s disease is improved due 
to both the increased resolution and the increased sensitivity to iron depo-
sition (chapters 8 and 9). The larger spectral separation of metabolites due 
to an increased chemical shift results in more accurate quantification of me-
tabolites in for example Huntington’s disease patients. Patient acceptance is 
of importance when 7 Tesla MRI is to be used in regular clinical practice, in 
healthy subjects the 7 Tesla examinations were tolerated very well (chapter 
10).
These initial findings combined with the fact that 7 Tesla examinations are 
well tolerated by subjects will likely result in more clinical examinations per-
formed at 7 Tesla. Due to some intrinsic issues (mainly B1 and B0) and the 
high cost, 7 Tesla MRI is not likely to replace all studies currently performed 
at lower field strength. Therefore it should probably not be considered to be 
a “one-stop-shop” technique; some applications are better served at lower 
field strength. High resolution brain imaging; especially combined with the 
increased sensitivity to the distribution of iron, or the ability to visualize very 
small arteries has already shown added value and could lead to new insight 
in early disease processes of neurodegenerative diseases. Future clinical re-
search should focus on these areas, which could improve patient outcome. 
For most other anatomies more technical developments are needed before 






Het doel van dit proefschrift was om methoden te ontwikkelen voor de 
klinische toepassing van 7 Tesla (T) magnetische resonantie beeldvorming 
(Magnetic Resonance Imaging, MRI). Ongeveer 15 jaar geleden is de eerste 
7 T scanner geïntroduceerd met een diameter die groot genoeg is voor 
het gehele menselijke lichaam. Sindsdien heeft er veel wetenschappelijk 
onderzoek met behulp van 7 T MRI plaatsgevonden. In 2011 zijn er meer 
dan 40 in vivo studies gepubliceerd (PubMed). Echter het aantal puur 
klinische studies is nog zeer beperkt. Een van de redenen is dat bestaande 
methoden die gebruikt worden op lagere veldsterktes niet gemakkelijk 
aan te passen zijn voor 7 T. Door verstoringen die direct gerelateerd zijn 
aan het hoge veld, zoals de toegenomen gevoeligheid voor magnetische 
veldinhomogeniteiten (B0) en de verminderde homogeniteit van de zend- 
en ontvangstvelden (B1) zijn er specifieke protocol en scanner aanpassingen 
nodig. Wanneer scan protocollen en technieken van een lagere veldsterkte 
zonder aanpassingen worden overgenomen zijn de behaalde resultaten 
meestal suboptimaal dan wel slechter. In dit proefschrift wordt een aantal 
technische ontwikkelingen beschreven om klinische studies mogelijk te 
maken en zo het volledige potentieel van hoog veld te benutten. Een 
aantal voordelen van 7 T MRI zijn de toegenomen signaal ruis verhouding, 
contrast en spatiële resolutie.
In het eerste deel worden technieken beschreven om de toepassing van 
MRI in het hart en de kuitspier te verbeteren.
Hoofdstuk 2 beschrijft de ontwikkeling van een lokale zend- en 
ontvangstspoel om beeldvorming van het hart mogelijk te maken. 
Verschillende spoelconfiguraties zijn onderzocht om een B1-zend veld te 
creëren zonder gebieden met destructieve interferentie. Deze interferenties 
worden veroorzaakt door de kortere radiofrequente (RF) golflengte 
bij een hoger magnetisch veld. Verschillende spoelen zijn empirisch 
geoptimaliseerd waaronder een enkele “loop” spoel en een kwadratuur 
dubbele loop spoel. Met een vrij eenvoudige kwadratuur spoel was het 
mogelijk om een voldoende groot gebied van het hart in beeld te brengen, 
zonder gebieden van destructieve interferentie. RF veiligheidsvalidaties zijn 
uitgevoerd om te zorgen dat de experimenten binnen de veiligheidsmarges 
vallen, de zogeheten Specific Absorption Rate (SAR). In dit hoofdstuk 
worden enkele toepassingen van deze kwadratuur spoel getoond, 
zoals beeldvorming van het bewegende hart (cine) en morfologisch 
beeldvorming van het rechter coronair vat (RCA).
De verschillende spoelen en technieken die in het vorige hoofdstuk zijn 
beschreven, worden gebruikt in hoofdstuk 3 om in studieverband de RCA 
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af te beelden. Tien gezonde vrijwilligers zijn middels een nagenoeg identiek 
protocol gescand met een 3 T en 7 T MRI scanner. Er zijn verschillende 
metingen uitgevoerd, onder andere is er gekeken naar de de verhouding 
tussen contrast en ruis van bloed en epi cardiaal vet, de signaal-ruis ratio 
van bloed, de vaatscherpte van de RCA als ook  de diameter, lengte en 
efficiëntie van de navigator bewegingscorrectie. De beelden vervaardigd  
op de 7 T MRI scan toonden een toegenomen vaatscherpte en signaal-ruis 
ratio ten opzichte van de op 3 T verkregen resultaten. 
In hoofdstuk 4 wordt een nieuwe kalibratiemethode geïntroduceerd die 
lokaal het zend B1-veld bepaalt. De RF versterker moet gekalibreerd worden 
om een bepaalde fliphoek die is gerelateerd aan het B1-veld, te verkrijgen. 
De waarde van de kalibratie hangt af van de locatie in het lichaam, de 
positie van de spoel en de lichaamsgrootte. Het is gebruikelijk bij lagere 
veldsterktes om de meting uit te voeren over een groot gebied, omdat 
voor deze veldsterktes de flip hoek als constant verondersteld kan worden 
binnen dit gebied. Voor 7 T gaat deze aanname niet meer goed op door 
de kortere golflengte van het RF veld en het frequente gebruik van lokale, 
intrinsiek inhomogene zendspoelen. De nieuwe kalibratiemethode die is 
ontwikkeld gebruikt de verhouding tussen twee signalen, zogenaamde 
gestimuleerde echo’s, om de flip hoek te bepalen in een klein zelf te 
bepalen gebied. Door een aantal iteraties met verschillende RF instellingen 
kon de juiste fliphoek gevonden worden. Om het effect van de methode 
aan te tonen is deze gebruikt voor gelokaliseerde spectroscopie scans van 
de kuitspier. Dit zijn scans die zeer gevoelig zijn voor een juiste bepaling van 
de fliphoek. Wanneer deze nieuwe methode werd gebruikt werd er een 
hogere signaal-ruis ratio gevonden, dan met de conventionele methode, 
wat aantoont dat de nieuwe methode tot een nauwkeurigere fliphoek 
bepaling leidt. De exacte toename was afhankelijk van de locatie van het 
meetgebied (voxel) in verhouding tot de zendspoel. Over het algemeen was 
de toename hoger voor gebieden waar het B1-veld minder homogeen was, 
op grotere afstand van de spoel.
Het tweede deel van dit proefschrift beschrijft technische ontwikkelingen 
voor hoge resolutie visualisatie van het brein.
In hoofdstuk 5 wordt T2
*-gewogen (een MRI contrast gevoelig voor 
veldverstoringen) beeldvorming beschreven in patiënten met de 
ziekte van Alzheimer (AD). Een van de kenmerken van deze ziekte is de 
opeenhoping van een eiwit (β-amyloïde) met ijzer. Hoge resolutie T2
*-
gewogen beeldvorming is een veelbelovende techniek om deze afzettingen 
te visualiseren. Echter de beeldkwaliteit was ernstig verslechterd wanneer 
deze techniek werd toegepast in AD patiënten vergeleken met beelden in 
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gezonde vrijwilligers. De hypothese was dat de afname in beeldkwaliteit 
veroorzaakt werd door fluctuaties in het statische magnetische veld 
(B0-fluctuaties). Dit werd bevestigd in beelden van gezonde vrijwilligers 
waar deze B0-fluctuaties kunstmatig aan toe werden gevoegd tijdens 
acquisitie, wat leidde tot vergelijkbare artefacten. De B0-fluctuaties 
worden veroorzaakt door ademhaling en hoesten, maar ook door 
lichaamsbewegingen die niet gerelateerd zijn aan bewegingen van het 
hoofd. Verder werd aangetoond dat typische hoofdbewegingen (translaties 
en rotaties) tijdens acquisitie, een veel kleiner effect op de beeldkwaliteit 
hadden dan B0-fluctuaties. Aan de T2
*-gewogen sequentie is een “navigator 
echo” toegevoegd, waarmee dynamisch de B0-fluctuaties gemeten konden 
worden tijdens acquisitie. Deze informatie kon achteraf gebruikt worden in 
de reconstructie om de beeldkwaliteit aanzienlijk te verbeteren. Hierdoor 
was het mogelijk om in AD patiënten een goede beeldkwaliteit te behalen.
Een uitbreiding van deze techniek wordt beschreven in hoofdstuk 6. Na 
correctie met de hiervoor beschreven navigator echo techniek waren de 
beelden nog altijd van een mindere kwaliteit dan in gezonde vrijwilligers. 
De hypothese was dat de magnetische veldfluctuaties die gemeten werden 
in AD patiënten een spatiële verdeling hadden. De eerder genoemde 
navigator echo correctie was in staat om alleen globale B0 afwijkingen in 
een enkele plak te meten en niet de mogelijke spatiële component. In dit 
hoofdstuk is een nieuwe navigator geïntroduceerd, de  “sensitivity encoded 
navigator (SENSE navigator) die het magnetische veld meet met behulp 
van de 32 ontvangst spoelen van de hoofdspoel. Omdat elk afzonderlijk 
element alleen signaal ontvangt van een klein gebied in het hoofd, is 
het mogelijk om hieruit de spatiële distributie van het magnetische 
veld af te leiden door deze metingen te combineren met apart gemeten 
spoelgevoeligheidsprofielen. Deze methode is verder uitgebreid met een 
frequentie-gecodeerde uitleesgradiënt, die de meting nog nauwkeuriger 
maakte. Hoge resolutie T2
*-gewogen opnames zijn gemaakt in gezonde 
vrijwilligers terwijl ze gevraagd waren hun neus aan te raken, of diep in 
en uit te ademen, om zo de gevonden veldverstoringen in patiënten na 
te bootsen. De SENSE navigator techniek was in staat om nauwkeurig 
de geïnduceerde B0-fluctuaties te meten. In het tweede deel van dit 
hoofdstuk wordt een reconstructie methode geïntroduceerd die de spatiële 
en dynamische magneetveld veranderingen gebruikt om de beelden te 
corrigeren. De complexiteit van de reconstructie schaalt met de vierde 
macht van de acquisitiematrix, daarom is er gekozen voor een iteratieve 
oplossing gebaseerd op de geconjugeerde gradiënt minimalisatie om zo 
het geheugengebruik en de reconstructie tijd te minimaliseren. Resultaten 
laten zien dat met deze methode de beeldkwaliteit sterk verbeterd 
kon worden. De aanpak die gebruik maakte van de SENSE navigator in 
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combinatie met de frequentie uitleescodering leverde de beste resultaten. 
Patientenstudies zijn de volgende stap om deze nieuwe techniek in de 
klinische praktijk te kunnen valideren en implementeren. 
De lange scan tijd van de meeste hoge resolutie T2
*-gewogen scans beperkt 
de toepassing om het hele brein af te beelden met deze techniek. 
In hoofdstuk 7 wordt een nieuw en snel 3D echo planar imaging (EPI) 
protocol geïntroduceerd. Deze techniek heeft een zeer hoge efficiëntie 
waardoor het mogelijk was om een hoge signaal-ruis efficiëntie te behalen. 
Normaal gesproken wordt deze techniek alleen gebruikt voor snelle lage 
resolutie functionele MR, omdat er mogelijk meer vervormingen kunnen 
optreden. Om dit te onderzoeken is de voorgestelde EPI sequentie 
vergeleken met een conventionele 3D T2
*-gewogen protocol met gelijke 
resolutie, T2
* weging en scantijd. Het spatiële bereik van het EPI protocol 
was een factor 4.5 groter dan het conventionele protocol en er werd 
een toename van een factor 2 in signaal-ruis ratio gemeten. Dit maakte 
het mogelijk om het hele brein af te beelden met een isotrope resolutie 
van 0.5 mm, in minder dan 6 minuten scantijd. De langere uitleestrein 
van het EPI protocol  zorgt onvermijdelijk voor meer  vervorming en 
mogelijke gebieden van signaaluitval. Echter met de gekozen parameters 
voor het protocol konden beide tot een minimum beperkt worden. De 
vervorming was minder dan 3 mm voor de laagste breinplakken. Omdat 
de magnetische veldstoring het grootst is in de laagste plakken,  zijn deze 
het meest gevoelig voor vervormingen, de vervormingen van andere hoger 
gelegen plakken is dan ook veel minder. De nieuwe sequentie levert de 
stappen die nodig zijn, zoals resolutie en scan bereik om optimaal gebruik 
te maken van het hoge T2
*-gewogen contrast van 7 T MRI.
Het derde deel van dit proefschrift is gericht op huidige klinische 
toepassingen van 7 T MRI.
Hoofdstuk 8 beschrijft beeldvorming in AD patiënten met als doel 
veranderingen in de cortex ten gevolge van de opeenhoping van 
β-Amyloïde en ijzer weer te geven. De fase van het complexe MRI signaal 
van een T2
*-gewogen sequentie is erg gevoelig voor veldverstoringen 
ten gevolge van onder andere toename van ijzerconcentratie. Er zijn 
T2
*-gewogen beelden geacquireerd in 15 mild tot matig aangedane AD 
patiënten en 16 gezonde controle personen. Fase metingen zijn uitgevoerd 
in de cortex van verschillende hersengebieden en in de hippocampus. Er 
werd een toename van het fase verschil gevonden tussen grijze en witte 
stof in de cortex van AD patiënten vergeleken met gezonde personen. 
Deze verschillen waren sterk geassocieerd met de “Mini Mental State 
Examination” (MMSE), een test voor de meest fundamentele cognitieve 
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functies. Geen verschillen werden gevonden in de hippocampus fase 
waarden. De toegenomen fase verschillen op T2
*-gewogen beelden zouden 
een nieuwe biomarker kunnen zijn om vroege veranderingen gerelateerd 
aan amyloïde pathologie te meten.  
In hoofdstuk 9 wordt de huidige status van klinische studies op 7 T 
met patiënten met neurodegeneratieve aandoeningen besproken. Een 
aantal van de technische uitdagingen en oplossingen wordt behandeld. 
Ondanks het beperkte aantal puur klinische studies tot nog toe, zijn er 
de volgende veelbelovende resultaten verkregen die mogelijk kunnen 
leiden tot een betere diagnose. Met 7 T MRI was het mogelijk om de 
lenticulostriate arteriën in groot detail te visualiseren in patiënten met 
CADASIL (cerebral autosomal dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy). Dit is nog niet eerder vertoond op een 
lagere veldsterkte. In AD patiënten en patiënten met hippocampus sclerose 
zijn anatomische veranderingen in de substructuren van de hippocampus 
gevonden door gebruik te maken van hoge resolutie beeldvorming. Het 
toegenomen contrast en de hoge resolutie maakten het mogelijk om de 
periveneuze locatie van multiple sclerose laesies in beeld te brengen als 
ook  de veel voorkomende corticale deelname van deze afwijkingen. Dit zijn 
slechts enkele voorbeelden, gezien de snelle vooruitgang van de afgelopen 
jaren is het te verwachten dat de bijdrage van 7 T MRI, vooral in het veld 
van neurodegeneratieve ziektes, zal toenemen. Veel van de aanvankelijke 
problemen gerelateerd aan bv. RF veld inhomogeniteiten en het gebrek aan 
geoptimaliseerde sequenties zijn reeds opgelost.
Hoe personen een 7 T MRI onderzoek beleven wordt beschreven in 
hoofdstuk 10. Om de belofte van een hogere spatiële resolutie en 
toegenomen gevoeligheid om ziektes te detecteren waar te maken, is het 
belangrijk te onderzoeken hoe 7 T onderzoeken worden verdragen en wat 
de mogelijke bijwerkingen zijn. In totaal hebben 101 gezonde personen 
die een 7 T onderzoek hadden ondergaan een vragenlijst ingevuld met 
vragen over mogelijke ongemakken, zoals misselijkheid, duizeligheid en 
lawaai van de scanner. Het meest genoemd (34% van de personen) was 
duizeligheid tijdens het inschuiven in de scanner, gevolgd door last van 
scanner lawaai (33%) en duizeligheid tijdens het uitschuiven uit de scanner 
(30%). Een metaalsmaak werd genoemd door ongeveer 1 van de 10 
personen. Ofschoon er vaker melding werd gemaakt van bij-effecten dan bij 
onderzoeken op een lagere veldsterkte noemde maar 3% van de personen 
het 7 T onderzoek onaangenaam. Deze resultaten zorgen voor verder 
bewijs dat 7 T MRI goed verdragen wordt door patiënten.
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conclusie
Dit proefschrift laat zien dat om volledig te profiteren van de verwachte 
toename in signaal-ruis ratio en toegenomen contrast, er specifieke 
sequentie en hardware aanpassingen nodig zijn. Veel van de standaard 
technieken, die op lagere veldsterktes gebruikt worden, vereisen 
aanpassingen om rekening te houden met specifieke randvoorwaarden 
van 7 T, zoals inhomogene RF velden (hoofdstuk 2,3 en 4) en toegenomen 
gevoeligheid voor B0 artefacten (hoofdstuk 5 en 6). Met de juiste 
aanpassingen is het mogelijk om studies uit te voeren in bijna alle 
anatomische structuren, waaronder ook lastige gebieden zoals het hart. De 
belofte van 7 T MRI: hogere signaal-ruis ratio, resolutie en sneller scannen 
kunnen (gedeeltelijk) waar worden gemaakt. Dit heeft geresulteerd in een 
verbeterde visualisatie van de rechter coronair arterie. Met behulp van 
specifieke kalibratie methodes die rekening houden met de inhomogene 
RF verdeling was het mogelijk om een hogere signaal-ruis ratio te behalen 
in MR spectra van de kuitspier. De hoge magnetische veldsterkte zorgt 
voor een zeer hoog contrast op T2
*-gewogen beelden, alleen neemt 
hiermee ook de gevoeligheid voor artefacten veroorzaakt door B0-
fluctuaties toe. In patiënten, die vaak minder goed stil kunnen liggen dan 
gemotiveerde ( zou je gemotiveerd ook zo noemen, alsof patienten niet 
gemotiveerd zijn) gezonde vrijwilligers, levert dit een sterke verslechtering 
van de beeldkwaliteit op. Een correctietechniek om deze artefacten te 
verminderen was ontwikkeld, waarmee het mogelijk werd om met hoge 
kwaliteit beelden op te nemen in AD patiënten (hoofdstuk 5,6 en 8). 
Verbeteringen in de efficiëntie van T2
*-gewogen sequenties resulteerden in 
beeldvorming van de gehele hersenen binnen een klinisch geaccepteerde 
scantijd. Dit is van groot belang voor de klinische introductie van 7 T MRI. 
De afgelopen jaren is het aantal 7 T studies voortdurend toegenomen, toch 
is er nog maar een klein aantal puur klinische studies. De diagnostische 
toegevoegde waarde van 7 T MRI begint zichtbaar te worden  in studies 
met patiënten met neurodegeneratieve aandoeningen. Het grootste 
aandeel van klinische studies tot nu toe onderzoekt dan ook patiënten 
met neurodegeneratieve aandoeningen. De hoge resolutie die te behalen 
is met 7 T MRI, heeft geleid tot een nauwkeurigere visualisatie van 
Multiple Sclerose afwijkingen en de weergave van kleine vaten die niet 
zichtbaar zijn op lagere veldsterktes. De visualisatie van microbloedingen 
en veranderingen van ijzer ophoping, beide veel voorkomend bij 
neurodegeneratieve aandoeningen, zoals de ziekte van Alzheimer, is 
verbeterd door de hogere resolutie en de hogere gevoeligheid voor ijzer 
(hoofdstuk 8 en 9). De grotere spectrale scheiding van metabolieten 
door de toegenomen “chemical shift” resulteert in een nauwkeurigere 
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kwantificatie van metabolieten in bijvoorbeeld de ziekte van Huntington. 
De 7 T MRI onderzoeken werden goed verdragen door gezonde vrijwilligers 
die deel hadden genomen aan een onderzoek (hoofdstuk 10), wat een 
belangrijk voor de klinische introductie.
Deze bevindingen uit de beginfase van 7 T MRI, gecombineerd met de hoge 
tolerantie van personen voor 7 T MRI onderzoeken, zal hoogstwaarschijnlijk 
leiden tot meer klinische toepassingen. Door een aantal van de inherente 
problemen (B1 en B0) en de hoge kosten zal 7 T MRI niet alle studies 
vervangen die op dit moment op lagere veldsterktes uitgevoerd worden. 
Sommige toepassingen lenen zich beter voor lagere veldsterktes, omdat 
de verwachte toegevoegde waarde niet opweegt tegen de toegenomen 
problemen. Hoge resolutie beeldvorming van het brein en dan vooral 
gecombineerd met de hoge gevoeligheid voor ijzer concentraties, of 
de mogelijkheid om zeer kleine vaten in beeld te brengen hebben al 
toegevoegde waarde laten zien. Op termijn kan dit leiden tot betere 
inzichten in vroege ziekteprocessen van onder andere neurodegeneratieve 
aandoeningen. Verder klinisch onderzoek zou zich moeten richten op deze 
reeds veelbelovende toepassingen, die mogelijk zullen leiden to een vroege 
en betrouwbare klinische diagnose. Voor de meeste andere anatomische 
gebieden is er nog meer technische ontwikkeling nodig om volledig te 
kunnen profiteren van 7 T MRI.
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